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Foreword

We present here a selection of empirical conclusions, or
findings, from the body of family planning research that
has accumulated over the last two decades. Twelve topics of current interest are reviewed, as a sequel to three
similar publications* issued in 1971,1972, and 1974.
A "Findings" document compresses what has been
learned into straightforward declarative statements, giving summary evidence to support each statement. In
cases where a conclusion is quite well founded, with extensive supporting evidence, only illustrative or summary references are needed. In other cases citations are
required for individual studies. Generalizations that are
unsupported or too ambiguous to permit a definite statement do not qualify for inclusion. Methodology and
theory are not the primary concern; the focus is on research results that merit particular attention.
Thus, we have identified reasonably solid conclusions, arranged them in this compact format, and listed
the important evidence. The decision as to what does and
does not constitute a finding is necessarily judgmental.
Moreover, not all of the findings reported here are substantiated to the same degree; some are especially tenuous, and many will change as additional evidence appears. Much of the evidence is uneven, and many
findings are derived from studies in only a few locations,
so readers should generalize only with caution.
Twenty years ago the first "Findings" report was introduced, for reasons that remain true today. As new
workers enter the field they encounter an oral tradition
consisting of mixed opinions, prejudices, and information. Lacking a concise compilation of empirical results,
the newcomer faces a plethora of material of varying
quality, too much ever to be fully absorbed. Furthermore,
conclusions that seemed certain a few years ago have
undergone a shifting base of support as past studies have
been forgotten, rejected, and supplanted. It has seemed
important, therefore, to establish a record outlining evidence that indeed underlies each finding, with identification of which country or region it comes from. With
time, this record should evolve, and then the current
compilation will serve as a point of departure for restatement.

The 12 chapters fall naturally into four groups. The
first two chapters, Prevalence of Contraceptive Use and
Fertility Patterns, and Large-Scale Family Planning Programs, give an overall view of the massive changes that
have occurred in reproductive behavior and in the organized programs designed to service and encourage them.
The next four chapters follow naturally, to present approaches taken by the programs: Community-Based Distribution; Contraceptive Social Marketing; Postpartum
Programs; and Charges and Payments. These chapters
deal with prominent features in the extension of services
to different publics. The matter of charges, and cost recovery in general, has received increasing attention and
is an issue for the first three types of programs. All four
chapters concern program approaches for which considerable experience has accumulated and extensive data
are available. The next three chapters, Contraceptive Continuation and Effectiveness; Sterilization; and Induced
Abortion, relate to specific birth-control methods. Contraception, including sterilization, has produced most of
the historic fertility decline throughout the developing
world, but all contraceptive methods carry some risk of
failure, and abortion is often used as a back-up method
or, more often, as a separate recourse. Septic abortion is
a leading public health problem, one that is responsible
for a large percentage of maternal deaths in the developing world. The final three chapters, Contraception,
Fertility Patterns, and Infant/Child Mortality; Contraceptive Use and Maternal Morbidity/Mortality; and Contraceptive Use and Health, pertain to the health advantages of contraceptive methods, as well as to the risks
they may carry.
Numerous topics are necessarily omitted as separate
chapters, either because they are of less current interest
or because they lack a solid body of empirical evidence
that permits clear conclusions. Many of these are of considerable importance, and some are treated partially
within the various chapters. As studies accumulate more
can be said about some, though probably not all, of the
following: the role of men; program approaches adapted
to unmet needs of various types; the cost-effectiveness
of program variations; mass media approaches; the rela-

' The three publications are: Forrest, J. E. 1971. "Postpartum services in family planning: Findings to date." Reports on Population/Family Planning
No. 8, July 1971; Ross, J. A., A. Germain, J. E. Forrest, and J. Van Ginneken. 1972. "Findings from family planning research." Reports on Population/
Family Planning No. 12, October 1972; and Marckwardt, A. M. 1974. "Findings from family planning research: Latin American supplement."
Reports on Population/Family Planning No. 12, June 1974.

live importance of different components of the quality
of programs; strategies that combine family planning and
health offerings; the effects of ideological positions, including religious ones, on family planning or the use of
particular methods; contraceptive use among the young
and unmarried; and the role of condoms which, though
little used in the developing world, have gained prominence for their relation to AIDS prevention.
During the three-year gestation of this book, colleagues both at the Population Council and elsewhere
have generously critiqued parts or all of the manuscript.
We thank each one, and exempt all from the shortcomings that surely remain. Helpful suggestions, many of
them extensive, were made by: John Bongaarts, Rodolfo
Bulatao, George Cernada, John Cleland, James Foreit,
Tomas Frejka, Martin Gorosh, Barbara Ibrahim, Stephen

vi

Isaacs, Cynthia Lloyd, W. Parker Mauldin, Barbara
Mensch, Vincent Miller, Axel Mundigo, Naomi Rutenberg, Irving Sivin, John Stover, John Townsend, Ricardo
Vernon, Mary Beth Weinberger, and Beverly Winikoff.
We express special appreciation to Nina Schwalbe for
management of the many drafts of the manuscript and for
improvements to the technical quality of numerous sections.
We are grateful to Julie Reich for her insightful editing of
these rather unusual materials, and to Sue Rosenthal and
Suzanne Antonelli for final manuscript preparation. Our
thanks go also to Susan Rowe and Lauren Lam for the exceptional quality of their secretarial assistance.
Partial funding for the project was provided by the
United Nations Population Fund and by the Rockefeller
Foundation; without this assistance the volume could not
have appeared in its present form.

Chapter 1

PREVALENCE OF CONTRACEPTIVE USE
AND FERTILITY PATTERNS
A transformation in contraceptive use comes from
changed individual behavior, but it also reflects societal
changes. These include new norms, a new climate of public opinion, and new infrastructures for services and supplies. Profound modifications in reproductive processes
occur, which produce smaller family sizes and lower fertility rates. However, these changes move unevenly
through the society, and they have moved quite unevenly through the developing world as a whole.

PREVALENCE
1.

Over the last 25 to 30 years, contraceptive use has
risen from about 10 percent to about 50 percent of
all couples in the developing world (United Nations, 1989). Over the same period the total fertility rate (TFR) has fallen from 6.1 to 3.9 births per
woman (United Nations, 1991). These changes constitute a profound transformation of childbearing
patterns (see Figures 1 and 2).
l.a. However, geographic patterns vary. Among the
10 largest developing countries, two have high
prevalence levels, of 60 percent or more couples using a method: China (72 percent) and Brazil (66 percent). Five countries have intermediate levels of use,
at about 35-55 percent: Mexico (53 percent), Indonesia (49 percent), India (43 percent), Bangladesh (39
percent), Vietnam (53 percent), and the Philippines (34
percent). Two others are at about 10 percent: Pakistan
(12 percent) and Nigeria (8 percent). Certain other
countries of substantial size also have very low levels of contraceptive use, probably below 10 percent:
These include Sudan, Zaire, Ethiopia, and Myanmar
(Ross et al., 1992; Mauldin and Segal, 1988).
l.b. Most countries have low levels of contraceptive
prevalence, but most people live in countries with
moderate to high prevalence.
Figure 3 gives the distribution of 107 countries
by level of contraceptive prevalence. As it shows, almost half (48 percent) of all countries are below 30
percent prevalence, and more than two-thirds (68
percent) are below 50 percent prevalence. On the
other hand, low-prevalence countries are generally

the smaller ones, and most people (80 percent) live
in countries where prevalence is above 30 percent.
I.e. Sustained increases in prevalence, exceeding two
percentage points per year over 10-11 years, have
been registered in seven countries (bringing levels
up to 48-72 percent using, depending upon the country). (All prevalence levels were measured between
two or more national surveys.) The seven countries
are: El Salvador, Mexico, Colombia, Hong Kong,
South Korea, Indonesia, and Sri Lanka. Two other
countries have experienced similar increases over a
period of 5-7 years. They are Morocco and Tunisia,
whose contraceptive prevalence levels have risen to
36 and 41 percent, respectively. The most rapid pace
registered, a 3.1 percentage point gain per year over
10 years from 1975 to 1985, occurred in South Korea
(United Nations, 1989, Table 4.) The path of increase
in prevalence for numerous countries appears in
Figure 4.
l.d. The geographic pattern of the TFR is also uneven: The regional differences parallel those for contraceptive use. The TFR, which was high and uniform across regions in the early 1960s, is now quite
uneven. Only East Asia's is near replacement, at 2.4.
Other regions' TFRs are higher: Latin America's is
3.6, South Asia's is 4.4, the Middle East/North
Africa's is 5.1, and sub-Saharan Africa's is still 6.6,
nearly the same as in 1960-65.
I.e. Even for the largest countries, the picture is
mixed. While prevalence is already high in China
and Brazil, other large countries have room for further increases. Remarkably, India alone contains 26
percent of all the new contraceptors needed to reach
replacement fertility in the developing world, whereas the next few countries contain fewer than 8 percent each (Table 1).
l.f. As some countries approach ceiling levels of
prevalence (about 75 percent), future increases must
come progressively more from countries with lower
prevalence levels, less favored social settings, and
weaker family planning programs. These factors may
retard the pace of increases in prevalence.
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Figure 1 Contraceptive prevalence trends in the
developing world, by region

level. But the population will grow by 30 percent
from 1987 to the year 2000, requiring an additional
114 million users, or 168 million users altogether, to
meet the projections.
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The fertility level corresponds closely to the proportion of couples using contraception. Figure 5
shows the pattern across both developing and developed countries. Most countries lie within a narrow band of one child on either side of the line.
Thus, for general purposes, changes in contraceptive prevalence and fertility can be related: A 15-point
increase hi contraceptive prevalence implies that the
total fertility rate may fall by about one child.

Prevalence by Method
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Source: Population Council Databank, 1993.

l.g. Furthermore, if prevalence is to continue to rise,
use rates must increase enough to more than compensate for increasing numbers of women entering
the childbearing ages. For example, to meet the
United Nations medium fertility projections for the
year 2000 would require 54 million more users if the
base population of couples remained at its present

3.

Three contraceptive methods, sterilization, the pill,
and the IUD, account for 81 percent of all contraceptive use in the developing world.
3.a. The remainder is due to use of the condom (6
percent) and various traditional methods (11 percent). The injectable accounts for only 2 percent of
all users (Table 2), although its use appears to be increasing in certain countries.
3.b. Sterilization is used by 44 percent of all couples
who currently practice contraception. This percent-

Figure 2 Fertility trends in the developing world, by region
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Source: United Nations, 1991.
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East Asia

Latin America

South Asia

Middle East and
North Africa
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Figure 3 Developing countries distributed by level of
contraceptive prevalence

4.

No. of countries
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4.a. China is exceptional in the prominent role played
by the IUD: 30 percent of couples (42 percent of users) rely on it, compared to only 11 percent of users in
all other LDCs. China is also unusual regarding sterilization: 36 percent of couples (50 percent of users) rely
on it, and 22 percent of those currently using sterilization are men. Further, the large province of
Sichuan, where the new "no scalpel" vasectomy technique was developed, accounts for one-sixth (17 percent) of all male sterilizations in the country (see Sterilization chapter). In Sichuan province, in 1984, 71
percent of new sterilizations were for men, vs. 20 percent for all China (Ross, 1991; Ross et al., 1992).
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4.b.In the two most populous regions, East Asia
(mainly China) and South Asia (largely India), half
of all users currently rely upon sterilization (Table 2).
These two regions differ in other respects, however;
only 11 percent of users in South Asia (vs. 40 percent in East Asia) use the IUD; 15 percent (vs. 5 percent) use the hormonal methods of the pill and
injectables; and 17 percent (vs. 3 percent) use such
"other" methods as the condom, rhythm, and withdrawal.

Source: Population Council Databank, 1993.

age reflects a gradual build-up over the past, since
only small proportions undergo sterilization in any
given year. That is, sterilization's acceptance rate is
low but its continuation rate is high. Moreover, some
build-up is due to the young ages of some adopters,
as well as to the long history of the method's availability in certain countries (see Sterilization chapter).
3.c. The reverse applies to the pill: It has a high acceptance rate but a rather low continuation rate; consequently, its prevalence depends heavily upon those
choosing it recently. The IUD is intermediate between the pill and sterilization in this respect.
A pattern of low continuation applies to all resupply methods and to all traditional or coitus-related methods, such as rhythm and withdrawal
(which also have the highest failure rates).
3.d. The method mix for annual adoptions of contraceptives differs greatly from that for the full body of
all current users. Sterilization and the IUD account
for only 10 percent and 21 percent, respectively, of
each year's adoptions; on the other hand they account for about three-fourths of all current users, due
to their accumulation over the years. Resupply methods (the pill, injectables, and condoms) do not accumulate, and they account for a full 69 percent of the
clients seen each year (traditional methods excluded;
see United Nations Population Fund, 1991, Tables
III.2 and III.4).

Countries and regions vary widely in their method
mixes and in the number of methods they make
available. Those that offer several method choices
have medium to high levels of contraceptive prevalence; others have lower levels (Jain, 1989; Lapham
and Mauldin, 1985).

Table 1 Differences between number of contraceptive users
and number needed for replacement fertility
*MWRA
1990
(000)

75% of
MWRA
<000)

# users
1990
(000)

Difference
(000)

%distribut ion of
differences

India
144,091
Nigeria
18,001
Pakistan
18,816
Bangladesh
22.041
Indonesia
33,026
Ethiopia
8,495
Iran
9,053
Zaire
6,457
Tanzania
4,739
Uganda
4,506
Egypt
8,982
Sudan
4,280
Mexico
14,682
Philippines
9,290
Afghanistan
3.148
Nepal
3.771
Kenya
4,313
Ghana
3,259
Mozambique
2,699
Vietnam
10,030

63,400
13,501
14,112
16,531
24,770
6,371
6,789
4,843
3,554
3,379
6,736
3,210
11,012
6,968
2,361
2,828
3,235
2,444
2,025
7,522

108,068
1,315
2,239
7,262
17,249
323
2,786
917
142
221
3,666
145
8,507
4,541
50
684
1,224
437
27
5,655

44,668
12,186
1 1 ,873
9,269
7,521
6,049
4,004
3,926
3,412
3,159
3,070
3,064
2,505
2,427
2,311
2,144
2,011
2,007
1,998
1,867

25.9
7.1
6.9
5.4
4.4
3.5
2.3
2.3
2.0
1.8
1.8
1.8
1.5
1.4
1.3
1.2
1.2
1.2
1.2
1.1

Country
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.

83 other countries
Total

—

—

—

—

24.7

—

—

—

—

100.0

Source: Ross eta!., 1992.
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Figure 4 Trends in the percentage of married women of childbearing age currently using contraception, developing regions
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1990

Figure 4 (continued)
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Figure 5 Contraceptive prevalence and total fertility rate, developing and developed countries, 1993
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Source: Population Council Databank; 1993.

5.

4.c. The Latin American method mix is similar to that
of South Asia, except that there is less sterilization use
and more pill use. The other two regions are quite dif
ferent: In sub-Saharan Africa and North Africa/Middle
East the overall proportion of couples using contracep
tion is much smaller and those who do use rely more
heavily upon traditional and folk methods ("Other" in
Table 2) than do people in other regions.

reported in national surveys. They exclude vaginals
and condoms, which are classified under "modern
methods"; the issue of their labelling as either tradi
tional or modern is a minor one anyway, since use
of vaginals is minimal, never exceeding 2 percent of
couples in 62 of 66 countries surveyed, and use of
condoms never exceeds 5 percent of couples in 56 of
the 66 countries surveyed (Ross et al., 1992).

Historically, as the overall prevalence of contracep
tive use has grown, it has done so through modern
methods, which have outpaced or replaced growth
in use of traditional methods.1

S.b.In the developing world (Table 2), only 11 per
cent of all contraceptive users rely upon traditional
methods. This percentage is low partly because most
users are in countries where traditional methods play
a minor role, as in China and India. In two regions,
sub-Saharan Africa and the Middle East/North Af
rica, traditional methods have a higher share of us
ers, at 31-37 percent, but total use is low there. As a
percentage of all couples, rather than users, tradi-

5.a. Traditional methods are rather little used in the
developing world as a whole. They involve no resupply, since they include withdrawal, rhythm, ab
stinence for contraceptive intent, and "other," all as

Table 2 Percentage distribution and number (in OOOs) of contraceptive users, by method, according to region, 1990

Mothod
Sterilization
Female
Male
Pill
InjectaWe
IUD
Condom
Other
Total

Sub-Saharan
Africa

Middle East/
North Africa

%

(N)

%

(N)

%

(N)

%

(N)

%

(N)

%

(N)

10
10
0
27
13
9
4
37

1,083
1,078
5
2,830
1.328
983
397
3,901

5
5
0
33
1
23
7
31

775
761
14
5,191
100
3,613
1,136
4,845

49
38
11
5
0
40
4
3

88,429
69,054
19,466
9,034
582
71 ,258
6,311
4,751

49
37
11
11

36

17

63,154
48,618
14,578
14,869
5,040
13,702
11,905
21,641

4
18

100

10,521

15,860
1 5,394
467
12,663
885
4,740
1,860
8,024

100

44
35
9
12
2
25
6
11

1 69,301
134,904
34,529
44,587
7,934
94,296
21,609
43,163

15,661

100

180,365

100

130.310

100

44,033

100

380,890

Source: Mauldin and Ross, 1992, p.7.
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East Asia

Latin
America

South Asia

4
11

9

35
1
29
2
11

Total

Table 3 Percent of MWRA using traditional methods over time,
by region, for selected countries
Region

% using traditional methods

Latin America
Bolivia
Cobmbia
Costa Rica
Ecuador
Paraguay
Peru
Asia

Malaysia

Philippines
Sri Lanka
Middle East/North Africa
Turkey

15-18
11-13
9-12
9-12

13-16
24-24

10-31
15-23
22-25
29-34

Note: No relevant cases in sub-Saharan Africa.
Comment: No time trend is available for Vietnam, but in its 1988 survey, 15 percent
of couples were using traditional methods. In South Korea, Taiwan, and Hong Kong,
traditional method use appears to have been falling, to below 10 percent of couples.
Source: Population Council Databank, 1993.

tional methods in those two regions fall below 10 per
cent in all 30 countries surveyed, except Mauritius,
Lebanon, and Turkey (Ross et al., 1992, Table 8).
5.c. The same pattern, of rather low use of traditional
methods, holds in the other two regions: It exceeds
10 percent of couples in only four of 15 Asian coun
tries and in only seven of 21 Latin American coun
tries. For the whole developing world use of tradi
tional methods falls below the 10 percent level in 52
of 66 countries with national surveys; only 14 coun
tries fall at or above it. For 10 of these 14, time trends
are available, as follows.
5.d. Time trends: Traditional methods have remained
important over time in certain countries, when
judged as a percent of all couples using them. Table 3
provides figures for countries with multiple surveys,
where the latest survey gives 10 percent or more us
ing. Most ranges apply to periods in the 1980s.

Prevalence by Personal Characteristics
6.

The prevalence of contraceptive use is uneven
across subgroups; it has increased in certain sub
groups that were historically slow to adopt a
method.
6.a. Prevalence is typically highest in the middle
range of age and parity (Robey et al., 1992). Interest
in contraception builds after the first and second
child arrive and as the couple ages. After rising to a
peak, it declines as secondary sterility sets in. Lower
prevalence among older women can also reflect his
torical factors, as their attitudes were formed dur
ing more conservative times. Lower prevalence at the

upper parities may also reflect the age factor; more
over, high parity is itself a result of low contracep
tive use over the years.
6.b. The age distributions for the three principal con
traceptive methods are quite similar in shape, and
they overlap greatly. By mean age, sterilization us
ers are oldest, then IUD users, and then pill users;
however, the means conceal the very large overlaps
in the three distributions (Population Council unpub
lished tabulations from national sample surveys).
6.c. Time trends show a nearly universal downward
movement in the average age and parity of contra
ceptive users. Younger couples, with fewer children,
have adopted contraception at a faster pace than
have other subgroups (Ross et al., 1988; Ross, 1979).
In all age groups the percentage using a method has
risen; among young couples this has been encour
aged by declines in desired family size.
6.d. The education pattern for contraceptive use is
consistent across countries: Use rises regularly with
education level (Weinberger, 1991). This is not nec
essarily true, however, for each contraceptive meth
od; for example, patterns of sterilization by educa
tion are quite inconsistent across countries.
6.e. Differences in prevalence by education level tend
to persist as overall prevalence rises. A comparison
of WFS and DHS surveys done in the same 15 coun
tries, roughly 10 years apart, shows rising use levels
in all groups, but with a persistent education gap.
Average WFS levels were 16 percent using among
the uneducated and 48 percent using among those
with 10 or more years of schooling. Later, in the DHS
surveys, these figures rose to 31 and 58 percent, re
ducing the gap only from 32 to 27 percent.
However, the gap appears to diminish consid
erably in countries where prevalence rises to a high
level, as in Thailand. In such cases, a contraceptive satu
ration point is reached among the highly educated, and
the less educated groups move to catch up.
6.f. Paradoxically, while use is greater among the
better educated, the less educated groups have been
chiefly responsible for the historic increases in na
tional prevalence levels. Their large numbers control
both the level and the trend of the overall prevalence
figures. (Note that younger couples tend to be bet
ter educated, which partly explains their relatively
rapid uptake of contraception.)
6.g. By residence, contraceptive use is nearly always
greater among urban than rural populations. Over
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time, use has risen almost evenly in both urban and
rural sectors; thus, in many countries the gap be
tween them has not yet narrowed. The comparison
of WFS and DHS surveys for the same 15 countries
as for education shows mean rural prevalence at 20
percent and urban at 36 percent in the WFS series.
The subsequent DHS values were 36 percent for ru
ral areas (the same as in the urban sector 10 years
earlier) and 51 percent in urban areas, thus preserv
ing the same differential as before (Weinberger,
1991). However, as with education, residential dif
ferences probably narrow when use among urban
residents stabilizes at a high (saturation) level and
use among the rural sector continues to rise.
7.

A contraceptive method that sets in motion a wide
spread delivery system will change the method mix.
7.a. Use of the pill increased sharply in Thailand
when medical authorities recognized that the method
lent itself to distribution throughout the rural sector
by means of auxiliary nurse midwives already sta
tioned there (see CBD chapter).
7.b. The pill and condom can be delivered by unpaid
village workers, permitting the creation of commu
nity-based programs that have vastly expanded use
(especially of the pill) in numerous countries. In In
donesia the pill is delivered to roughly 35,000-50,000
service points (see CBD chapter).

FERTILITY TRENDS
As noted above and in Figure 2, fertility trends have been
sharply downward in the developing world as a whole.
This section provides details and describes geographic
disparities in that overall picture.
8.

Total fertility rates have declined sharply in the re
gions of Asia and Latin America, but rather little
in Africa (Figure 6).
8.a. Using the UN regional definitions, Northern and
Southern Africa are culturally distinct, but both have
experienced appreciable fertility declines. However,
in Middle Africa and Western Africa, no change in
fertility levels is visible (see Figure 6) between 196570 and 1985-90, and the fall is merely .13 of a child
in sub-Saharan Africa as a whole. Nevertheless, DHS
survey reports indicate that declines have apparently
begun in Botswana, Kenya, and Zimbabwe, and per
haps in part of Nigeria.
8.b. The largest subregional declines have occurred
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in East and Southeast Asia, as well as in the Carib
bean and Central America.
9.

Since the mid 1960s, fertility has declined by over
25 percent in 17 of 43 developing countries, of
which 19 are in Asia and the Pacific, 17 in Latin
America, and 7 in Africa.
9.a. The total population of the seven African coun
tries2 with these substantial fertility declines is rela
tively small, about 133 million people; the bulk of
sub-Saharan Africa has shown little decline. In Latin
America, however, the population of countries with
large fertility declines and countries with already low
fertility (Argentina and Uruguay) totals more than
400 million, or about 93 percent of the population of
Latin America. In Asia, 11 countries have had fertil
ity declines of 40 percent or more, and declines of at
least 25 percent have occurred in the countries there
with populations over 100 million, with the excep
tion of Pakistan (China, India, Indonesia; also Bang
ladesh, with a 24 percent decline). Countries with
declines of 25 percent or more total over 2.5 billion
people, or 84 percent of the Asia total (75 percent out
side of China) (United Nations, 1991).
9.b. The 14 countries with populations of 45 million
or more experienced, in the aggregate, a decline in the
TFR of 40 percent over some 15 to 20 years (late 1960s
to early or late 1980s) (Table 4). These countries contain
78 percent of the total developing world, including
China; without China the decline was 27 percent rather
than 40 percent. These two declines represent 62 and
41 percent (with and without China) of the movement
to replacement fertility (TFR of 2.1).

10. For LDCs as a whole, the pace of decline dimin
ished in the last two five-year periods,3 as it did
overall in Latin America and in Asia (see Figure 6).
lO.a. The pace of decline was irregular in subregions,
especially in Asia (note that East Asia, with China,
Japan, and South Korea, had reached a near mini
mum fertility level by the 1980s and could hardly
fall much further).
lO.b. Thus, the fall in the TFR diminished through
1980-85, and remained slow in 1985-90 for all LDCs,
for all Latin America, and for all Asia. For subregions
the decline in the TFR persisted only in Northern and
Southern Africa, in the three Latin American subre
gions, and in three Asian subregions, again an irregu
lar pattern. Note that the TFR in East Asia, with
China, was already rather low and could not easily
fall further.

Figure 6 Trends in total fertility rates, developing regions and subregions
All LDCs

TFR

7.1

Africa

TFR

6.1
5.1
4.1
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3.1

-

2.1
1965-70

1970-75
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Sub-Saharan

1980-85
•&—

All Africa

1985-90

2.1
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3.1

1985-90

Asia

Eastern

Southern

Latin America

Western

All sub-Saharan

Middle

Northern

All LDCs

Asia

TFR

1980-85

1975-80
Year

Latin America

TFR

-

2.1
1965-70

1970-75

1975-80
Year

1980-85

—•—

Western

—&—

All Asia

— ®—

Southern

—D—

Eastern

— A—

South East

1985-90

1965-70

1970-75

1975-80
Year

1980-85

—•—

Central America

A

—®—

All Latin America

— >£—

1985-90

South America
Caribbean

Source: United Nations, 1991.

11. Declines are less marked when the TFR is corrected
for infant and child survival, and for age structures
that support high crude birth rates.
ll.a. The TFR refers strictly to live births; many newborns die shortly thereafter. Because fewer newborns
have been dying in recent years, the actual number
of surviving entries to the child population has not

declined as much as births have. These softer declines
are displayed in Figure 7, which shows the TFR de
cline along with a second line, for the net reproduc
tion rate, which corrects for survival.4 The decline
for surviving children is not as impressive as the de
cline for births; the survival line is 19 percent higher
(63/53) by the end of the period shown. Through
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11.b. The crude birth rate (not shown) also declines
less than the TFR; by 2000-2005 it is also projected
to fall to only 63 percent of its 1965-1970 value. Be
cause the CBR is based upon the total population,
present age structures, which will persist for some
decades, will tend to sustain high birth rates and
large absolute numbers of births.

Table 4 Among countries with populations of 45 million or more
in 1985, total fertility rates and percentage change in fertility,
1965-70 to latest data available

Country
Bangladesh
Brazil
China

Population
size
Total fertility rate
1985
(in OOOs) 1965-70* Latest data

India
Indonesia
Iran
Mexico
Nigeria
Pakistan
Philippines
Thailand
Turkey
Vietnam

101,147
135,564
1 ,059,522
47,578
769,183
166,464
47,624
79,376
95,198
103,241
55,120
51 ,604
50,345
60,059

6.91
5.31
5.99
6.56
5.69
5.57
6.97
6.70
6.90
7.00
6.04
6.14
5.62
5.94

5.05
3.53
2.30
4.38
4.20
3.30
5.64
3.80
6.90
7.00
4.74
2.32
3.04
4.06

Total

2,822,027

6.01

3.60

Egypt

%
crlange

(1989")
(1984DHS)
(1988")
(1988DHS)
(1989")
(1987DHS)
(1980-85 UN)
(1986 DHS)
(1980-85 UN)
(1980-85 UN)
(1980-85 UN)
(1987 DHS)
(1988")
(1988°)

-27

% decline
towards
replacement level

-34
-62
-33
-26
-41
-19
-43

-39
-55
-95
-49
-42
-65
-27
-63

0
0
-22
-62
-46
-32

0
0
-33
-95
-73
-49

-40

-62

12. Fertility is unlikely to decline unless mortality has
declined sufficiently to raise life expectancy to
about 50 to 60 years.
12.a. With rather few exceptions, TFRs are about 6—
7.5 children per woman in countries where life ex
pectancy is below 50 years. Above 55 years, a much
closer association appears, with fertility falling rather
regularly with lower mortality (see Figure 8 for 106 de
veloping countries; updated from Bongaarts, 1986).

•UN data for 1965-1970.

•Sources: Data for Bangladesh, China and Turkey— Population Council Data Files,
1991; India— R. Ridker, World Bank, personal communication, April 30, 1991; and
Vietnam — Socialist Republic of Vietnam, National Committee for Population and
Family Planning, Vietnam Demographic and Health Survey, Hanoi, 1990.
Source: Freedman and Blanc, 1992.
Reproduced with the permission of the Alan Guttmacher Institute from Ronald
Freedman and Ann K. Blanc, "Fertility Transition: An Update," International Family
Planning Perspectives. Volume 18, No. 2, June 1992.

12.b. Certain outliers in Figure 8 are exceptional in
various respects. India and Indonesia, with strong
family planning programs, have lower fertility than
expected, while in a cluster of Middle Eastern coun
tries (upper right of Figure 8) high fertility persists
in the presence of relatively high life expectancy
(these countries are Iraq, Iran, Jordan, Oman, Saudi
Arabia, and Syria).

time more children remain in the population than
previously, so the downward trend in surviving chil
dren is not as sharp as the downward trend in births.

12.c. "No fertility transition has been observed to

Figure 7 Total fertility rate (TFR) and net reproduction rate (NRR): time trend for all developing countries
1965-70 value indexed to 100
100

1965-70

1970-75

1975-80

1980-85

1985-90
Year

Source: United Nations, 1991.
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1990-95

1995-2000

2000-2005

Figure 8 Total fertility rates and life expectancies at birth for 106 developing countries (average for 1985-90 period)
Total fertility rate

40

45

50

55

60
Life expectancy (years)

65

75

70

80

Source: United Nations, 1991.

start in any developing country until expectation of
life at birth had stayed above 50 for at least five years
and finally reached at least 53." Life expectancy of
53 has been in the recent past "...almost always a nec
essary condition for fertility transition..." and 56 a
necessary condition for a rapid transition. However,
those levels are not sufficient, since many countries
lack a transition even many years after reaching
them. Other factors may count, such as education,
urbanization, and contraceptive availability, indi
vidually or in combination (Bulatao and Elwan,
1985).
13. The more recent the fertility decline, the faster it
has been, on average.
13.a. Fertility declines in some developing countries
occurred considerably more rapidly than had the his
toric declines in Europe. Kirk's (1971) analysis, con
firmed by Berelson (1978), showed that "... there
has been an acceleration in the rate at which coun
tries move through the demographic transition from
high to low birth rates...the average length of time re
quired for a country to pass through this stage...has
been greatly reduced, from some 50 years for coun
tries entering the transition in 1875-99 to half that
time or less for those countries entering the transition...since 1950." (See Table 5)
14. Subreplacement fertility has been reached by some
developing countries and most developed countries
(United Nations, 1991; Freedman and Blanc, 1992).

14.a. As of the 1985-90 period, Cuba, Hong Kong,
Mauritius, Singapore, South Korea, and Taiwan were
all below replacement (ranging from 0.65 to 0.93 sur
viving daughters per woman). Others were close to
replacement: China at 1.11, North Korea at 1.17, and
Thailand at 1.15.
14.b. In developed countries fertility is at an all-time
low: 24 of the 30 countries included in United Na
tions statistics were below replacement fertility in
1985-90, including the United States and all of West
ern Europe, except Ireland; in addition, the former
USSR had an NRR of 1.11.
14.c. Historically, low fertility has sometimes been
followed by rebounds; since low fertility is gener
ally due to voluntary and deliberate control, it is sub
ject to reversals.
Table 5 Years historically and currently required for countries to
reduce annual crude birth rates from 35 to 20
Period in which
birth rate
reached <35
1875-99
1900-24
1925-49
1950-

Number of years required
to reach birth rate of 20

Numberof
countries

Mean

Median

Range

9
7
5
22

48
38
31
22

50
32
28
21

40-55
24-58
25-37
11-40

Note: First three rows from Kirk. 1971. Fourth row from Berelson, 1978, as an update
of earlier estimates by Kirk and with extension from 6 to 22 countries. Both Kirk and
Beretson used linear extrapolation to determine years needed to complete the crude
birth rate decline to 20.
Source: Kirk, 1971; Berelson, 1978.
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NOTES
1.

Where overall contraceptive prevalence is high, traditional meth
ods account for a smaller proportion of the method mix, as seen
across 167 national surveys (multiple surveys in some countries
over time).
Method mix by level of prevalence"
Overall prevalence level, users (%)
Method
Sterilization
IUD
Pill
Injectables
Condom
Vaginals
All modern
Traditional
All
(N)

<20

20-39

18
7
26

19
13
33

3
5
1
60
40
100
(50)

4
4
2
75
25
100
(46)

40-59
24
14
25
4
7
2
76
24
100
(50)

60+
33
9
25
3
13
2
85
15
100
(21)

•Figures are unweighted and therefore differ from those in Table 2. The
traditional method share appears largel because every country is given
equal weight, and in many small countries the traditional methods ac
count for much of the rather low amount of all contraceptive use.
Source: Population Council databank.
2.

These countries are Algeria, Egypt, Mauritius, Morocco, Reunion,
South Africa, and Tunisia.

3.

Based on United Nations information; from empirical data through
1980-85, and largely from projections for 1985-90.
This line is for the net reproduction rate (NRR), which corrects the
total fertility rate for the prevailing female mortality rates. It gives
the number of daughters produced from one generation to the next
under current fertility and female mortality rates. Note that some
of the difference in Figure 7 reflects survival gains after the child
hood years, though these are minor.

4.
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Chapter 2

LARGE-SCALE FAMILY PLANNING PROGRAMS
Large-scale programs to expand contraceptive use and/
or reduce fertility rates now cover most of the develop
ing world's population. However, the programs vary
considerably in strength and coverage, as well as in the
variety of contraceptive methods they offer. Many indi
vidual countries have weak programs, but most people
live in countries having the stronger programs. China
and India alone have half of the total population of the
developing world (Table 2). The largest eight countries
have two-thirds of the total, and five of these countries,
containing 58 percent of the total, have strong programs.
All countries after the 17th in Table 1 claim less than one
percent of the total; program strength ranges widely in
these countries.
The principal functions of the programs are to pro
vide services, information, persuasion, and legitimation;
countries vary greatly in the relative emphasis they give
to these aspects. They also differ in coverage of the popu
lation for each function. Some programs operate only in
clinics in the larger cities; at the other extreme, some de
liver a variety of services to the doorstep in the villages.
The programs use various modes of delivery (see
other chapters for information on community-based dis
tribution, social marketing, and postpartum programs).
The findings immediately following are based upon
30 ratings, or scores, of program effort as applied to ap-

proximately 100 developing countries (all those with
populations of one million or more). The ratings are
based upon the judgments of knowledgeable respon
dents for each country. The 30 scores fall into four di
mensions of effort as shown in the box: policy, services,
evaluation, and availability of methods. Each score, for
each country, can range from zero to four, so the maxi
mum total score is 120. Because the totals vary for the
four dimensions, all scores are given as percents. The Pro
gram Effort Score used below is the percent attained out
of the 120 maximum for all 30 scores. Detailed results
appear in Mauldin and Ross (1991).
1.

l.a. Program effort scores now average 42 percent,
within a range of 0 to 87 percent of the maximum of
120. Assessments in 1972, 1982, and 1989 produced
mean program effort scores of 20,29, and 42, respec
tively, rising by 45 percent between 1982 and 1989.
l.b. Over time the distribution of countries by the
program effort score has shifted favorably (Figure 1 ),
with a systematic movement of most countries to
ward higher scores. In each period additional coun
tries established programs, thus moving upward
from zero, and those already possessing programs
strengthened them, raising their scores.

Table 1 Population concentration in the 20 largest developing
countries
Largest developing
countries
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
1 6.
17.
18.
19.
20.

China
India
Indonesia
Brazil
Pakistan
Bangladesh
Nigeria
Mexico
Vietnam
Philippines
Turkey
Thailand
Iran
Egypt
Ethiopia
North Korea
Myanmar
Zaire
South Africa
Colombia

LDC total

Population
(000)
1,139,060
853,094
184,283
150,368
1 22,626
115,593
108,542
88,598
66,693
62,413
55,868
55,702
54,607
52,426
49,240
42,793
41,675
35,568
35,282
32,978

Percent of
LDC total

Cumulative
percent

27.9
20.9
4.5
3.7
3.0
2.8
2.7
2.2
1.6
1.5
1.4
1.4
1.3
1.3
1.2
1.0
1.0
.9
.9
.8

27.9
48.8
53.3
57.0
60.0
62.8
65.5
67.7
69.3
70.8
72.2
73.6
74.9
76.2
77.4
78.4
79.4
80.3
81.2
82.0

4,085,640

Note: LDC = less developed countries in United Nations statistical series.
Source: United Nations, 1991.

Repeated assessments show that most developing
countries have improved their program efforts sub
stantially since 1972.

I.e. Improvement has been quite general. The over
all score rose for each of the four components, and
did so within every geographic region, between 1982
andl989(Tflb/e2).
1.d. Nevertheless, as of 1989, half of all family planning
programs still scored less than half of the maximum.
2.

All programs, including the stronger1 ones, are se
lective in their efforts among the 30 scores.
2.a. In general most emphasis goes to basic policy
positions, to essential infrastructure items, and to the
availability of four of the six birth control methods
shown (Figure 2).

3.

Stronger programs exceed weaker ones on every
one of the 30 scores, but the differences are sharp
est on outreach items.
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PROGRAM EFFORT
POLICY AND STAGE-SETTING ACTIVITIES
*1.
*2.
3.
4.
*5.
6.
7.
*8.

Official government policy on fertility/family planning and population growth
Favorable statements by government leaders
;|l|||l^|;l« i;Level of family planning program leadership within government
Minimum legal age at marriage at least 18 for females; extent of enforcement
Laws permitting contraceptive imports; in-country manufacture
;
Legalization of mass-media advertising of contraceptives ;: ' : ' : l ; i:l!lili:|i||l|l|ll: :.'
Involvement of numerous ministries and government agencies ' :; ':f||lilli§p!l
Percentage of total program budget from in-country sources ; -:Mm!ijjij:•||;;|;

SERVICE AND SERVICE-RELATED ACTIVITIES'""'"--:: -

9.
10.
'''llll|l-; : ; 11:s:' : - : : : :; ":::'
12.
*13.
*14.
15.
;:; ;: ;.:s; ;: ; : ;: : ; :; .;:;.;-. ; * 16.
^Illiiiil:--'': 17.
*18.
19.
•:;.-;.;-:-;:;;::
*20.
Illlllilil.'
21.

Involvement of private-sector agencies ^^fmw
^mmmfm^:wm^
Use of government personnel to carry out program; accountability at all levels
Community-based distribution (CBD) ' ' • -'.'^^SS^^^^^^^^^W^M
Social marketing programs
:
:
"^^^
Postpartum family planning programs
Wi^iiimSii
Home visiting by family planning workers
;;ll!|^l^lllllllil|s
Adequate administrative structure and staff
llllJililillillllllllllll
Adequate training programs
-: :
: : ; •.. . '':.,:••::;:::|::i;i:llllllllllilllllllll^
Extent that staff carry out assigned tasks •
: ^.IxlllllillllilllllillPIIII^
Adequate logistics and transport; '.'
^^W^^^jj^^^l^iy^^'-:.^-.
Adequatesupervision^:|;;i;ii:;|;|||l||||:|l^
' ""•^"'"•"'"""""""""""^fSjj^l^
Use of mass media •^^''"'"^^^^
Incentives and/or disincentives ^:: lllllllll:llillli:liilllllllllillllll

RECORD-KEEPING AND EVALUATION
*22. Collection, reporting, and feedback on clinic recprds; ;;;;::
*23. Evaluation ; :s|||l|:::
; :;; :
;
:i ; ;||^||||ii||||||||||§
24. Management use of evaluation findings to improve program

AVAILABILITY AND ACCESSIBILITY OF FERTILITY CONTROL METHODS
**25.
**26.
***27.
***28.
***29.
*30.

•

Male sterilization
Female sterilization
Oral contraceptives (or injectables, if more popular)
:
Condoms (or other barrier method, if more popular)
ii^iillilliilllil
lUDs :
:• '•
-||i;i-i: :
Safe induced abortion : ;:;: - : -' : '" : ' : ":"-;: ;: '
:,::;,:::,::,: i>:liPiilll;S5;:: ": ' :; "

•Induded in 1972 program effort scale
"Items 25-26 included as one item in 1972 program effort scale
"'Included as two items in 1972 program effort scale".;•; v: ; ft
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Figure 1 Distribution of program effort scores, 1972, 1982,
and 1989
Number of countries

0-9

1972
Component
and year

10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89
Program effort score (percent of maximum)

Number of countries

Table 2 Family planning program effort scores (% of maximum),
by component, according to region, 1982 and 1989

1982

Program effort
1982
1989
Change
Policy and stage
setting
1982
1989
Change
Service and service
related
1982
1989
Change
Record keeping
1982
1989
Change
Availability
1982
1989
Change

Middle
Sub- East/
South Saharan North
Africa Africa
Asia

Latin
America

All
countries

East
Asia

29
44
15

63
64
1

42
52
10

15
36
21

20
33
13

40
54
14

34
47
13

66
67
1

45
55
10

25
45
20

26
32
6

39
48
9

25
42
17

58
60
2

38
49
11

12
35
23

16
32
16

34
49
15

29
50
21

57
62
5

43
51
8

13
44
31

21
39
18

42
62
20

31
44
13

76
71
-5

45
56
11

10
26
16

21
32
11

53
68
15

Note: The percentages are calculated by unit weights, not population weights.
Source: Mauldin and Ross, 1991.

keting of contraceptives at subsidized prices, postpartum programs, and home visiting
4.
0-9

10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89
Program effort score (percent of maximum)

Number of countries

4.a. Between 1982 and 1989, 19 programs moved
from the weaker to the stronger group. Termed "shift
countries," these improved on nearly all 30 scores,
but especially on the three infrastructure items of task
completion, administrative structure, and training,
as well as on the use of mass media, on the manage
ment use of evaluation resources, and on making fe
male sterilization more widely available.

1989

5.

0-9

Weaker programs that improve over time do so selectively, rising on certain scores more than others.

Some programs are constricted by formal barriers.

5.a. Controls on contraceptive imports, legal prohi
bitions against certain methods, and bans on the use
of mass media all exist in some countries. In addi
tion, medical barriers exist that involve elaborate
screening procedures, multiple visits for examina
tions, and other impediments to contraceptive adop
tion (Shelton et al., 1992; Ross et al., 1992).

10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89
Program effort score (percent of maximum)

Source: Population Council Databank, 1993.

6.

3.a. The outreach items that differentiate best
between stronger and weaker programs are commu
nity-based distribution of contraceptives, social mar-

Most contraceptive use in the developing world is
program supplied, though regional variation exists
(Table 3). (See Chapter 1, for details on the method
mix.)
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Figure 2 Program effort scores, 1989, stronger vs. weaker programs
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6.a. Over 80 percent of all contraceptive users receive
their supplies and services from public-sector pro
grams. Essentially all of this use is of the modern
methods (sterilization, IUD, pill, injectable, and
condom).
6.b. Regional variation in the source of supply, how
ever, is considerable (Figure 3). The proportions in
Table 3 vary from 99 percent publicly supplied for
East Asia (heavily China) down to 29 percent pub
licly supplied for North Africa and the Middle East.
The figure for Latin America is also low, at 38 per
cent; however, the "private sector" there includes
many non-profit organizations, such as the Profamilia program in Colombia, which provide a substan
tial share of contraceptive services.
7.

There is no apparent trend for the private sector to
supplant the public sector as a source of supply;
nevertheless, the private sector is important in some
countries.
7.a. Repeat surveys in 16 countries show the public
sector gaining ground in eight countries and losing
it in five, with no change in three (shift defined by a
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change of five percentage points between sectors)
(Mauldinetal.,1993).
7.b. There is no apparent trend toward a larger role
for the private sector in distributing resupply meth
ods (the pill and condom). In 17 countries with na
tional surveys that permit a division of source of sup
ply by government, NGO, and commercial, time-trend
patterns are obscure in some cases, with the remain
der of countries equally balanced between shifts up
and down for the private sector (Population Coun
cil Databank, 1993).
7.c. Cross et al. (1991) examined survey evidence in
13 countries to determine whether the private sec
tor's share of supplies and services for modern con
traceptive use increased during the 1980s (3-9 years
between surveys). Contrary to expectations the pri
vate sector's share increased in only one country, de
clined in seven, and is holding steady in the rest. The
pattern was essentially similar for the urban sector.
Also, in 12 of the 13 countries, pharmacies clearly
lost market share. Data from 27 surveys carried out
in the 1980s (including the 13 countries above)
showed the private sector's share of resupply meth-

Table 3 Percentage of contraceptive users relying upon the
public sector, by region* and selected countries

Region and country
East Asia
China
South Korea
Entire region
South Asia
India
Indonesia
Bangladesh
Thailand
Vietnam
Entire region
Middle Eastf
Nonti Africa
Turkey

Egypt

Morocco
Tunisia
Entire region
Sub-Saharan Africa
Nigeria
Kenya
Zimbabwe
Ghana
Botswana
Entire region
Latin America
Brazil
Mexico
Colombia
Peru
Ecuador
Dominican Republic
Entire region
Total

Figure 3 Source of supply for contraceptive users in three
developing regions (available data)

Number of
userslnpublic
sector (000)

Public sector
users as percent
of all users

177,117

167,722
4,977
175,218

100.0
85.5
98.9

75,338
17,249
7,262
6,763
5,655
119,340

57,068
13,074
5,526
5,539
5,457
91,211

75.8
75.8
76.1
81.9
96.5
76.4

6,547
3,666
1,392
635
12,609

1.243
846
868
485
3.651

19.0
23.1
62.4
76.4
29.0

1,315
1,224
777
437
91
5,870

487
599
703
133
86
3,144

37.1
49.0
90.5
30.6
94.2
53.6

18,446
8,507
3,680
1,802

35,948

4.998
5,257
835
883
265
271
13,533

27.1
61.8
22.7
49.0
32.2
44.0
37.6

350,884

286,757

81.7

Number of users
1990(000)
167,722
5,821

825
616

'Regional totals are only forcountries with known numbers of total contraceptiveusers
and users in the public sector. These countries include 92 percent of all users in the
developing world.
Source: Population Council Databank, estimates based on national surveys.

ods to be greater than that of long-acting methods, but
time trends were not part of that analysis.
8.

The overall prevalence of contraceptive use is re
lated to the number of methods made available.
8.a. Adding a new contraceptive method to those
available in an existing program increases prevalence
by about 12 percentage points and decreases the
crude birth rate by 5.3 points. The effect of availabil
ity does not diminish when other elements of fam
ily planning program strength are taken into account
(Jain, 1989).2
S.b.The introduction of major new contraceptive
methods has resulted in jumps in contraceptive
prevalence; programs have sometimes fostered such
introduction on a large scale (Freedman and Freedman, 1992).
8.c. Programs that offer a number of methods in
crease the likelihood that users will find a method

300

Millions of users

250
200
150
100
50

Africa

Americas

Africa

Americas

Public sector

Asia and Pacific

Asia and
Pacific
Other

Source: Population Council Databank, 1993.

appropriate to their needs, leading to higher preva
lence levels. Although other factors affect the rela
tionship, the association is clearly suggestive of ben
efits that follow broadened method availability.3
Number of
methods available
0
1-2

5-6

Contraceptive
prevalence (%)

9
25
42
64

8.d. In Matlab, Bangladesh, contraceptive prevalence
rose from 7 percent to 20 percent when injectables
were provided at the household level. The introduc
tion of sterilization services was accompanied by an
other 10 percentage point increase in prevalence. A
household visitation program to insert ILJDs in
creased prevalence yet again. Although the new
methods were associated with excellent continuation
rates, they were not the only elements that contrib
uted to increased prevalence, since other program

CHAPTER 2 FINDINGS 17

8.L The availability of methods in many parts of the
developing world is restricted by sheer lack of out
lets. Early programs addressed this problem by au
thorizing paramedics to provide pills and insert
lUDs. The safety of IUD insertion by paraprofessionals is one of the strongest findings in the operations
research literature (Foreit, 1991). In a Thailand
experiment, auxiliary nurse-midwives in four prov
inces were trained to prescribe the pill with a check
list of contraindications, omitting pelvic examina
tions. The number of program acceptors rose over
three-fold in a six month period, with no increase in
the complication rate and with continuation as good
as that among the clients of physicians. The new sys
tem was extended to all of Thailand, raising the num
ber of pill outlets from 350 to about 4,000 (Rosenfield
and Limcharoen, 1972, cited in Foreit, 1991).

improvements occurred simultaneously (Phillips et
al., 1988,1989).
8.e. In an experiment in Kaoshiung City, Taiwan,
pills were added to the method mix to test the effect
on IUD acceptance. Subsequently, IUD acceptance
continued to rise, and there was a net increase in to
tal program acceptors. The pill was then added to
the island-wide program (Cernada and Lu, 1972).
8.f. The addition of the pill to large-scale programs
in Thailand, Taiwan, South Korea, and Hong Kong,
and the addition of the condom in India, produced
net increases in contraceptive prevalence (Freedman
and Berelson, 1976). After the Nirodh condom was
added to the private sector in India, with accompa
nying publicity, condom sales rose from about
600,000 per month to about 7,000,000, of which 80
percent were the Nirodh type (Jain, 1973).
8.g. Method-specific failure rates (see Chapter 7) are
lower in countries with high family planning effort
scores (Moreno and Goldman, 1990, evidence from
15 DHS surveys). By offering a wider choice of meth
ods, including low-failure methods, strong programs
may help direct users to methods best suited for
them, and they may provide better counselling about
how to use methods effectively; all of these efforts
encourage higher prevalence levels.
8.h. Improved availability of contraceptive methods
tends to raise contraceptive prevalence (Tsui and
Ochoa, 1992, reviewing the body of post-1992 evi
dence). However, countries vary greatly in the vari
ety of contraceptive methods they make available.
A method is defined as "available" if at least half
of the population has ready access to it. The table
below distributes the 65 countries with information
according to the number of methods available:4
Number of
methods available
0
1
2
3
4
5
6

7

Number of
developing countries

9.

Programs that encourage adoption of long-acting
methods among couples who wish to substantially
delay or permanently prevent births can decrease
the risk of contraceptive failure, the costs of distributing resupply methods, and the burden of recruiting new users to replace dropouts.

9.a. To maintain a contraceptive prevalence level of
approximately 75 percent (when the annual discon
tinuation rate is 60 percent, as it is with some meth
ods in some countries), programs must recruit 45 ac
ceptors annually for every 100 MWRA. Only 15
acceptors per 100 married women are needed when
the annual discontinuation rate is 20 percent. To in
crease prevalence when discontinuation is high, the
numbers of acceptors required are even greater than
those needed to maintain it (Jain, 1989).

21

10
5

8
7
2

65

Thus, 21 countries fail to make any contracep
tive method readily available to at least half the
population. These countries, largely in Africa and the
Middle East, represent one-third of the 65 with data.
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8.j. Outlets have been increased through other means,
such as community-based distribution (see Chapter 3),
contraceptive social marketing (see Chapter 4), postpartum programs (see Chapter 5), and mobile teams;
there are also outlets at military and some workplace
sites and schools.

9.b.Even when discontinuation is low, prevalence
will decline unless new users appear each year to re
place dropouts and to keep up with the growth in
the number of eligible couples. For the developing
world as a whole, 100 million new users will be
needed during the 1990-2000 decade just to keep
prevalence at its 1990 level of 51 percent. To raise
prevalence to 59 percent by 2000, consistent with the
United Nations medium population projection, will
require an additional 86 million users (Mauldin and
Ross, 1992).

10. The influence of contraceptive effectiveness on fer
tility depends upon the level of prevalence.
10.a. When prevalence is low, that is, when few
people use a method, contraceptive effectiveness has
little impact on the birth rate. For example, when preva
lence is 30 percent, an increase in overall method ef
fectiveness from 50 percent to 90 percent will lower the
birth rate only modestly. But when prevalence is high,
the change in effectiveness applies to most of the popu
lation, and the impact on the birth rate can be large.
11. Contraceptive use is closely associated with pro
gram effort, regardless of socioeconomic setting.
11.a. Within each socioeconomic setting, the level of
contraceptive use rises as program effort improves
(Figure 4; countries weighted equally). Successive
analyses for different time periods have found these
patterns to be consistent (Freedman and Berelson,
1976; Mauldin and Berelson, 1978; Lapham and
Mauldin, 1984,1985; Mauldin and Ross, 1991).
11.b. Cross-country analyses that take account of
both individual and country sources of variation sug
gest that program effort raises contraceptive preva
lence (Freedman and Freedman, 1992).
12. Fertility levels are also closely associated with pro
gram effort.
12.a. Again, within each socioeconomic setting, fer
tility is generally lower where program effort is
Figure 4 Relation of contraceptive prevalence to program
effort, by socioeconomic setting
Contraceptive prevalence

12.b. One study, based upon regression methods, re
lates the decline in TFR to the effects of program ef
fort and of socioeconomic development (as measured
by the UN Human Development Index). The aver
age net program effect, weighted across 48 countries,
has been to reduce the TFR by 1.4 births per woman.
This implies that organized programs (both govern
ment and NGO) "...have been responsible for fully
half of the fertility decline from 6.4 to 3.9 births per
woman between the pretransition period and the late
1980s" (Bongaarts, 1993). The results are consistent
with those obtained in an earlier study (Bongaarts
etal.,1990).
12.c. Major fertility declines have occurred in the
presence of strong family planning programs where
social and economic conditions were believed to be
unfavorable; prominent examples are China, Indo
nesia, and Thailand (Freedman and Freedman, 1992).
Additional examples include Bangladesh and certain
states of India.
12.d. Reviews of earlier evidence also support the
conclusion that organized family planning programs
can affect the course of fertility (Hermalin, 1982;
Forrest and Ross, 1978).
12.e. Areal variations in contraceptive prevalence
and fertility within a single country are associated
with variations in the strength and quality of pro
gram effort, as in Indonesia, Malaysia, and Taiwan
(Freedman and Freedman, 1992).
13. Program effort is only partly determined by the so
cial and economic setting. It is not simply a reflec
tion of a country's level of development.

Program effort
[~|

greater (Table 4). Analyses for successive time peri
ods have found consistent patterns (sources as in
11.a. above).

Very weak or none

13.a. Among countries that rank high on social set
ting, program effort in 1989 varied: weak or very
weak/none in seven countries, moderate in 10, and
strong in only five. Overall correlations between pro
gram effort and social setting varied from 0.14 to 0.67,
depending upon the measures used (Mauldin and
Ross, 1991).

Low

Upper middle
Lower middle
Socioeconomic setting

Source: Population Council Databank

High

13.b. Nevertheless, it is difficult to develop a strong
program in a poor social setting, with its fragile in
frastructures of transportation, communication, and
trained personnel. In the 1989 study only one coun
try, Bangladesh, ranked low on social setting and
high on program effort, and only two countries, In-
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Table 4 Relatbn of total fertility rate (1990) to program effort (1989) and social setting (1985)
Prog ram effort

Social
setting

Strong
1.
2.
3.
4.

High

Mexico
Mauritius
Taiwan
South Korea

Sub- total

Uppermiddle

1 . Botswana
2. El Salvador
3. Tunisia
4. Indonesia
5. Sri Lanka
6. Thailand
7. China
Sub- total

2.17

5.00
4.68
3.74
3.29
2.57
2.40
2.35
3.43

1 . Venezuela
2. Lebanon
3. Costa Rica
4. Colombia
5. Panama
6. Trin. & Tobago
7. Chile
S.Jamaica
9. North Korea
10. Cuba
1 1 . Singapore
Sub- total
1. Guatemala
2. Zimbabwe
3. Iran
4. S. Africa
5. Egypt
6. Philippines
7. Ecuador
S.Peru

9. Malaysia
10. Dom. Republic
11. Guyana
Sub- total

Lowermiddle

1 . India
2. Vietnam
Sub-total

4.20
3.90
4.05

1 . Zambia
2. Kenya
3. Ghana

4. Pakistan
5. Honduras
6. Morocco
Sub- total

Low

1. Bangladesh
Sub-total

Weak

Medium
3.34|
1.95
1.70
1.69

3.62
3.59
3.14
3.03
3.01
2.83
2.69
2.52
2.45
1.85
1.80

1 . Jordan
2. Brazil
3. Argentina
4. Uruguay
Sub-total

Sub- total

Mean
6.15
4.56
3.65
4.79

3.60

3.09

1 . Syria
2. Congo
3. Algeria
4. Paraguay
5. Turkey
Sub-total

6.51

6.29
5.14
4.46
3.49

1 . Saudi Arabia
2. Libya
Sub-total

7.12
6.76
6.94
4.41

5.18

4.23
7.20
6.70
6.34
6.22
5.24
4.51
6.04

5.33

1. Nepal

5.74

5.33

Sub-total

5.74

3.30

1. Iraq
2. UAE.
3. Kuwait

2.77
5.57
5.56
4.96
4.32
4.26
4.12
4.08
3.79
3.75
3.55
2.58

1 . Yemen
2. Tanzania
3. Cameroon
4. Nigeria
5. Madagascar
6. Cen. Afr. Rep.
7. Zaire
8. Bolivia
9. Lesotho
10. Papua N.G.
1 1 . Haiti

7.11
6.90
6.75
6.55
6.19
6.09
5.93
5.78
5.05
4.89

Sub-total

6.25

1 . Rwanda
2. Uganda
3. Benin
4. Mali
5. Niger
6. Guinea
7. Afghanistan
8. Burundi
9. Ethiopia
1 0. Togo
1 1 . Sierra Leone
1 2. Burkina Faso
13. Angola
14. Guinea
1 5. Mozambique
1 6. Guinea-Bissau
17. Bhutan
Sub-total

Mean

Very weak/none
5.84
3.31
2.87
2.38

7.49

8.14

7.30
7.11
7.11
7.11
7.00
6.85
6.79
6.78
6.58
6.50
6.50
6.36
6.33
6.31
5.78

1.
2.
3.
4.
5.

Malawi
Somalia
Mauritania
Sudan
Chad

Sub-total

7.41
7.12
6.75
6.69
5.92
5.17
4.56
3.86

5.95

5.93

7.60
6.60
6.50
6.36
5.84
6.58

6.58

5.53
6.71
6.03

4.10

1. Ivory Coast
2. Oman
3. Liberia
4. Laos
5. Namibia
6. Gabon
7. Cambodia
8. Myanmar
Sub- total

6.03

5.07

(Unit weights for means)
Note: Total fertility rate taken from 1990 United Nations medium estimate.
tRead: The total fertility rate is 3.34 in Mexico, which has a strong program effort and a high soda! setting.
Source: Population Council Databank, based on Mauldin and Ross, 1991.

dia and Vietnam, ranked in the lower middle social
setting group and in the strong program effort group.
14. Socioeconomic differentials in contraceptive use
tend to weaken under strong programs.
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14.a. The adoption of birth control by disadvantaged
sectors of the population in countries with strong
programs has been very substantial, as in Taiwan
and Indonesia, probably improving the equity and
speed of fertility decline.

NOTES
1.

2.

"Stronger" programs are all those that rate higher than 45 on the
program effort score; these include the "strong" and the "moder
ate" ones in Table 3. "Weaker" programs are all those at or below
the 45 cutoff; these include the "weak" and "very weak/none" ones
in Table 3.
Jain used data from Lapham and Mauldin (1984,1985) on family
planning program strength from 100 developing countries in a re
gression model that predicted prevalence and birth rate as a func
tion of a country's score on method availability.

3.

Source: Population Council Databank.

4.

As judged by observers in each country, reported in Ross et al.
(1992), Table 14.
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Chapter 3

COMMUNITY-BASED DISTRIBUTION
The essential feature of community-based distribution
(CBD) programs is that they deliver services and infor
mation to populations beyond the reach of fixed clinics
and health centers. They cover villages and sometimes
urban slums where services are scarce. Usually, CBD
projects use lay workers, often unpaid, to distribute sup
plies from small depots or to deliver them door to door.
They were established on the premise that without them,
large populations would have limited access to services
and would continue to have a low prevalence of contra
ceptive use. (For general reviews of CBD programs for
family planning and related health objectives see Foreit
et al. [IS 78]; Gallen and Rinehart [1986]; Kols and Wawer
[1982]; and Osborn and Reinke [1981]).

ery five women in union reported a visit by a
CBD worker, most within the last month. Among
rural women currently using a modern contra
ceptive, 42 percent obtained it from the distribu
tors, and among those not using a modern method,
35 percent knew of the CBD program as a poten
tial source; about half of these women had used
the CBD system in the past. About one in five nonusers reported visits by CBD distributors, about
half within the last month (Zinanga, 1990).

PROVIDERS
2.

COVERAGE
1.

In numerous countries, substantial proportions of
the rural population are reported to be covered by
CBD programs, according to country informants
(estimates subject to informant perceptions) (Ross
et al., 1992, Table 12).

The number of providers in CBD programs ranges
from few to many, and the level of activity varies
among workers, especially where they are unpaid
(Ross et al., 1992).
2.a. The range of the numbers of providers in CBD
programs is:
*

1,000 to 4,000 workers in several countries: Hon
duras, Kenya, Brazil's BEMFAM program (pri
vate family planning association), Guatemala,
Taiwan, Ecuador, Syria, and South Korea.

*

7,500 providers in Morocco; 11,000 in Turkey;
and about 12,000 in Mexico (Ministry of Health
system).

*

19,000 providers in Indonesia (covering a reported
67,000 villages and hamlets); 28,000 in Bangladesh;
and 970,000 reported for China (covering 800,000
villages) (Ross et al., 1992, Table 12).

l.a. By region, the proportions covered are as fol
lows:
*

Latin America: 30-40 percent in the Dominican
Republic, Ecuador, El Salvador, and Guatemala;
60 percent in Mexico; 70 percent in Honduras;
and "most of the rural and urban population"
in Colombia.

*

Middle East/North Africa: 22 percent in Syria;
60 percent in Morocco.

*

Asia: 70 percent rural and 35 percent urban in
Indonesia; 80 percent rural and 90 percent ur
ban in Thailand; 90 percent in South Korea; 90
percent rural and 95 percent urban in China;
"most of the rural and urban population" in
Bangladesh and Taiwan.

* Sub-Saharan Africa: 13 percent in Botswana; 30
percent in both Kenya and Zimbabwe; and
"most of the population, both rural and urban"
in Mauritius. Zimbabwe has an exceptional pro
gram. In the 1984 national survey, one out of ev
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EFFORT LEVELS
3.

Countries can be distributed according to the ex
tent of effort they give to their CBD programs, us
ing a scale from 0 to 4. This scale is based upon the
proportion of the total population that is covered
by the CBD program.
3.a. Many programs operate only in the rural sector,
which dilutes the score; however, the score also re
flects urban programs where they exist.

Score
0-.99
1.0-1.99
2.0-2.99

3.0-3.99
4.0a

No. of countries

1982

1989

74
10
11
2
6
103

69
6
7

4.d. CBD "... is less costly than clinic services, easier
for many people to reach, and available in a broad
range of settings. Family planning services have been
delivered by CBD for over 20 years; by the mid 80s
CBD services were available in over 40 countries,
largely in Asia and Latin America, but increasingly
in Africa" (WHO, 1989).

5
16
103

Source: Population Council Databank, 1992
a4.0 is used for all values of 4.0 and above.

3.b. Most countries fall low on the scale, because they
have not yet established a CBD program or because
its coverage is still restricted to only part of the coun
try. Sixteen countries fall at high values; the rest are
spread thinly at intermediate points.

4.e. Early CBD experience for acceptance, continua
tion, and prevalence produced the following out
comes (Foreit et al., 1978):

3.c. Between 1982 and 1989, the distribution of scores
shifted favorably, with 21 countries instead of eight
at scores of three or above.

*

Acceptance: In nine CBD programs, acceptance
rates for contraception ranged from 10-16 per
cent of couples in three cases, 29-49 percent in
four, and 69 percent in two.

*

Continuation: Twelve-month continuation rates in
six CBD programs for the pill were 33-41 percent
in four programs and 56-76 percent in two other
programs. For condoms, rates were 42 percent, 57
percent, and 82 percent in three programs.

*

Prevalence: Prevalence of contraceptive use rose
by 7-14 percentage points in four projects, to lev
els of 15 percent, 31 percent, 35 percent, and 38
percent, depending upon the project.

OUTCOMES
4.

Periodic reviews of CBD projects and programs
have confirmed their positive effects upon contra
ceptive prevalence.
4.a. "It has been postulated that substantial unmet
demand exists for effective methods of fertility con
trol and that community-based contraceptive distri
bution (CBD) systems can make significant inroads
in meeting this demand at reasonable cost. Experi
ence to date clearly confirms the validity of the the
sis. Contraceptive prevalence rates have typically
doubled from 15 percent or less to roughly 30 per
cent within a year or two after CBD program initia
tion. The question is no longer the feasibility of the
CBD approach; rather, the issue is how the approach
can be applied most effectively and efficiently" (Osborn
and Reinke, 1981, reviewing 28 CBD projects).
4.b. "Operations research projects around the world
have demonstrated that providing services through
home visits and/or local supply depots can signifi
cantly increase contraceptive use. While some stud
ies are more rigorous and conclusive than others, all
of the studies in rural areas with initially low levels of
use found increased use after community-based ser
vices became available" (Gallen and Rinehart, 1986).
4.c. "Operations research studies have already shown
that CBD can be an extremely effective approach for
supplementing clinic services, especially in rural ar
eas. For family planning, they have also shown sig
nificant and rapid increases in contraceptive usage
in rural areas" (Kennedy, 1986).

DISTRIBUTION STRATEGIES
Much CBD experience can be expressed as who provides
what to whom and by what means.
5.

Who: Distributors have usually but not always
been unsalaried residents who are selected and
trained by regular program staff.
5.a. Various approaches are used to establish and
maintain distributor motivation: close supervision,
enhanced social position in the community, pay
ments to cover transportation expenses, provision of
shoes and rain gear, and so on. Some programs that
charge clients for supplies permit the workers to keep
part of that income (Bouzidi and Korte, 1990).
5.b. In Zimbabwe, the distributors are full-time, sala
ried workers on the regular government payroll,
with full benefits. Distributors in Morocco are also
full-time and salaried.
5.c. In Kenya, some 23 agencies provide village-based
services, covering about 35 percent of rural admin
istrative units; workers are generally volunteers,
working under various compensation arrangements
(Phillips and Lewis, 1992).
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5.d. In Sudan, resident village midwives who had
previously received nine months' formal training for
midwifery were used as unpaid volunteers to dis
tribute, door to door, oral rehydration solution (ORS)
and contraceptive pills, and to provide nutrition edu
cation (El Tom et al., 1984,1989; Lauro, 1987).
5.e. Both men and women have been used as dis
tributors; in two Peruvian projects, male and female
distributors were recruited, trained, and supervised
through similar procedures. Males were found to dis
tribute more condoms and females, more pills; over
all, males did as well or better than females in total
numbers of clients recruited and total couple-years
of protection provided. By adding male distributors
to the program to recruit more male clients, total
prevalence may rise due to the increased availabil
ity of male methods, especially the condom (Foreit
et al., 1992). In a Zaire project men and women per
formed about equally well as distributors; women
were slightly more productive, as measured by
couple-years of protection provided (Bertrand et al.,
1989); (see also Townsend, 1991).
5.f. In general, paid workers recruited in sufficient
numbers to cover a large population create a heavy
cost burden, while unpaid workers often lack moti
vation. Consequently, some CBD programs have
been difficult to maintain. Townsend's (1991) review
stresses that "high turnover, together with the recur
rent costs of recruitment and training, continues to
be a characteristic of many programs using volun
teer community workers."
6.

What: The usual commodities given for family
planning are pills and condoms, sometimes spermicides, and (rarely) injectables.
6.a. Other services include the delivery of oral
rehydration supplies, malaria tablets, iron supple
ments, and anti-parasite preparations.
6.b. Distributors also refer clients to health facilities for
the clinical methods of lUDs, injectables, and steriliza
tion, as well as immunization and other MCH services.
6.c. Among 31 countries replying to a 1987 question
naire, 16 reported that their CBD programs provided
family planning and MCH services, as well as im
munization referral. Nine provided family planning
services only; three offered family planning and im
munization referral; and three provided only MCH or
immunization referral. Thus, 28 of the 31 provided
some type of family planning service (Ross et al., 1988).
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7.

To Whom: Most CBD programs are directed at ru
ral populations. Some, such as the one in Morocco
and a pilot project in Zaire, have included urban
components.
7.a. The Zimbabwe CBD program selected rural ar
eas of a fixed size (radius about 15 km), to control
the worker's travel time. Relatively underserved ar
eas were chosen, each one fairly close to a health cen
ter or clinic, which could handle referrals and treat
ment of side effects. All households containing
eligible women are visited regularly for recruitment
and resupply purposes (Zinanga, 1990).

8.

By What Means: Workers have operated in three
modes: (a) by maintaining a small depot of supplies
to which local residents come, (b) by going door to
door, and (c) by holding educational meetings (in
schools, in health facilities, and elsewhere in the
community).
8.a. Combinations are employed: An initial home
visit may be followed by one or two reinforcement
visits during which supplies are given, after which
the recipient must go to a depot or other facility for
resupply. However, in some large programs, such
as those in Bangladesh, Zimbabwe, and the Sudan,
home visits continue on a permanent basis for resup
ply, referrals, and additional recruitment (rural lo
cations only) (Gallen and Rinehart, 1986).

9.

CBD programs take different forms, even within
the same country, depending partly upon each
organization's character, its adaptations to local cir
cumstances, and its general role in the society.
9.a. In Kenya, many voluntary associations maintain
CBD programs, with a remarkable diversity in the
way they go about their work. Table 1 documents the
variation that exists in the projects studied (Phillips
and Lewis, 1992). All, however, reflect the common
theme of carrying services out beyond the catchment
areas of fixed clinics.

CHARGES FOR SERVICES
10. Most countries charge for CBD services.
lO.a. Among the 48 countries possessing a large CBD
program in a 1991 survey, 31 charge for supplies and
services and only seven do not (10 unknowns). How
ever, charges are usually nominal or small (Ross et
al., 1992, Table 12).

Table 1 CBD agencies, by type of implementation strategy, Kenya
Implementation strategies
Recruitment
scheme

Political
Mason

Supervisory
scheme

Outreach
strategy

Household and
clinic based

Weak

Strong, clinic
based

Household
canvassing

None

Clinic based

Weak

Weak

Not specified

None

Village
economic group

Strong

Village
coordination
and technical
support

Women's self
help groups

Health service
fees

Mobile teams and
clinic based

Weak

Weak

Depots

Community

Health service

Mobile teams

Weak

Weak

Depots

Household

Weak

Strong

Household
canvassing
and depots

Clinic and
household

Strong

Strong

Household
canvassing

CBD agent

Financing

Client fee

IEC strategy

Clinic with
community
participation

Paid staff

External

None

DFH/MOH

Clinic

Unpaid volunteers

Public sector

MWYO

Community

Paid volunteers

Community
plus external

CHAK

Church

Unpaid volunteers

Community plus
external

CORAT

Church volunteers

Unpaid volunteers

CBD agency
FPAK

PCEA

Clinic outreach

Paid

External
fees only

Health service

CMA

Clinic outreach

Paid

External

None

Notes :FPAK — Family Planning Association of Kenya; DFH/MOH — Division of Family Planning, Ministry of Health; MWYO — Maendeleyo ya Wanawake Organization; CHAK
—Christian Health Association of Kenya; CORAT—Christian Organization Research Advisory Trust; PCEA—Presbyterian Church of East Africa (Chogoria); CMA—Crescent
Medical Association.
Source: Phillips and Lewis, 1992, Table 2. p.17.

TRAINING
11. CBD workers are a distinct cadre in terms of their
qualifications, work environment, and needs. They
usually require specialized braining, since they are
not well educated or even literate, have little tune to
leave home for instruction courses, and must work
most of the time without immediate supervision, un
like clinic personnel (Gallen and Rinehart, 1986).
ll.a. Training usually takes from three days to two
weeks, and trainers are usually regular program
staff, or doctors and nurses on ad hoc assignments.
ll.b. Phased training is usually needed wherever mul
tiple duties are involved. In Sudan, it was found that
training for a single function, with reinforcement in the
field prior to training for the next function, was much
more effective than simultaneous training for multiple
functions (El Tom, 1985; El Tom et al., 1984, 1989).
ll.c. Recurrent training for reinforcement of skills is
needed for substantial proportions of workers. In the
Guatemala APROFAM program, those CBD work
ers who were trained recently performed better than
others on tests of contraceptive knowledge (Bertrand
et al., 1981). In Ecuador, Ministry of Health commu
nity workers had low average scores on knowledge
of course contents from their training one year pre
viously (PRICOR, 1986).
12. Individual training has been superior to group
training in some trials.

12.a. In Peru a traditional refresher course for CBD
workers was compared with individual retraining
that was conducted by each supervisor at the work
er's own site. The latter resulted in 34 percent higher
levels of family planning knowledge than did the
group retraining. It also occupied much less of each
distributor's time than attending the lengthy group
course; moreover, nearly every distributor was con
tacted individually, whereas over one-third were ab
sent from the group course (Leon, 1989).
12.b. Individual training also worked better in the
Dominican Republic. There, a trial of "...one-on-one
reinforcement of knowledge during supervision was
31 percent more effective... than the traditional method
of providing retraining to large groups of promoters.
It also doubled the level of couple-months of protec
tion achieved, while reducing by about 75 percent the
percentage of pill users with contraindications" (Profamilia, 1990, cited inTownsend, 1991).

SUPERVISION
13. Persistent, supportive supervision is essential to
good worker performance.
13.a. Reinforcement by supervisors of the basic
knowledge of CBD distributors is important. In a Pe
ruvian experiment distributors lacking regular rein
forcement by supervisors lost about one-fifth of their
family planning knowledge within five months of
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taking a basic course. Meanwhile, an experimental
group to which supervisors gave systematic retrain
ing improved their knowledge scores by 33 percent
(Leonetal., 1990).
13.b. Studies from Bangladesh and Colombia found
the following supervisor approaches to be associated
with better worker performance: joint home visits
with workers to observe their interaction with cli
ents, questioning of clients about the worker's activi
ties in the presence of the worker, discussion of clients'
problems with the worker (Bernhart and Kamal, 1991;
Gomez, 1981; both cited by Townsend, 1991).
13.c. The optimal frequency of supervisory visits is
uncertain. Evidence from Guatemala, Turkey, Oyo
State in Nigeria, and Ecuador supports frequent su
pervisory contacts. However, a change from monthly
to quarterly supervisory visits in the Brazil BEMFAM
program and in the Colombia Profamilia program
did not appear to harm performance and saved time
and money (Gallen and Rinehart, 1986).
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Chapter 4

CONTRACEPTIVE SOCIAL MARKETING1
In contraceptive social marketing (CSM) programs, con
traceptives are distributed at subsidized prices through
existing retail outlets. The objectives are to make contra
ceptives more widely available, at lower cost, through a
larger variety of locations, and with better hours of op
eration than previously. The CSM program acts to
supplement other modes of delivery, giving consumers
an added choice among the various channels of contra
ceptive supply.

CSM coverage in broad ranges (Table 1 ), report that
up to 25 percent of the urban or rural population (or
both) is covered in nine of 23 responding countries,
25 to 50 percent is covered in seven countries, and
above 50 percent is covered in eight countries.

EFFORT LEVELS
2.

COVERAGE
1.

In some countries, an appreciable proportion of the
urban population and even part of the rural popu
lation are covered at least to some extent by the
CSM program.

CSM Score

l.a. Observers in developing countries, estimating

0-.99
1.0-1.99
2.0-2.99
3.0-3.99
4.0a

Table 1 Percentage of urban and rural populations covered by
social marketing programs in developing countries

Country

Year

Cameroon
Ghana
Zimbabwe
Bolivia
Colombia
Costa Rica
Dominican Republic
El Salvador
Guatemala
Honduras
Jamaica
Mexico
Peru
Trinidad and Tobago

1989
1989
1989
1989
1989
1989
1989
1990
1989
1989
1989
1989
1989
1989
1989
1989
1989
1989
1989
1989
1989
1989
1986

Egypt

Morocco
Bangladesh
India
Indonesia
Nepal
Pakistan
Sri Lanka

Taiwan

%
of urban
population
covered

%
of rural
population
covered

<25

<25

25-50
<25
<25
25-50

25-50
<25

>50
>50
25-50
25-50
>50
>50
25-50
<25
>50
25-50
<25
>50

<25
<25
25-50

<25
>50
98

Countries have been distributed along a scale from
zero to four according to the extent of the effort they
give to their CSM programs. This scale is based upon
the proportion of the total population that is covered
by the CSM program. Many programs operate chiefly
in the urban sector, which dilutes the score, but ru
ral programs are included wherever they exist

No. of countries

1982

1989

88

67
9
9

4
3
0
8
103

7
11
103

Source: Population Council Databank, 1992
"4.0 is used for all values of 4.0 or above.

2.a. Most countries fall at low values, because they
have not yet established a CSM program or because
its coverage is still limited. Some countries fall at high
values; the rest are at intermediate points.

<25
<2S
>50
25-50

2.b. Between 1982 and 1989, the distribution of scores
shifted favorably, with 18 countries instead of eight
at scores of three or above.

<25
u
25-50
25-50
25-50
U

25-50
25-50
u
25-50
<25
<25
25-50
<25

>50
94

u = unknown.
Source: Rossetal.. 1992, Table 13. As explained there, detailed sources were 1987
and 1989questionnaires sent to developing countries; SOMARC/The Futures Group,
SOMARC II 1990 Sales Report, Washington, DC, courtesy of Sharon Tipping; and
Social Marketing Forum (various issues). Other information came from J. Sherris, B.
Ravenhdt, and R. Blackburn, "Contraceptive Social Marketing: Lessons from
Experience," Population Reports Series J, No. 30, July-Aug jst 1985.

SALES AND CYP
3.

Most CSM activity is concentrated in a few large
countries, but some smaller countries do as well or
better on a per capita basis.
3.a. Sales and CYP (couple-years of protection) re
sults2 for 44 countries (Table 2) show a disparate glo
bal picture: India's Nirodh program, which accounts
for most of India's CYP, alone has one-third of all
CYPs; Bangladesh has one-seventh and Egypt oneseventh. Next come Pakistan, at eight percent; IndoCHAPTER4 FINDINGS 27

Table 2 Contraceptive social marketing sales summary: Sales/CYP data
Country
and year
Bangladesh
1990
1991
Benin
1990
1991
Bolivia
1990
1991
Brazil
1991
Burkina Faso
1991
Burundi
1990
1991
Cameroon
1990
1991
Central African
Republic
1991
Colombia
1990
1991
Costa Rica
1990
1991
Dominican Republic
1990
1991
Eastern Caribbean
1990
1991
Ecuador
1990
1991
Egypt
1990
1991
El Salvador
1990
1991
Ethiopia
1990
1991
Ghana
1990
1991
Guatemala
1990
1991
Guinea
1991
Haiti
1990
1991
Honduras
1990
1991
India
1991

Sales

Orals
6,207,791

Condoms

Foam

Total CYP

83,698,808
82,676,369

212.430

7,965,466

na

1,316,635
1 ,439,492

—
—

382,364
633,932

—
—

3,824
6,339

58,009
88,934

118,368
376,743

—
—

5,646
10,609

—

405,504

—

4,055

_

2.794,952

_

27,950

—
—

94,000
1 64,984

—
—

940
1,650

—
—

1 .990,255
3.193,996

—
—

19,903
31 ,940

—

310,080

—

3,101

5,444,480
5,973,632

6,407,785
6,319,715

3,006,656
2,163,276

512,951
544,360

—
—

2,330,515
2,937,152

—
—

23,305
29,372

579,910
497,579

449,547
869,016

—
—

49,104
46,965

—
—

121,839
90,399

na
na

1,218
904

585,570
716,792

na
214,305

—
—

45,044
57,281

2,082,434
2,011,655

17,057,744
14,668,488

—
—

330,765
301 ,428

296,540
287,345

1 ,807,056
1 ,769,372

—
—

40,881
39,797

—
—

699,506
3.782,454

—
—

6,995
37.825

452,444
435,300

3,586,500
3,748,300

1 ,602,200
1 ,909,400

86,690
90,062

170,234
183,460

1,321,857
1 ,600,464

608,500
589,656

32,398
36,014

—

1 40,236

—

1,402

10,215
37,464

357,139
576,513

—
—

4,357
8,647

248,280
215,788

739,722
599,912

—
—

26,496
22,598

164,525

327,199,600

—

3,284,652

Sales

Country
and year
Indonesia
1990
1991
Ivory Coast
1991
Jamaica
1990
1991
Jordan
1990
1991
Kenya
1990
1991
Malawi
1991
Malaysia
1991
Mexico
1990
1991
Morocco
1990
1991
Nepal
1990

Orals

Condoms

Foam

Total CYP

745,772
1,153,321

5.858,381
5,928,956

—
—

115,951
148,007

—

1 ,828,434

—

18,284

525,672
546,218

1.792,516
1,917,852

—
—

58,361
61,195

—
—

334,095
115,488

—
—

3,341
1,155

na
2,677

300,714
497,884

—
—

3,007
5,185

—

159,416

—

1,594

—

823,540

—

8,235

—
—

3,974,688
5,579,393

—
—

39,747
55,794

—
—

1 ,053,669
1 ,774,809

—
—

10,537
17,743

190,869
247,853

2,947,323
4,422,651

486,864
671,796

49,024
70,010

—
—

1,131,582
1,876,129

—
—

11,316
18,761

—
—

73,835,136
73,385,375

—
—

738,351
733,854

—

94,317

—

943

592,926

—

1 ,842,924

64,039

—
—

201 ,744
1 ,266,048

—
—

2,017
12,660

547,628
655,722

5.664,125
6,766,566

76,593
80,697

99,532
118,913

814,327

—

-

62,641

—
—

209,288
208,149

—
—

2,093
2,081

—

4,469,430

—

44,694

—

302,106

—

3,021

—
—

7,898,413
18,301,507

1 ,658,880
1 ,947,208

95,573
202,487

43.793
67.033

769,420
1,182,083

—
—

11,063
16,977

—
—

—
—

—
—

3,747,065
7,694.721

1991

Nigeria
1990
1991
Pakistan
1990
1991

Papua New
Guinea
1991
Peru
1991
Philippines
1990
1991
Sri Lanka
1990
1991
Thailand
1991
Trinidad
1990
1991

Turkey
1991
Uganda
1991
Zaire
1990
1991

Zimbabwe
1990
1991

Total global CYPs
1990
1991

na = not available
Note: One CYP equals 13 cycles of pills, 100 condoms, or 100 foaming tablets.
Sources: OKI International, Family Planning World2(3). May/June 1992 and John Stover, personal communication.
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Figure 1 CYPs as percentage of target market3
Bangladesh

Bolivia
Burkina Faso
Cameroon
Colombia
Costa Rica
Dominican Republic
Ecuador
Egypt
El Salvador
Ethiopia
Ghana
Guatemala
Honduras
India
Indonesia
Ivory Coast
Jamaica
Mexico
Nepal
Nigeria
Pakistan
Peru
Philippines
Sri Lanka

Thailand
Turkey
Zaire
Zimbabwe
10

8
Percent

Target market calculated as 80 percent of women in union, ages 15-44.
Source: DKT International, "1991 Contraceptive Social Marketing Statistics,"
June 1992.

nesia, at eight percent; and Colombia, at seven per
cent: The other programs, some in small countries,
have trivial proportions of the total. However, these
may amount to appreciable proportions of their own
populations, as in Jamaica and elsewhere (below).
3.b. Measured against their own population sizes, the
size of programs still varies widely (Figure T), but Ja
maica, Costa Rica, the Dominican Republic, and El
Salvador fall at higher points here than in Table 2.
The range is from 0.1 to 16 percent of women in union
(taken as 80 percent of all women of reproductive
age); measured in this way, the median value in Fig

ure Us only 2.8 percent, but seven countries are above
5 percent and three are above 10 percent.
The reference to 80 percent of women in union
is a severe and inappropriate standard in some coun
tries, since the program may focus only on the urban
sector or on part of the country. In fact, some CSM
programs now direct their marketing campaigns to
carefully selected income groups that are neither the
very poor, who cannot pay, nor the well-to-do, who
need no subsidization. Of five income-level groups
from well off through poor, the focus is on members
of the two middle-income groups who desire spac
ing methods.
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SUBSTITUTION
4.

grams are managed by various agencies (Sherris et
al., 1985; Sheon et al., 1987). Examples:

In countries with high contraceptive prevalence,
CSM programs may partially substitute for other
supply sources, attracting current users who are
simply switching from another source. However,
in countries with low contraceptive prevalence,
CSM programs do not appear to compete apprecia
bly with other contraceptive suppliers (Sherris et
al., 1985; Binnendijk, 1986). Marketing strategies are
used to minimize substitution for the commercial
sector (Stover, 1993a).
4.a. Projects in Kenya, Bangladesh, and Nepal found
that CSM programs offer little competition to public
and private sector programs. However, the CSM pro
grams in Sri Lanka, Thailand, and Colombia (all
countries with high prevalence) may have reduced
private sector sales (Sheon et al., 1987).

4.c. Switching from free government supplies to
CSM sources reduces the public burden and amounts
to partial cost recovery from sales income.

4.e. A review of eight CSM programs (Table 3) found
that about 25 to 50 percent of customers were new
users, with the rest divided between switchers and
others, in unclear proportions. (Some "previous us
ers" may have been nonusers for some time prior to
buying supplies from the CSM program.)

MANAGEMENT FEATURES
5.

CSM program experience has yielded certain man
agement guidelines; however, no one management
structure is appropriate for every country. The strat
egy chosen must fit the local circumstances.
5.a. Several different CSM structures are used; pro
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a family planning association (Colombia, Sri
Lanka, El Salvador, and Honduras)

*

private sector organizations established solely
for that purpose (Nepal, Mexico, Thailand, and
Guatemala)

*

semi-autonomous or quasi-governmental agen
cies, governed by a board or council (Bangladesh
and Egypt)

*

government agencies (India and Jamaica)

*

an established commercial distributor (Caribbean).

5.b. CSM programs operate in a complex institutional
environment; they are exposed to difficulties that of
ten arise in the unpredictable interplay of govern
ment, donors, and the commercial world. Multiple
agreements must be negotiated and kept, special per
missions are needed, and the business venture must
succeed. Whatever management strategy is adopted,
communication and coordination with relevant gov
ernment agencies are vital. In the initial stages of a
program, technical experts are an important link be
tween host governments, donor agencies, and CSM
management (Sherris et al., 1985).

4.b. In Bangladesh most contraceptives are supplied
by the government program. As the supplies pro
vided by the CSM program grew, the number of con
traceptives supplied by all programs grew by the
same amount, suggesting little switching (Sherris et
al., 1985).

4.d. Programs that are directed primarily at higher
income clients probably encounter more switching,
since many such clients may have been buying at
regular commercial prices (Sherris et al., 1985). How
ever, CSM programs may still improve the availabil
ity of supplies for such clients if commercial outlets
have been inactive.

*

PRICING
6.

Two goals conflict in setting CSM prices: low cost
versus program sustainability. Certain guidelines
have emerged:
6.a. In setting prices, a year's supply should cost less
than 1 percent of the yearly household income of
lower income groups; prices should be comparable
to those of other commonly purchased household
commodities (such as soap). Further, prices should
be approximately half the cost of other commercially
available contraceptives (Binnendijk, 1985; Sherris et
al., 1985; Sheon et al., 1987).
6.b. Prices should be low enough so that all poten
tial customers can afford them, but not so low as to
imply poor quality (Sherris et al., 1985). In Thailand,
many women experiencing side effects from a lowcost brand of pills switched to a higher priced brand,
under the assumption that the higher price implied
higher quality.
6.c. Prices of products should rise with inflation.
Generally, sales are unaffected by small price in-

Table 3 Previous use of family planning among current customers of social marketing programs, as reported in customer surveys,
1986-1990

Method and country
Oral contraceptives
Dominican Republic
Honduras
Peru
Condoms
Barbados
Ghana
Indonesia
Mexico
Morocco

Year

Number
surveyed

Previous users of same method
.
.
.
by type of previous source

New users
of family
planning(%)

1986-87
1986
1989

(252)
(222 j b
(362)

34
na
53 C

1989
1990
1988
1988
1990

(140)
(249)
(101)'
(388)
(242)

31
43
26
32
40

_
.
Previous users

Subsidized

Commercial

Other"

methods

13
49

40
41

0
10
2

13
na

9
7
0
33'

27

na

na

0
3
0
0
na

1 \J

3
40
21'

32'
31
44'
34
17
na

na = not available.
"Source not identifiable as either subsidized or commercial, or source unknown.
" Previous oral contraceptive users only.
c Includes 19 percent who had used traditional methods.
d May indude previous users of other social marketing products.
'Ever-users of Dua Lima condoms.
'May include multiple responses. Row adds to 103%.
Source: Lande and Geller, 1991, Table 3.

creases but are reduced by large increases. Thus, to
avoid a drop in sales, prices should be increased
slowly over time (Sherris et al., 1985), especially for
condoms, since their sales tend to respond more di
rectly to prices than do pill sales (Boone et al., 1985).
In El Salvador's program, a 100 percent increase in
prices was blamed for a 50 percent decline in sales
(Sheon, 1987).

phasized their safety, effectiveness, and appropriate
ness for married couples, to overcome their poor im
age (Sherris et al., 1985).
7.c. Person-to-person promotion and education are
important to educate retailers and health care pro
viders about the product and to stimulate interest in
the CSM program (Sherris et al., 1985; Schellstede
and Ciszewski, 1984).

6.d. Price mark-ups should be high enough to en
courage distributors, wholesalers, and retailers
(Sherris et al., 1985). However, the original price must
be modest enough so that after these mark-ups, the
final price to the consumer will be attractively low.

7.d. Promotion efforts need to be both extensive and
continuous, and any governmental or public objec
tions to program advertising will probably lessen
over time. Hiring an experienced advertising agency
may be the most cost-effective way of promoting the
products (Sherris et al., 1985).

PROMOTION
7.

7.e. Promotion costs are often the largest item in a
CSM budget. India's CSM program spent approxi
mately 75 percent of its budget on advertising, and
Egypt spent over one-third on it (Sherris et al., 1985;
Sheon, 1987).

CSM programs actively promote and advertise their
products, especially condoms and pills.
7.a. Radio and TV, as well as other media, have been
used to promote contraceptives to large audiences.
Promotion campaigns have had four objectives: to
draw attention to the products by brand name, to
create a product image for the intended submarket
(young people, couples, and so on), to inform the au
dience about how the product works and how to use
it, and to tell clients where to get the product and
what it costs (Sherris et al., 1985).

7.b. In most countries, condom promotions have em

COST-EFFECTIVENESS
8.

Several factors affect the cost-effectiveness of CSM
programs (Binnendijk, 1986; Sherris et al., 1985).
8.a. Programs tend to have high costs in the first year
of operation, and then to become more cost-effective
(Figure 2). This reflects low initial sales and high startCHAPTER4 FINDINGS 31

Figure 2 Cost per couple-year of protection, selected developing countries
Indonesia

1990S

1986

1987

1988

1989

Mexico

1990S

1990

1991

1987

1991

Year
1990$

Morocco

Zimbabwe

1990$

1989

1991

Annual

1988

1989

1990

Cumulative

Source: Slover, 1993b.

up costs, such as recruiting and training staff, launch
ing an advertising campaign, and contacting retail
outlets to inform them about the CSM venture. "Not
all these costs continue into future years of the
project," and as sales increase, "... the costs are di
vided by a larger number of CYP provided (Stover
and Wagman, 1992).
8.b. Early delays may occur that reduce sales while
fixed costs remain. Changes in program manage
ment, in government policies and regulations, and
in the economic and international environment, as
well as other factors, can all cause delays.
8.c. Programs whose main objective is to reach as
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many couples as possible tend to be less cost-effi
cient than those that target clear subgroups and seek
some degree of self-sufficiency.
8.d. Cost-effectiveness is influenced by the general
level of development and economic conditions. Costs
of commodities, labor, and other program inputs
vary by country, as do such infrastructural aspects
as the ease of transport, media coverage of the
population, communication facilities, and banking
systems.
8.e. Programs with high sales volumes tend to have
lower costs per unit sold. Condom sales tend to re
spond primarily to marketing activities, including

price levels and advertising, whereas oral sales tend
to respond more to social and economic conditions,
including level of income and education, and com
munication systems. Oral sales also increase as pre
scription requirements decline. Program duration is an
important predictor of both oral and condom sales rates
(Boone et al., 1985; Sherris et al., 1985; Sheon et al., 1987).
8.f. Because CSM programs use existing commercial
channels and have no clinical facilities or medical
personnel, they appear to cost much less than other
delivery systems. A comparison of 63 projects in 10
countries put their average cost per CYP at about US
$2.00, compared with about US $13.00 for a regular
clinic service and about US $14.00 for communitybased distribution programs (Huber and Harvey,
1989).
8.g. All cost calculations are subject to qualifications.
Most CSM programs receive substantial donor sup
port to make subsidized prices possible, contracep
tive supplies are often imported free of charge to the
program, and different cost calculations treat such
items differently.
8.h. Costs to donors and local governments depend
upon the CSM model employed. Over the years a
partial evolution has occurred, shifting certain types
of costs away from the donors and to the local imple
menting organizations. Contraceptive commodities
can be obtained more cheaply from local sources, or
can be purchased commercially by the project itself.
Existing local companies can implement the project
and distribute the products, instead of creating new
infrastructures from donor funds. Finally, a CSM
project may be entirely operated and financed as an
indigenous activity, with the donor contribution de
voted only to all or part of the advertising and pro
motion costs. These features help to contain the do
nor role to the start-up phase, with a declining
burden through time, and thereby enhance the
sustainability of the CSM activity (Stover, 1993a and
1993b).

the consumer level. This impairs most estimates of what percent
age of products actually reach (and are used by) the consumer.
Both CYP and cost per CYP are calculated from sales data, thus
they usually reflect any inaccuracies inherent in the sales data.
Couple-years of protection uses the quantity of each method needed
to protect one couple for one year. For pills, this is generally as
sumed to be 13 cycles. For condoms and spermicides, it is usually
TOO units. Some programs have estimated the conversion to be as
high as 150 condoms or spermicides for each CYP, reflecting a dif
ferent estimate of coital frequency or an allowance for wastage.
Cost per CYP is calculated by dividing the total cost of running the
program by the total CYP obtained. Cost calculations have their
own problems; also, not all programs measure cost the same way:
For example, some include donated contraceptives, technical as
sistance, and so on, while others do not. Coverage estimates include
the percentage of MWRA, or alternatively all users, in the country
who obtain their supplies from the CSM program. The latter mea
sure reflects not only the action of the CSM program, but also the
availability of contraceptives from other sources as well.
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Chapter 5

POSTPARTUM PROGRAMS1
One mode of delivering family planning services is the
postpartum program, initiated in the late 1960s through
a special international demonstration effort (Zatuchni,
1970; Castadot et al., 1975). The concept is to offer women
information and services at three points of contact: at the
prenatal visit, at the time of delivery, and at the six-week
checkup. Outpatient family planning services are in
cluded for all couples regardless of interval since birth,
as are postabortal services. In practice, many hospitals
and maternity homes omit one or more of these features,
or omit some contraceptive methods.

ter abortion). In particular, estrogen-based pills
reduce the quantity of breastmilk and pass ste
roids on to the infant. Appropriate hormonal
methods are the progestin-based ones, such as
the injectable, the minipill, and NORPLANT®.
Historically, most postpartum programs have
been urban-based and in established medical fa
cilities; consequently, large rural populations
have been relatively neglected (exceptions noted
below).
A full postpartum program requires coordina
tion among several departments of a hospital:
prenatal, delivery, abortion care, surgery (for
sterilization), and multiple outpatient depart
ments, especially where family planning and
maternal and child health (MCH) are separate.
Also, overtaxed medical facilities sometimes de
fer family planning services, including steriliza
tion, viewing them as elective procedures.

The advantages of postpartum programs include:
* The logistics are simple—adding family plan
ning to already established maternity services is
convenient for women and efficient for admin
istration.
* They offer a low-cost means of extending fam
ily planning services over a few years to much
of the active childbearing population, especially
in urban areas. Startup costs are low, as are mar
ginal operating costs; costs are also low com
pared to those of other delivery modes.
* They can advance health objectives by raising at
tendance at the six-week checkup, increasing in
fant immunizations, reducing the frequency of
short birth intervals with their severe dangers to
infant survival, reducing the frequency both of
repeat septic abortions and of unwanted births,
and raising the proportion of births that are at
tended through the attraction of contraceptive
services in the maternity facility.
* They can avert many unwanted conceptions by
providing contraceptives promptly after an abor
tion or birth, since the most fecund couples tend
to conceive quickly again, before obtaining con
traceptive protection. This applies especially to
those who breastfeed partially or not at all.

The disadvantages of postpartum programs include:
* Certain hormonal methods are not medically
appropriate soon after birth (though they are af
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COVERAGE AND POTENTIAL
1.

In many countries a substantial proportion of births
are now attended by medical personnel, though
variation across countries is still considerable.
l.a. In more than half of developing countries (51 of
96), over 50 percent of births are attended by health
personnel in established institutions (Table 1). In
about a third, over 70 percent of births are attended.
Still, the proportion of births that are attended var
ies greatly by country, from less than 10 percent to
over 90 percent. Further, variation among countries
is large within each of four regions.
l.b. Trained health personnel in many countries see
substantial proportions of women either prenatally, at
delivery, or postnatally, thus providing ready
occasions for dispensing family planning advice and
services. The following findings (Thapa et al. 1992)
document the potential for providing services around
the time of birth.
Prenatal: In 25 countries with DHS surveys, over 80
percent of pregnant women were seen prenatally in

pitals and maternity centers (Table 2) (this is the only
available global estimate). Coverage varies greatly:
The proportion of delivering women who receive the
service varies from less than 10 percent in 14 coun
tries to over 90 percent in seven. Even sub-Saharan
countries are distributed broadly: While over half fall
below 30 percent coverage, about one-third fall above
40 percent coverage.

Table 1 Distribution of 96 developing countries by the
percentage of all deliveries occurring in hospitals and maternity
centers
Percent
0-9
10-19
20-29
30-39
40-49
50-59
60-69
70-79
80-89
90-100

Latin
America

Asia
4
3

2
2
0
2
2
0
6
1
(22)

Total

Middle East/ Sub-Saharan
Africa
North Africa

Total

0
2
2
1
0
1
3
1
2
2

3
2
6
5
8
4
4
4
2
0

7
7
12
9
10
9
12
5
14
11

(14)

(38)

(96)

0
0
2
1
2
2
3
0
4

8
(22)

UNMET NEED
3.

Note: World Bank figures for 1985, covering 61 developing countries, give a similar
percentage distribution in the total column above. See World Bank, 1992, Table 28,
based upon WHO and UNICEF country information.
Source: Population Council Databank, 1992.

12 countries, and over 50 percent in 19.

3.a. Among women in union who were interviewed
7-9 months after a birth in 25 DHS surveys, a sub
group was "exposed": not pregnant and not abstain
ing, with menses having returned. Among women
in this group who were not using contraceptives,
substantial percentages did not want another child
or did not want one soon. As Table 3 shows, these
percentages ranged to very high levels. The base var
ies, that is, the proportions of exposed women who
were not using contraceptives tend to be quite high
in Africa and lower elsewhere, but these remarkably
high figures show much unmet need among this
group, whose menses have resumed. Other women
had already become pregnant by 7-9 months postpartum; those are omitted here (Thapa et al., 1992).

At delivery: Over 70 percent of women were attended
at delivery in nine countries, and over 50 percent in
12. In general, this distribution is somewhat less fa
vorable than for prenatal visits.
Postnatal: The available information pertains
to contacts with trained health personnel for at least
one immunization. Over 70 percent of women
report such a contact in 10 countries, and over 50 per
cent in 14, out of 21 surveys that included the ques
tion. These data are suggestive of the family plan
ning potential, even though immunization services
are often not linked to family planning services.
Closer linkage of various MCH services is a common
need.
2.

Many countries provide a family planning infor
mation and education service in delivery facilities.

4.

Substantial proportions of women who give birth
conceive again within nine months, and more do
so within 15 months (Table 4), leading to short birth
intervals that elevate the mortality risks for both
infants. (See Chapter 10 for further discussion of
this topic.) To alleviate this contraceptive services
are needed early, especially for the more fecund
couples, at highest risk of an unwanted conception.
Table 4 contains more than one birth for many
reporting women, since the data cover up to 15
years experience. Thus, women with more births
close together contribute more to the table, and they
are the ones with multiple infants at higher risks.
Some brief intervals are produced by early infant
deaths, with abbreviated lactation. (The following
figures are from Hobcraft, 1991, based on 25 DHS
surveys.)

5.

Many women become pregnant sooner after a pre
vious birth than they desire.

2.a. Respondents from 76 of the 96 countries in Table
1 reported that a family planning information and
education service exists for women delivering in hosTable 2 Distribution of 76 countries by percentage of women
delivering in hospitals and maternity centers who receive the
family planning information service
Percent
0-9
10-19
20-29
30-39
40-49
50-59
60-69
70-79
80-89
90-100
Total

Asia
2
0
3
0
1
1
0
4
2
3
(16)

Latin Middle East/ Sub-Saharan
Africa
America North Africa

3
0
2
1

2
1
2
1
0
1
1
0

4
2
(21)

0
(9)

2
2
4
1

Source: Population Council Databank. 1992.

1

8
6
3
4
2
4
1
0
0
2
(30)

Total
14
9
12
6
6
6
4
5
7
7
(76)

The failure to obtain contraception soon after giv
ing birth contributes to the unmet need for family
planning. At 7-9 months after giving birth, many
women are exposed to pregnancy who do not wish
to become pregnant but who still have not obtained
contraceptive protection.
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Table 3 Percentage of noncontracepting women in union
exposed to the risk of pregnancy 7—9 months after a birth, who
want no more children or want none soon

CURRENT METHOD
RECOMMENDATIONS

% of noncontracepting exposed
women who want to slop or spaca

Region and country
Sub-Saharan Africa
Burundi
Ghana
Kenya
Togo
Senegal
Botswana
Mali
Uganda

6.

94
86
79
77
67
63
59
55

Liberia

41

North Africa
Tunisia
Morocco
Egypt

80
80
66

6.a. However, many officials recommend otherwise,
contrary to the best international standards. In nine
countries the recommendations are to start pill use
(not differentiated by type) too early, and for the
IUD, too late. Country variation is considerable (gen
erally on the late side) for condoms, injectables, and
sterilization, with no consistent differences by region
(not shown).
In general, estrogen-based methods are inadvis
able at any time during lactation. Barrier methods
may be used at any time, and sterilization can occur
at any time (and vasectomy for the spouse even dur
ing pregnancy). IUD insertion can occur at any time.
The expulsion rate is higher when insertion occurs
very soon after birth, but among delivering women
who desire the IUD some would return for it later
whereas others would find it difficult to do so; there
fore, the decision on an early insertion is a matter of
judgment.

Latin America
Colombia
Peru
Ecuador
Dominican Republic
Bolivia
Guatemala
Trinidad and Tobago
Brazil
Mexico
Asia
Sri Lanka
Thailand
Indonesia

95
90
90
86
83
82
81
73
64

•

89
84
76

Note: In the sub-Saharan and North African countries, as well as in the three Asian
countries, a majority of these noncontraceptors want to space; in most of Latin
America, a majority want to stop.
Source: Thapaetal., 1992.

5.a. Only 11 percent (average) of respondents in 25
DHS surveys wanted their next birth to come within
two years of their previous one, but 35 percent had
birth intervals that were shorter than two years
(Hobcraft, 1991, Table 11; Westoff, 1991, Table 4.1).
In every country the difference between the actual
and desired birth-interval length was very large.
Also, these data omit unwanted early pregnancies
that end in induced abortion.

Table 4 Percentage of births conceived early (within nine
months or 15 months of a prevbus birth), by region
Number of
countries

Region
Latin America
North Africa
Sub-Saharan Africa
Asia
Mean

(9)
0)
(10)
(3)
25 DHS surveys
18WFSsurveys

Percent

<9 months"

<15 months 6

17-30
18-24
7-20
14-15

36-47
37-41
20-37
30-31

17
22

35
42

'Birth interval 17.9 months or less.
'Birth interval 23.9 months or less.
Not*: Some births were 1-2 months premature, so conceptions occurred later than
indicated.
Source: Hobcraft, 1991.
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Currently, health officials in many countries sug
gest that breastfeeding mothers initiate contracep
tive use within about four months of giving birth
(before 18 weeks), that is, before weaning would
normally occur, and some recommend it within the
first six weeks (Table 5). Such recommendations,
when implemented for the appropriate methods,
help protect against another pregnancy for those
who breastfeed partially or not at all.

INTEREST IN POSTPARTUM SERVICES
7.

Interest in postpartum services has been substan
tial in many countries.
7.a. There is extensive behavioral evidence that many
women desire contraceptive assistance at or soon af-

Table 5 Number of weeks postpartum that breastfeeding
mothers are advised to start using contraceptic>n, by mletnod, «b
developing countries
Weeks postpartum
Method
Pills
Injectables
IUD
Barrier/condom
Spermicides
Sterilization

<S

6-11

12-17

<A7

18+

9
1
8
9
1
0

20
13
26
18
5
4

9
8
9
4
2
3

38
22
43
31
8
7

15
10
16
11
3
5

Number of
countries
(53)
(32)
(59)
(42)
(11)
(12)

Note: For 86 developing countries; not all countries replied for each method.
Source: Population Council Databank, from 1989 questionnaire survey to country
informants.

ter birth, as do many who present at hospitals with
incomplete abortions. As early as the 1966-73 period,
when contraceptive options were more limited than
now, large-scale postpartum programs experienced
substantial response rates. The 138 hospitals partici
pating in the International Postpartum Program
during those years saw 3.5 million obstetric cases (in
cluding women presenting with incomplete abor
tions). Some 1.1 million women adopted contraception
through the program, most of them before leaving the
hospital or within three months afterwards; the others
came for service after a longer delay, or they heard
about the program by word of mouth without hav
ing been a patient at one of the hospitals. As an av
erage over the 21 countries involved, the ratio of con
traceptive adopters to the obstetric volume was
nearly one to three. This substantial response encour
aged widespread adoption of the postpartum ap
proach, both in maternity services and in outpatient
clinics (Castadot et al., 1975; Zatuchni, 1970).
7.b. Motivation for postpartum contraception ap
pears in results from a uniform series of small stud
ies in six countries, based on 100 to 110 respondents
in each country: Colombia, Dominican Republic, In
dia, Kenya, Mali, and Turkey (Landry et al., 1992).
Mean values across all sites, for women interviewed
before leaving the hospital, were as follows: 43 per
cent had ever used a method, and 20 percent had
been using a method when they became accidentally
pregnant. Fifteen percent took a method before leav
ing the hospital, an additional 29 percent stated they
intended to begin use within six weeks, and a fur
ther 34 percent, within six months, for a total of 78
percent starting or intending to start use within six
months. Forty-nine percent said they did not want
the last pregnancy either at that time or ever, and 55
percent said they now want no more children.
7.c. Motivation for early contraception is evident in
a Peruvian experiment. A variety of contraceptive
methods were offered prior to discharge to women
who delivered in one ward, and 81 percent accepted
a method before leaving the hospital. Women who
delivered in a control ward that received no in-hospital contraceptive services also adopted contracep
tive methods at an appreciable rate soon after leav
ing the hospital; interviews at six months found 82
percent of the experimental group using a method
and 69 percent of the control group doing so. Thus,
substantial, early contraceptive practice was found
in both groups, with somewhat more in the experi
mental group. Approximately 50 percent of subjects
were lost to follow-up, but both groups had equiva

lent non-respondent characteristics (Foreit et al.,
1993; Population Council, 1992).
7.d. Among current users of sterilization in 16 of 18
countries studied in DHS surveys, over 30 percent
had taken the method postpartum; in 10 of these
countries, over half had done so (Rutenberg and
Landry, 1991).

EFFECTS UPON ABORTIONS
8.

Some facilities that offer postpartum or postabortion contraception have experienced a decline
in the number of septic abortion cases seen.
8.a. In the International Postpartum Program, hos
pitals experienced a decline in the monthly number
of abortion cases, with a 10 percent fall from the
three-year average prior to the postparrum program
to the period 18-24 months later. A similar compari
son over time for six US hospitals showed a 22 per
cent decline, though with an irregular time trend
(Zatuchni, 1970).
8.b. Analysis of individual hospitals showed consid
erable variation: 10 hospitals experienced declines in
septic abortion cases from 18-41 percent, five expe
rienced an increase, and nine showed no clear
change. Some evidence suggested that declines in the
number of abortion cases partly reflected the gen
eral availability of family planning services in the
area (Zatuchni, 1970, pp. 69-74), as well as other fac
tors, in addition to the impact of the hospitals' own
postpartum and postabortion services.

BREASTFEEDING AS A
CONTRACEPTIVE METHOD
9.

Breastfeeding lengthens the birth interval, on av
erage, but is only partially useful for the individual
as a contraceptive strategy, and it has limited pro
grammatic potential as a substitute for contracep
tive methods.
9.a. On a population basis, extended breastfeeding
depresses the fertility rate (Bongaarts, 1975); how
ever, except under special circumstances, it is no
guarantee for the individual woman. Pregnancies
can occur during the early months of breastfeeding,
and even before the return of menses. In one study,
ovulation occurred before the menses returned in 20
percent of women who were bottlefeeding their
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in the developing world at large. In their careful as
sessment of breastfeeding data in WFS and DHS sur
veys for 47 countries, Trussell and colleagues (1992)
found that breastfeeding durations have not changed
markedly. They are somewhat longer in some coun
tries and somewhat shorter in some others. They are
consistently longer among less educated and rural
women, and they are increasing among urban wo
men. Durations are clearly longer in Africa and Asia
than in Latin America.

babies and in 45 percent of women who were breast
feeding (Howie et al., cited in Winikoff and Mensch,
1991, p. 295).
9.b.The strict practice of breastfeeding for the first
six months after birth has been examined as a delib
erate contraceptive option. "More than 98 percent
protection from pregnancy in the first six months"
is promised if two conditions are met: that breast
feeding is full or nearly full, and that amenorrhea
continues. If either condition is compromised, other
means are then needed to retain a high degree of pro
tection (FHI, 1988; Kennedy et al., 1989). The report
says that women relying on breastfeeding for its con
traceptive efficacy should delay introduction of other
foods, although it also notes that these are usually
needed between the fourth and sixth months.

THE OVERLAP QUESTION
10. Early contraceptive use is advisable even though
some of it overlaps with postpartum amenorrhea.

9.c. Full breastfeeding, in any case is very uncom
mon, as Figure 1 makes clear. This is unfortunate, and
even though many countries are trying to encour
age breastfeeding, actual practice falls far short of
giving protection against unwanted pregnancy. The
brevity of full breastfeeding limits its protective ef
fect, and contraceptive supplementation is required
if unmet need is to be addressed.
9.d. Despite its fallibility as a contraceptive for the
individual, breastfeeding greatly enhances infant
health; moreover, it does not appear to be in decline

lO.a. When breastfeeding confers reliable protection
against pregnancy, simultaneous contraceptive use
is thought to be redundant. However, several con
siderations qualify this. Much breastfeeding gives
incomplete protection, as does some contraception.
A programmatic emphasis on breastfeeding alone
will result in unwanted pregnancies, yet breastfeed
ing is needed quite apart from its contraceptive ef
fects. Programs that avoid overlapping protection by
trying to delay contraception until the return of each
woman's menses will not work well, since field pro
grams cannot be so closely fine tuned. As with breast-

Figure 1 Percentage of infants 0-4 months who are breastfed exclusively
Percent breastfed exclusively

Source: Ross et al., 1992, Figure 8; see also Table 35. Taken from DHS surveys.
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feeding alone, such a strategy will cause unwanted
pregnancies. It involves the risk of what has been
termed "underlap," i.e., a gap between postpartum
ovulation and the initiation of contraception.
lO.b. Many women want contraceptive services (in
cluding sterilization) after delivery, while they are
still at the facility (see 7.c.); indeed, some explicitly
choose a facility for delivery that will provide con
traception simultaneously. Overlap is a trivial con
sideration with sterilization, and is minor for the bet
ter lUDs, since the duration of overlap with full
breastfeeding is a small part of their total protection
time. Further, there are acceptable personal trade-offs
with overlap: Women can initiate protection when
they wish rather than having to wait; in addition,
early access to condoms is needed as a measure
against AIDS and other sexually transmitted diseases
(STDs).
lO.c. All these considerations underlie the provision
of contraceptive advice and services, along with
breastfeeding instruction, at all three points of con
tact: the prenatal visit, delivery, and the six-week
checkup.

NOTES
1.

This chapter is based partially upon draft materials prepared by
Steven R. Green.

2.

A responseof "six weeks" is included in the "6-11 week" category.
A response of "three months" is included in the "12-17" week cat
egory.

3.

Column totals are not shown because the same respondent could
reply to several items.

4.

Data are only approximate; respondents within the same country
often gave differing responses.
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Chapter 6

CHARGES AND PAYMENTS ASSOCIATED WITH
PROVISION OF FAMILY PLANNING SERVICES
Governments must decide on appropriate charges for the
family planning supplies and services they provide.
These charges vary greatly across methods and countries,
but programs usually subsidize family planning by pro
viding services free. Some countries provide payments
to contraceptive acceptors, motivators, and providers.
Others charge for services. Price levels reflect compet
ing goals: recovering costs to the program, maximizing
the number of users, and simplifying the administrative
tasks of service providers.

ilization, but charged for reversible methods of con
traception, such as pills and condoms.
3.b. In the late 1980s India, Vietnam, and Bangladesh
paid acceptors of lUDs and sterilization, but pro
vided other methods free (Cleland and Mauldin,
1991).
3.c. Panama and the Dominican Republic charged
for sterilizations, but provided reversible methods
free. Ghana charged for reversible methods, but pro
vided sterilizations free (late 1980s).

STRUCTURE OF PAYMENTS AND
CHARGES
We distinguish among three categories: charges for services
or methods, no charges, and payments to acceptors, pro
viders, or motivators. Table 1 classifies methods available
from programs according to these price categories.
1.

Most developing countries provide most methods
free of charge.

1.a. Of 59 developing countries for which informa
tion is available, 57 provide one or more methods
free, while 35 provide all methods free. Only Sing
apore and Peru charge for all methods.
2.

Oral contraceptives and condoms are most likely
to carry charges. Sterilization is least likely to carry
a charge and most likely to carry a payment.
2.a. Of the 22 countries that make charges, all but
seven charge for oral contraceptives and condoms.
Only six countries charge for female sterilization,
while two charge for male sterilization.
2.b. As of 1989, six countries provided payments to
sterilization acceptors; two provided payments to
IUD acceptors.

3.

Pricing policies within countries are not always
consistent across methods. These inconsistencies
may reflect a desire to encourage the use of high
continuation methods.
3.a. In 1989 Pakistan paid acceptors of (female) ster
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TYPES OF PAYMENTS
Payments associated with contraceptive use or reproduc
tive behavior can be classified according to the behavior
for which the payment is made, who the recipient of the
payment is, what the nature and the amount of the pay
ment is, and when the payment is awarded.
4.

The most common type of payment to contraceptive adopters is a one-time cash award for sterilization or an IUD, as compensation for costs associated with adoption (such as lost work time and
travel).

4.a. In the mid-1980s, the Indian program compen
sated sterilization and IUD acceptors for expendi
tures on drugs, meals, transportation to and from the
clinic, and lost wages (US$9.00 for sterilization, $1.00
for lUDs) (Satia and Maru, 1986).
4.b. Until recently sterilization acceptors in Bangla
desh received the equivalent of about $5.50 (approxi
mately one week's wages) and a sari or lungi to use as
a clean surgical garment (Cleland and Mauldin, 1991).
4.c. Between 1980 and 1989, Sri Lanka compensated
sterilization acceptors for "actual and anticipated
costs." The amount of the payment varied between the
equivalent of $4.00 and $20.00 (De Silva et al., 1988).
4.d. A pilot program in India demonstrated that
small cash incentives attracted large numbers of

Table 1 Charges and payments to contraceptive acceptors, public sector, by country
Charge acceptor fees
Region

Countries

Methods
provided"*

Africa

Benin
Congo
Ethiopia
Ghana
Guinea
Lesotho
Madagascar
Nigeria
Zaire

l,O,ln,C,S
l,O,ln,C,S
l,O,S,D,St
l,O,ln,C,St,S
l,O,ln,C,S
l,O,ln,C,St,S
l,O,ln,C,St,D,S
l,O,ln,C,S
I,O,ln,C,St,S

Middle East

Latin America/
Caribbean

Lebanon

Dom. Rep.
Guatemala

I,O,C,S

St
I,O,C,S

Neither charge
nor pay acceptors
Countries

Charge acceptor fees

Methods
provided""

Burkina Faso
All
All
Burundi
All
Cameroon
All
Chad
All
Central African Rep.
Ethiopia
In
All
Kenya
Mali
All
All
Mauritania
Mauritius
All
All
Mozambique
All
Niger
St
Nigeria
All
Rwanda
All
Sierra Leone
All
Mil
Sudan
All
Tanzania
All
Mil
Togo
All
Uganda
All
Zambia
Alt
Zimbabwe
All
Morocco
All
Algeria
All
Tunisia
All
Iran
All
Turkey
All
Jordan
ln,St,N
Syria
Brazil
Chile

Region

Countries

Methods
provided ••b

Latin America/
Caribbean
(continued)

Panama
Peru
Puerto Rico
Venezuela

I.O.St.S
All
l,O,C,St,D,S
l,St,S

Asia

Hong Kong
Indonesia
South Korea
Malaysia
Pakistan
Singapore
Sri Lanka

l,O,ln,C,St,D.S
N,St
O,C
S,D,St(M),l,O,ln,C
S,C,O
All

Taiwan

O,I,C

All
All

o,c

Neither charge
nor pay acceptors
Countries

Methods
provided*^

All
Colombia
All
Costa Rica
i,o,c,s
Dom. Rep.
All
Ecuador
E! Salvador
All
Guyana
All
Haiti
All
Honduras
All
Jamaica
All
Mexico
All
Nicaragua
All
Panama
C
Paraguay
All
Trinidad &
All
Tobago
O,ln
Venezuela
All
Bangladesh
All
China
Hong Kong l,O.ln,C,D,S
l,St
India
l,O,ln,C
Indonesia
All
North Korea
l,St,Ab
South Korea
St(F)
Malaysia
All
Mongolia
All
Nepal
St.ln.l
Pakistan
All
Philippines
St,N,ln,l
Sri Lanka
Taiwan
St
All
Thailand
All
Vietnam

'Codes are: I = IUD; C = condoms; O = orals; In = injectables; St = sterilization (male or female); Ab = abortion; D = diaphragm; S = spermicides; N = NORPLANT®.
"The methods listed are those for which the countries charge.
The methods listed are those for which the countries neither charge nor pay.
Notes: A few countries (listed below) provide payments to acceptors (usually only for sterilization or the IUD). Information is shown here as of 1989 (or 1987 in a few cases).
Bangladesh: Sterilization ($5.42)
IUD ($0.46)
Sterilization ($0.62) (1987)
India:
IUD ($0.68) (1987)

South Korea:
Nepal
Pakistan:
Sri Lanka:
Thailand:
Vietnam:

Sterilization—Monetary subsidies to low-income sterilization acceptors for lost wages.
Sterilization ($3.68)
Sterilization (female) ($ 1.00-$2.43)
Sterilization ($13.87)
Sterilization ($4.44)
IUD ($1.11)
IUD ($1.00)
Sterilization ($4.00)

Source: Rossetal., 1992.

women to clinics, where many of them accepted tem
porary methods. For some women, payments con
tinued on a monthly basis after initial acceptance.
Method continuation rates were unrelated to the du
ration for which payments were received (Stevens
and Stevens, 1992).
5.

Some programs pay motivators or, more commonly,
providers of contraceptive services on a per-case
basis. These payments may raise contraceptive
prevalence by increasing the diffusion of informa
tion to potential acceptors and by encouraging

health care providers to devote attention to family
planning services.
5.a. In the Asian region, Indonesia, the Philippines,
and Taiwan make per-case payments to service pro
viders for oral pills; a few countries in other regions
also do. A number of additional countries make percase payments for IUD insertions and sterilizations
(Table 2) (Ross et al., 1992).
5.b. India, Bangladesh, and Indonesia at different
times have provided small payments to people who
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Table 2 Public sector payments to providers8 for contraceptive
acceptance

low levels. Women in high-prevalence communities
who were family planning acceptors could borrow
money from the funds at interest rates of only 1 or 2
percent (Ancok, 1984).

Method and provider
Country
Ethiopia
Lesotho
Sierra Leone
Lebanon
Colombia
Dom. Republic
El Salvador
Paraguay
Bangladesh
Indonesia
South Korea
Nepal
Pakistan
Philippines
Sri Lanka
Taiwan

Female
sterilization

Male
sterilization

Intrauterine
device

Oral
contraceptives

M
na
na
M.N
M
M
O
M.O
M.N
M
M.O
M,N,O
M,N,0
O
M.N
O

M
na
na
M,N
M
M
O
na
M.N
M
M,O
M.N.O
na
0
M,N
O

na
M
M
M,N
na
M
O
na
O
M,N
M
M,N
na
O
na
O

na
M
M
M,N

6.b. In Madhy'a Pradesh, India, village councils re
ceived money for development projects if they
achieved sterilization targets. In Gujarat, village
councils received one bag of cement for each vasectomy acceptor (Fincancioglu, 1982).

na
O
O
na

na
M.N
na
na
na
O

6.c. In one area of Thailand, village distributors of
contraceptives purchased a water buffalo to rent to
villagers. Rental rates were two times higher for
noncontraceptors than for contraceptors (David and
Viravaidya, 1986). In another area contraceptors
could obtain larger loans than could noncontracep
tors (Weeden et al., 1986).

na
M,N,O

• Provider codes are = M: medical doctors; N: nurses and/or midwives; O: others.
Notes: na = not applicable.
Countries making no per-case payments: Angola,
Botswana, Burkina Faso, Cameroon, Central African Republic, Chad,Congo, Ghana,
Guinea, Madagascar. Mauritania, Mozambique, Nigeria, Rwanda, Senegal, Sudan,
Tanzania,Togo, Uganda, Zaire. Zambia, Argentina, Chile. Costa Rica, Ecuador, Haiti,
Jamaica, Mexico, Panama, Morocco,Tunisia.Turkey, Myanmar,China, Hong Kong,
North Korea, Malaysia, Vietnam.
Source: Ross et al., 1992, Table 27.

6.d. Barnett (1987) lists a variety of community-level
measures to reward the uptake of contraceptives in
parts of Indonesia, Thailand, and India. However,
clear evaluations of their effects have not been done.
7.

motivate men and women to adopt contraception.
The role of these motivators has varied from describ
ing the steps involved in taking a method to accom
panying sterilization acceptors to the clinic and pro
viding support after the operation (Satia and Maru,
1986; Ancok, 1984).
5.c. Of 16 countries that make per-case payments,
most pay medical personnel. Taiwan, the Philip
pines, and El Salvador pay non-medical workers.
PROFAMILIA in Colombia provides per-case pay
ments to workers in its community-based program;
data from 1984 indicate an increase in sales due to
these payments (Townsend, 1993).
6.

Some incentive schemes focus on communities.
Designs vary, but the community typically receives
rewards for attaining certain levels of contraceptive
prevalence. Some rewards are a "public good," such
as installation of a tube well. Other rewards.may
be passed on to individual contraceptors within the
community.
6.a. In a rural area of the Philippines, one bank
granted loans at an interest rate of 10 percent (rather
than 12 percent) to women who accepted contracep
tion and did not get pregnant for one year (David,
1982). A similar scheme in Indonesia made funds for
income-generating projects available to communities
with high prevalence levels, but not to those with
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Some countries promote low fertility with non-cash
incentives and disincentives, such as preferential
access to health facilities and schools for small
families.
7.a. China provides advantages to only children and
their parents, such as preference in housing alloca
tion, supplements to monthly salaries, and priority
in school admissions (Chen et al., 1982).
7.b. In Indonesia public servants do not receive any
paid maternity leave after the first birth; rice allow
ances cover only a small number of children; and
only three children can be deducted from taxes
(Ancok, 1984).
7.c. Singapore has used a variety of incentives, first
to reduce fertility and, after it fell to an alarmingly
low level, to raise it among the better educated. Si
multaneously, Singapore sought to discourage births
among the less educated and poor by offering them
substantial housing financing if they chose steriliza
tion after the first or second child (mother below age
30), and also by raising the hospital delivery fee for
third and later births (Singh et al., 1991).
7.d. In India some couples who have only two chil
dren and accept sterilization may receive a green
card, which is meant to give them first priority in
terms of loans, housing allotments, and medical fa
cilities (Satia and Maru, 1986; Government of India,

ca. 1986). However, in practice the card appears to
have been little used.
7.e. Barnett's (1987) comprehensive compilation of
the incentive and disincentive measures tried in vari
ous countries includes such examples as agricultural
assistance to family planning acceptors, corporate tax
exemptions for firms providing employees with fam
ily planning services, priority for government hous
ing for contraceptors, and maternity leave for a lim
ited number of children.

THE EFFECT OF PAYMENTS ON
CONTRACEPTIVE USE
8.

Though the presence of compensation payments
appears to be an important factor in clients' decisions to accept sterilization, most clients express a
strong desire to limit family size as well.

8.a. Evidence from detailed case studies of acceptors
and surveys in Bangladesh indicates that the exist
ence of compensation payments contributes to the
decision to be sterilized (particularly for men) in a
large number of cases (Cleland and Mauldin, 1991).
8.b. In focus-group discussions with sterilization ac
ceptors in Bangladesh, all participants expressed a
need to limit family size, regardless of whether they
felt that the compensation payment had influenced
their choice. Age and parity of acceptors did not vary
seasonally or by level of payment, as one might ex
pect if a financial motive were more important than
a contraceptive motive (Cleland and Mauldin, 1991).
8.c. In Sri Lanka 60 percent of vasectomy acceptors
were using contraceptives before their vasectomy.
Increases in the payment did not change the percent
age of acceptors saying they had wanted their wife's
last pregnancy (De Silva et al., 1988).
9.

Payments or other rewards raise the prevalence levels of the methods for which rewards are offered.

9.a. In South Asia almost two-thirds of acceptors use
methods for which payments are made. In other re
gions (excluding China), only 12 percent of accep
tors use the methods for which acceptance is com
pensated in South Asia (Mauldin and Sinding, 1992).
9.b. A community incentive program in Thailand re
sulted in much higher levels of contraceptive preva
lence (all methods) and lower proportions of women
pregnant in program villages where incentives were

available than in matched control villages (see Fig
ure 1). In the program villages prevalence rose from
46 percent to 76 percent, and the proportion preg
nant fell from 10.9 percent to 5.4 percent. In the con
trol villages prevalence rose from 51 percent to only
57 percent, and the proportion pregnant rose from
7.4 percent to 8.2 percent (Weeden et al., 1986).
9.c. In Sri Lanka monthly acceptance rates for steril
ization varied directly with the level of the compen
sation payment. For example, the average number
of monthly vasectomy acceptors was 1,030 when
payments were the equivalent of $12.00 (January
1982-May 1983), but increased to 3,137 when pay
ments increased to the equivalent of $20.00 (June
1983-December 1985) (Thapa et al., 1987).
9.d. In South Korea acceptance rates for sterilization
increased by 67 percent for males and 53 percent for
females in the months following the doubling of pay
ments to acceptors, as compared to acceptance rates
for the same months one year earlier. Increases in
acceptance rates for lUDs, condoms, and pills were
much smaller, at 31 percent, 7 percent, and 1 per
cent, respectively (Reditt, 1982).
10. Where payments for method acceptance are available, the poor are more likely to adopt the compensated methods than are the rich.

10.a. In Bangladesh, India, and Sri Lanka, steriliza
tion acceptors receive compensation payments. In
each of these countries, people of low economic sta
tus are more likely to choose sterilization than are
people of higher economic status. In countries with
out compensation payments, there is no relationship
between economic status and use of sterilization
(Cleland and Mauldin, 1991).
lO.b. In Sri Lanka levels of payment for acceptance
of sterilization have fluctuated between the equiva
lent of $4.00 to $20.00. Higher levels of payments
were accompanied by larger proportions of accep
tors with incomes of less than about $40.00 per month
(De Silva et al., 1988).
lO.c. In a comparison of Bangladeshi women who had
and had not undergone tubectomies, matched by vil
lage, number of living children, and desire for more
children, the tubectomized women were worse off in
a number of ways, including land and livestock own
ership, household possessions, perceived inadequacy
of income, and experience of a severe food shortage in
the past five years (Cleland and Mauldin, 1991).
11. Payments for sterilization acceptance probably
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Figure 1 Percentage of married women aged 15-44 in program and control villages practicing contraception (CPR) and
percentage pregnant, Thailand, May 1983-May 1985
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Percent pregnant
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Percent pregnant
Source: Weeden ct al., 1986, p. 12, Figure 1.
Reproduced with the permission of The Alan Guttmacher Institute from Donald Weeden, Anthony Bennett, Donald Lauro,
and Mechai Viravaidya, "An Incentives Program to Increase Contraceptive Prevalence in Rural Thailand, " International
Family Planning Perspectives, Volume 12, No. 1, March 1986.

have a larger effect on the acceptance rates of men
than of women.
ll.a. The ratio of male to female acceptors of steril
ization in Sri Lanka varied directly with the amount
of the compensation payment (see Figure 2). In US$
equivalents, when the payment was $4.00 the ratio
was approximately .35. When the payment was in
creased to $20.00 the ratio rose to 1.8. Later, when
the payment was decreased to $8.00 the ratio fell back
to approximately .25. Subsequently the payment was
increased from $12.00 to $20.00 and the ratio in
creased again, from below .25 to about 1.2 (Thapa et
al., 1987).
11.b. Similar evidence exists for Bangladesh. In 1983
payments to acceptors were increased from the
equivalent of $4.00 to $7.00. The number of vasectomy acceptors more than doubled, while the num
ber of tubectomy acceptors rose only 1.2 times
(Cleland and Mauldin, 1991).
12. Payments to motivators are associated with in
creased use of methods for which the payments are
offered.
12.a. Between April and June 1987, 99 percent of fe
male and 84 percent of male sterilization acceptan
ces in Bangladesh were associated with a third party.
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For men, 43 percent of these motivators were selfemployed agents (rather than family planning field
workers); for women, 25 percent of motivators were
self-employed agents (Cleland and Mauldin, 1991).
12.b. In the mid-60s, the Tamil Nadu government
paid the highest per-case fees to motivators of any
Indian state. Correspondingly, acceptance rates for
vasectomy in Tamil Nadu were over three times
higher than in any other Indian state (Rogers, 1971).
12.C. In a 1970 experiment with rewards of powdered
milk in Ghana, contraceptive acceptance levels were
1.6 times higher when both clients and motivators
were milk recipients than when only the clients were,
and three times higher than when neither was
(Perkin, 1970).

THE EFFECT OF CHARGES ON
CONTRACEPTIVE USE
Charging users for contraceptive supplies has advantages
and disadvantages, both to the user and to the family
planning program. If charges for services are reinvested
in clinics, equipment, or more staff, charges may increase
the efficiency with which services are supplied, reduc
ing users' costs of travelling to clinics and waiting for
appointments. A charge for contraceptives also implies

Figure 2 Ratio of male to female sterilization acceptors, Sri Lanka
Ratio

1980

1981

1983

1982

1984

1985

Year
*Read: Two males for each female
Source: Thapa et al., 1987.

that the user is receiving something of value; moreover,
potential acceptors may question the motives of agen
cies that provide products free. On the other hand, large
volumes of small transactions are difficult administra
tively, and in economies with low levels of rnonetization,
users may have a hard time finding cash for contracep
tive supplies. One review (Lewis, 1986) of numerous
studies concerning price elasticity in contraceptive use
concludes that demand differs little between free services
and moderately priced ones, and that modest rises in
price have little effect on contraceptive use. Still, reduc
tions in prices have considerably increased use.
13. When prices are lowered, demand usually rises and
clients may continue use of resupply methods
longer.
13 .a. In Taiwan a reduction in the price of oral con
traceptives from the equivalent of $.25 to $.025 was
accompanied by an increase of 2,500 to 6,000 cycles
purchased per month (Cernada, 1982).
13.b. In the fourth quarter of 1976 Thailand abolished
charges for pills. The number of new users rose dra
matically, from 81,000 to 125,000 by mid-1977. The
number of new users of other methods increased by
much less. The increase in pill use seemed not to be
the result of women switching from other methods
or sources (Knodel et al., 1984), although in some ar
eas private sources of contraceptives that continued

to charge fees lost business (Baldwin, 1978).
13.C. Continuation rates for pills in Thailand were
slightly higher for women who received the pill free
than for women who paid (Knodel et al., 1984).
13.d. In Turkey the Ankara Maternity Hospital
provided free pills to clients, but due to a supply
shortage began providing only prescriptions, which
clients had to have filled at some expense. Continu
ation of use as of six months fell from 53 percent to
19 percent.
14. Other evidence suggests that demand for contra
ceptives that cost only a small amount may not dif
fer appreciably from demand for contraceptives
that are free.
14.a. In Taiwan pills were offered at three different
prices in three different areas: free, the equivalent of
$.13, and the equivalent of $.25. The numbers of new
acceptors were similar in the areas where pills were
free or offered at $.13, but were only half as large in
areas where $.25 was charged (Cernada, 1982).
14.b. A pill distribution scheme in Egypt sent visi
tors to women's homes to offer four cycles of pills
free. Women in one area were told they could visit a
nearby clinic to receive additional free supplies.
Women in another area were told they could visit a
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nearby clinic to purchase more supplies at $.05 per
cycle. In both areas, prevalence rose from 19 percent
to 27 percent over the nine-month study period
(Gadallaetal.,1980).
14.c. In a Philippine study, women were more likely
to choose methods for which a small price was
charged than to choose those that were free, although
beyond a certain threshold, the price discouraged se
lection of the method (Schwartz et al., 1989).
14.d. In Jamaica and Thailand the decision whether
to purchase contraceptives or obtain them free was
not affected by the price of the selected method
(within a low range). Instead, a woman's age and oc
cupation were more important; women of older age
and higher status tended to purchase (Schwartz et
al., 1989).
15. Use of the more effective contraceptive methods
may be less sensitive to price than is use of less ef
fective methods. Price differentials favoring more
effective methods may encourage women to choose
these methods.
15.a. In interviews in the Philippines and Thailand,
suppositional increases in the price of condoms
greatly lowered the predicted probability of use: the
likelihood of choosing condoms was predicted to
decrease by 45 percent, and 28 percent, respectively,
for an increase of one standard deviation in price.
However, percentage changes in the probability of
choosing injectables, pills, and lUDs were much
smaller, all below 7 percent. An increase in the price
of sterilization in Thailand would decrease the prob
ability of selecting sterilization by only 1.2 percent
(Schwartz etal., 1989).
15.b. In two Thai provinces experimental price
changes were introduced that raised the price of pills
relative to injectables; these were followed by shifts
from pills to injectables (Myers et al., 1991).
16. When women are questioned about barriers to
contraceptive use, very few mention cost as an is
sue. A partial exception occurs in Latin America,
where some women are unable to obtain a tubectomy because of the expense.
16.a. Participants in focus groups in Mexico almost
never mentioned cost as a criterion for choosing one
method over another, although cost appeared to af
fect the decision of where to obtain a method (FolchLyon etal., 1981).
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16.b. The recent round of Demographic and Health
Surveys asked women who had discontinued a
method in the past five years why they had stopped
using the method. Cost was rarely cited as the prob
lem. The proportion of women who discontinued
because of expense exceeded 5 percent only for
injectables, and then in only four of over 20 coun
tries (Bolivia, Guatemala, Thailand, and Indonesia).
16.c. In Brazil, Guatemala, and Honduras, women
who were interested in sterilization but had not yet
obtained it were asked why. Large proportions cited
the cost of the procedure (Janowitz et al., 1985).
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Chapter?

CONTRACEPTIVE CONTINUATION AND EFFECTIVENESS
Whatever the adoption rate for contraception, better con
tinuation raises prevalence quite sharply. Further, as
prevalence rises, method effectiveness increasingly de
termines the fertility level, since the failure rate involved
applies to larger numbers of couples.
Information on continuation and effectiveness comes
from three basic sources: clinic data, program information,
and household surveys. The first has provided precise es
timates of continuation and failure rates for individual con
traceptive methods; the second has produced rates that re
flect more general field conditions; and the third has
afforded a picture of behavior in the general population.1
Some continuation and failure rates are aggregated,
which involves merging data across all durations of use
and converting them to an artificial annual measure. Oth
ers derive from life-table techniques, based on a sepa
rate rate for each month of use, with cumulation of
monthly continuation rates to estimate the proportion of
original acceptors still contracepting after each period of
time. The life-table failure rate estimates the proportion
of original acceptors who would have experienced a con
traceptive failure by each interval of time. Most rates
given below are from life-table estimates and pertain
chiefly to developing countries. Because studies vary
greatly in their definitions and procedures, results are
presented by method and source of information. For
other reviews of methodology and detailed results, see
Trussell and Kost (1987), Jejeebhoy (1989), and Bongaarts
and Rodriguez (1991).
The subject of continuation takes on particular im
portance regarding overall prevalence of use (see Chap
ter 1). As Figure 1 illustrates, prevalence is much more
sensitive to the annual continuation rate than it is to the
acceptance rate. Prevalence can rise to 50 percent of the
population even though the acceptance rate is as low as
5 percent, providing the annual continuation rate among
users is 90 percent (Jain, 1989; cited in Bruce and Jain,
1991). The continuation rate varies greatly among con
traceptive methods, but a variety of method choices helps
couples initiate contraception earlier and find alternative
protection when their method becomes unsatisfactory.

CONTRACEPTIVE CONTINUATION
RATES
1.

Contraceptive continuation varies across methods.
Variation also exists within each method: continu
ation for the IUD is typically longer than that for
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the pill, which, in turn, exceeds that for the condom.
Injectable continuation rates appear to vary sub
stantially. Information to date gives high continu
ation for the NORPLANT® method. Rates for all
methods also differ depending upon the data
source (clinic, program, survey).
Estimates below, unless otherwise cited, come from a
general review of the literature (Frankenberg and Ross,
1992).

Oral Contraceptives
l.a. Most 12-month continuation rates for oral con
traceptives fall between 40 percent and 60 percent.
Regardless of the type of data (clinic, program, or
survey), the median is 45-50 percent. The range of
estimates from program data (23-72 percent from 13
studies) is wider than that from clinic data (40-64
percent from seven studies). An extensive review of
early experience found a wide range of continuation
rates, from 25 percent to 80 percent for all types of
data, which agrees with the outside limits of ranges
above (Mason, 1970).

lUDs
l.b. For ILJDs 12-month continuation rates typically
fall between 70 percent and 85 percent, above those
for the pill, even after taking account of age and fam
ily size. The median from program data (74 percent
from 13 studies) is considerably lower than the me
dian from clinic data (83 percent from 15 studies).
Program estimates range from 48 percent to 92 per
cent, while clinic estimates range from 68 percent to
90 percent.

Injectables
I.e. Twelve-month continuation rates for injectables
vary substantially, but are generally lower for clinic
data than for program data. Estimates from clinic
data range from 22 percent to 63 percent, with a me
dian of around 38 percent (based on six studies). Es
timates from program data range from 50 percent to
75 percent, with a median of 60 percent (based on
six studies).

The following evidence is from a long-term fol
low-up of IUD acceptors in Taichung, Taiwan (Moots
and Chen, 1973). (Although the data are from the
early history of family planning programs, they il
lustrate important points.)

Figure 1 Contraceptive prevalence rate resulting from
various combinations of annual acceptance and
continuation rates per 100 married women of
reproductive age (MWRA)
60

Percent using

2.a. Termination rates projected for years eight and
nine of the study, from data on IUD termination rates
in previous years, underestimated the extent to
which women would continue use.
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2.b. At the beginning of the study, 81 percent of the
IUD acceptors had never previously used a contra
ceptive method, but during the study period the per
centage using some effective method never fell be
low 65 percent.
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30

20

10

2.c. The percentage of IUD acceptors still using their
first IUD was 30 percent at 54 months of use and 19
percent at 104 months. However, when reinsertions
of lUDs were considered, over 50 percent of the
women were still using an IUD 90 months into the
study.

10.0

5%/50%

5%/90%
10%/75%
20%/40%
Acceptance rate/Continuation rate

Source: Bruce and Jain, 1991.

CONTRACEPTIVE FAILURE RATES
NORPLANT®
l.d. Estimates of one-year continuation rates for
NORPLANT8, all from clinic data, range from 80 per
cent in Scandinavia to 94 percent in China and 95
percent in Chile. Two-year continuation rates are 67
percent or higher (Sivin, 1988).

Condoms
I.e. The few studies available suggest that 12-month
continuation rates for condoms are no higher than
45 percent.

Periodic Abstinence
l.f. Clinic, survey, and program data on continua
tion of periodic abstinence suggest that 38 percent
to 42 percent of initial acceptors are continuing
method use at 12 months. Two studies put the rate
higher, at about 62 percent.
2.

In longer-term data,2 women appear to be protected
from pregnancy more effectively than extrapolation
of 12-month, first-segment, or first-method rates
would imply.

Failure rates are usually given only for the early years of
use, but these can be deceptive for the longer term (Fig
ure 2). The effectiveness level must be very high to re
duce the 10 year risk of failure below 1 percent.
3.

As with continuation, failure rates vary widely by
method, within method, and by source of information. However, they are nearly zero for both male
and female sterilization, low for injectables and
NORPLANT*, very low for the newer, improved
lUDs, and low for the pill when properly used
(though higher in practice). Failure rates are much
higher for condoms and periodic abstinence.

Sterilization
3.a. Failure rates in US data for both male and fe
male sterilization are extremely low, estimated at 0.4
and 0.15 over one year per 100 users for females and
males, respectively (Trussell and Kost, 1987). In de
veloping country data most 12 month life-table fail
ure rates range from 0.2 to 0.6 (Ross et al., 1985).

Oral Contraceptives
3.b. Estimates of one-year failure rates for pills hover
around 1 percent, according to clinic data. The meCHAPTER? FINDINGS 49

Figure 2 Relation of contraceptive failure to effectiveness
levels

100

NORPLANT*
3.e. First-year Pearl pregnancy rates for NORPLANT®
capsules are 0.2 per 100 woman-years (based on over
12,000 woman-years of use in 11 countries), and 0.2
in the second year (9 countries, 5,800 woman-years
of use). Excluding China both rates were 0.3 (Sivin,
1988).

Percentage with one or more failures in 10 years

Condoms
3.f. Program estimates of 12-month failure rates for
condoms, chiefly from developed countries, vary
from 10 percent to 24 percent. One clinic estimate
from the Caribbean puts the failure rate at 4 percent
(Bailey and Keller, 1982), but few studies of condom
failure in developing countries are available. Con
dom breakage can cause failure; breakage rates in
actual practice may range from 7-13 percent (pro
spective studies reported by Russell-Brown et al.,
1992). However, retrospective reports by 282 US re
spondents gave an average of one break per 161 uses
of condoms (Hatcher et al., 1988).
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Contraceptive effectiveness (percent)
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Source: Ross et al., 1989, p. 39.

dian failure rates from program and survey data are
5 percent (nine studies) and 6.4 percent (17 studies),
respectively. Estimates from survey data range from
2.7 percent to 14 percent, while estimates from pro
gram data range widely, from zero to 26 percent.

Periodic Abstinence
3.g. Failure rates for periodic abstinence from Demo
graphic and Health Survey data (14 developing coun
tries) range from 8.2 percent to 38.4 percent, around a
median of 19.9 percent (Moreno and Goldman, 1991).
Program data from the Philippines put failure rates at
14-20 percent (Laing, 1984a, 1984b, 1986).

lUDs
3.c. Failure rates of lUDs are low, but vary by tech
nological features of the device. Nonmedicated de
vices and the earliest copper lUDs have failure rates
above 2 per 100 woman-years of use. The most re
cent and widely used copper lUDs have failure rates
significantly below that. As the copper surface area
of the IUD increases from 200 to 350 mm2 or more,
pregnancy rates decrease from 2.1 per 100 womanyears to 0.4 per 100 woman-years. lUDs releasing at
least 20 meg/day of levonorgestrel also have very
low failure rates. lUDs releasing progesterone have
significantly higher failure rates than the best cop
per lUDs. (Estimates are from multicenter random
ized trials of lUDs conducted between 1970 and 1990,
encompassing more than 50,000 woman-years of ex
perience) (Sivin and Schmidt, 1987; Sivin, 1991).

Inj eatables
3.d. Most data for failure rates of injectables are from
clinical trials; 12-month rates are zero to 1 percent.
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CORRELATES OF CONTINUATION:
SIDE EFFECTS, MEDICAL REASONS,
AND FAILURES
4.

For lUDs, NORPLANT8, and injectables, side ef
fects (particularly menstrual irregularities) are by
far the most important reasons for discontinuation.
4.a. For the IUD, side effects caused most termina
tions in a multicenter World Health Organization
study and in studies of different types of lUDs in
seven countries. In six of the studies menstrual dis
turbances and pain ranked first among reasons for
IUD discontinuation. In another five studies side ef
fects were the second most important reason for dis
continuation, while "other medical reasons" were
also important (Bhatia and Kim, 1984; Shaaban et al.,
1983; World Health Organization, 1990; Somboonsuk
etal.,1978).

4.b. A study of IUD acceptors in Mexico City found
that women who unexpectedly experience increases
in menstrual blood loss are more likely to discon
tinue IUD use than are other women (Zetina-Lozano,
1983).
4.c. For injectable contraceptives, side effects or medi
cal reasons are the first or second most important rea
son for discontinuation in Thailand, Bangladesh,
Mexico, Egypt, and Pakistan. In Mexico and Paki
stan menstrual disturbances and "other medical rea
sons" rank no lower than third among reasons for
discontinuation (Somboonsuk et al., 1978; Meade et
al., 1984; Kazi et al., 1985; Narkavonnakit et al., 1982;
Salem etal., 1988).

ing more physically dangerous than childbearing
(Grubb, 1987).
5.e. Health concerns were not included as a reason
for pill discontinuation in Peru or the Philippines.
In both of these countries, however, discontinuation
for the purpose of immediately switching methods
was common (Kost, 1990; Choe and Zablan, 1991).
6.

6.a. Accidental pregnancy is a major reason for ter
mination of pill use in Peru, the Philippines, and
Bangladesh (Kost, 1990; Choe and Zablan, 1991;
Bhatia and Kim, 1984). Accidental pregnancy was
not, however, an important reason for discontinua
tion in early studies in Indonesia or Thailand (Teach
man et al., 1980; Somboonsuk et al., 1978).

4.d. For NORPLANT®, in Indonesia, Egypt, Chile,
China, India, and Thailand, women are most at risk
of terminating use because of menstrual problems
or pain. "Other medical reasons" are important in
all countries except Thailand (Lubis et al., 1983;
Shabaan, 1983; Salah et al., 1987; Gu et al., 1988; In
dian Council of Medical Research., 1988; Somboon
suk et al., 1978; Marangoni et al., 1983).

6.b. Failure is an important factor in discontinuation
of condom use in studies where data are available
on reasons (Bangladesh, Indonesia, and the Philip
pines) (Bhatia and Kim, 1984; Teachman et al., 1980;
Choe and Zablan, 1991).

4.e. For the IUD and NORPLANT®, short-term and
long-term experience tend to differ. Terminations in
the first few years are due more to medical reasons,
principally menstrual problems; thereafter, personal
reasons, especially planning a pregnancy, become
more important (Sivin, 1993).
5.

Among pill users, side effects and medical reasons
explain a substantial portion of discontinuations.
5.a. Side effects or medical reasons for pill discon
tinuation ranked first among women in Indonesia,
Thailand, and Bangladesh (Teachman et al.,1980;
Somboonsuk et al., 1978; Bhatia and Kim, 1984).
5.b. In Sri Lanka, among pill users who switched to
traditional methods, side effects were cited as the rea
son for doing so three times more often than the sec
ond most important reason, desire for more children
(Kane etal., 1988).
5.c. In pre-1970 studies, side effects accounted for a
large portion of pill discontinuation (Mauldin et al.,
1967). Kreager (1977) reached a similar conclusion
in an extensive review of discontinuation in devel
oping countries.
5.d. A survey of perceptions of the pill's safety that
was conducted in eight developing countries found
that over 40 percent of women viewed the pill as be

Failure is an important reason for discontinuation
of pills, condoms, and traditional methods.

6.c. Many rhythm users in the Philippines and Peru
discontinue the practice because of method failure
(Kost, 1990; Choe and Zablan, 1991). In Bangladesh
accidental pregnancy is a common cause of discon
tinuation among users of traditional methods (Bhatia
and Kim, 1984).

Results from Demographic and Health Surveys
7.

For 10 developing countries DHS surveys indicate
why women discontinued methods tried in the past
five years.3 The most common reasons given for dis
continuation of pills and lUDs were desire for preg
nancy and concern about side effects and health
problems. Method failure and "other" reasons were
substantially less important, but still accounted for
an appreciable portion of discontinuation. Reasons
rarely cited for stopping included inconvenience,
partner's disapproval, poor access and availability,
cost, and infrequent sex; however, these are the very
reasons that can prevent starting a method in the
first place.
7.a. For former users of oral contraceptives, health
concerns and fears of side effects ranked first among
reasons for discontinuation in six countries, while
desire for additional children ranked second. In the
remaining four countries the ranking of these two
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7.b. For IUD users health concerns accounted for the
largest proportion of discontinuations in eight coun
tries, while desire for another pregnancy ranked sec
ond. In the remaining two countries the ranking of
the reasons was reversed. Health concerns and de
sire for more children, taken together, explained over
50 percent of IUD discontinuations in each country.

8.e. Early reviews showed IUD continuation rates to
rise regularly with age in carefully conducted studies
in Taichung (Potter et al., 1967), in Taiwan as a whole
(Chow et al., 1967), and in the United States (Tietze,
1967). Age patterns were irregular in two early studies
from Thailand and India (Mauldin et al., 1967). Pill con
tinuation showed a mixed age pattern; if anything it
declined among older women (aged 35 or more), per
haps because users found it easy to stop as they expe
rienced declining fecundity or menopause (Jones and
Mauldin, 1967; Kraeger, 1977).

7.c. Method failure always ranked third or fourth in
importance among reasons for discontinuation, for
both pills and lUDs.

9. The effect of parity on contraceptive continuation
is somewhat mixed, but the relationship is gener
ally positive.

7.d. Partner disapproval and method inconvenience
were never cited as the reason for discontinuation
by more than 5 percent of respondents. Infrequent
sex and issues of access, availability, or cost were
mentioned only slightly more often.

9.a. In the Dominican Republic a multivariate analy
sis showed contraceptive continuation to increase
significantly with parity (Porter, 1984). Similar results
were obtained in a bivariate analysis of Indonesian
data, where women with two or fewer children had
a 12-month continuation rate of 39 percent, while
women with more than two children had rates of
over 52 percent (Teachman et al., 1980).

reasons was reversed. In each country the two rea
sons together accounted for more than 50 percent of
pill discontinuations.

7.e. In Thailand and Sri Lanka nearly 9 percent of
women discontinued the IUD to switch to another
method.

CORRELATES OF CONTINUATION:
PERSONAL CHARACTERISTICS
Note: Most studies examine only bivariate relationships,
rather than several factors together in a multivariate
model, and many group all contraceptive methods to
gether.
8. Typically, older women have higher rates of con
traceptive continuation than do younger women.

9.b. In Thailand 24-month continuation rates for us
ers of the injectable increased with parity, from 33
percent for women with two or fewer children to 47
percent for women with more than two (Narka
vonnakit et al., 1982).
9.c. In Bangladesh the number of children ever born
was not a significant predictor of continuation after
controlling for sex composition of the family; how
ever, sex composition was a good predictor (Rahman
etal., 1990) (see below).

8.a. Average annual continuation rates in the Philip
pines (1980) increased by age from 43 percent (ages
20-24) to 83 percent (ages 45-49) (Laing, 1985).

9.d. Among users of the rhythm method in the Phil
ippines, continuation rates in an early study de
creased with parity (Phillips, 1978).

8.b. In Indonesia (all methods combined) early 12month continuation rates ranged from 41 percent for
women aged 25 and under to 64 percent for women
aged 36 to 49 (Teachman et al., 1980).

9.e. Early reviews showed that IUD continuation
rates rose regularly with parity in the studies cited
above (for age trends) for Taichung, Taiwan, and the
United States. However, for the pill, continuation
patterns by parity were mixed and inconclusive
(Jones and Mauldin, 1967).

8.c. Among injectable acceptors in Thailand, continu
ation rates increased until age 40, then declined
(Narkavonnakit et al., 1982).
8.d. In Matlab, Bangladesh, the probability of continu
ation as of five years after adoption (all methods com
bined) was significantly higher for older women than
for younger women (Rahman et al., 1990).
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10. In countries where son preference is strong, sex
composition of the family affects contraceptive con
tinuation.
10.a. In Menoufia, Egypt, women with more sons
were more likely to accept oral contraception and still

be using it as of nine months than were women with
fewer sons, controlling for parity (Gadalla et al.,
1985).
10.b. In Matlab, Bangladesh, bivariate analysis
showed a strong relationship between family sex
composition and contraceptive continuation. Among
four- and five-child families, no women lacking sons
were continuing contraceptive use at 60 months,
while for women with at least one son, the rates were
46 percent and 50 percent, respectively (Rahman et
al., 1990).
10.c. In Matlab the strength of the relationship re
mained when socioeconomic controls were intro
duced. The risk of discontinuation was 44 percent
lower for women with one or more sons than for
women with no sons. (For women with one or more
daughters the risk was 33 percent lower than for
women with no daughters, suggesting that parents
want at least one daughter) (Rahman et al., 1990).
11. Education does not appear to have a strong effect
on contraceptive continuation.
11.a. Female education was not a significant deter
minant of continuation in the Dominican Republic,
the Philippines, South Korea, Trinidad and Tobago,
or Matlab, Bangladesh (Porter, 1984; Park and Kong,
1987; Abdulah, 1988,1990; Phillips, 1978; Rahman et
al., 1990).
ll.b. Early studies of IUD use in Turkey found no
relationship between education or literacy and con
tinuation (Ross et al., 1972).
11.c. In Matlab, Bangladesh, however, women living
in households headed by someone with a primary
school education had significantly higher probabili
ties of continuation than did women living in other
households (Rahman et al., 1990).
12. Desire for more children affects continuation.
12.a. In the Philippines women who did not want
more children had continuation rates 11 percentage
points higher than those of women who desired ad
ditional children (73 percent vs. 62 percent, respec
tively) (Laing, 1985).
12.b. In Thailand injectable users who did not want
any more children had continuation rates 50 percent
higher than those who did want more children
(Narkavonnakit et al., 1982).

CORRELATES OF FAILURE
Results from Demographic and Health Surveys
Differentials in contraceptive failure in 15 developing
countries are available from Demographic and Health
Survey data (Moreno, 1991). Across countries, median fail
ure rates are compared, and across individuals, failure
risks are compared (by proportional hazards techniques).
13. By method: Across countries life-table failure rates
are more than two times higher for barrier and tra
ditional methods than for effective modern meth
ods. The pattern remains after controlling for edu
cation and residence.
13.a. Across the 15 countries the median 12-month
failure rate for effective methods (pill, IUD, inject
able, and implant) was only 5.6 percent, while for
traditional methods (rhythm and withdrawal) and
barrier methods (condoms and vaginal methods), the
median failure rates were 18.4 percent and 16.3 per
cent, respectively. This ordering remains within cat
egories of residence and education.
13.b. Across individuals the type of contraceptive
method was the best predictor of failure (single-fac
tor analyses).
14. By age and parity: Across countries age and parity
were generally the second most important predic
tors of failure after method. Other, non-DHS evi
dence shows that age affects failure rates for lUDs.
14.a. Generally, younger women have higher failure
rates than older women. In one Scandinavian trial
35 year-olds had only 35 percent of the risk of fail
ure of 25 year-olds (Allonen et al., 1984). Older
women may be more likely to be sterile or may have
intercourse less frequently than younger women
(Sivin and Schmidt, 1987).
15. By residence and education: Generally, urban and
better educated women have lower failure rates, al
though results are variable.
15.a. Across countries, for effective and barrier meth
ods, failure rates are slightly lower in urban than in
rural areas, but the differences are not statistically
significant. For traditional methods the median fail
ure rate is 22 percent in urban areas, but only 15 per
cent in rural areas. Regardless of method type, esti
mates for rural areas are more wide-ranging than for
urban areas.
IS.b. Across individuals the relationship between
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17.a. In Peru 51 percent of rhythm users who failed
resumed the rhythm method within 12 months after
the pregnancy ended. For pill users experiencing an
accidental pregnancy, the figure was 42 percent
(Kost, 1990).

residence and risk of failure was statistically signifi
cant in only six of the 15 countries: Bolivia, Ecuador,
Colombia, Peru, Sri Lanka, and Tunisia. Where resi
dence was important, rural women had failure rates
up to twice those of urban women. In Colombia and
Sri Lanka residence effects were not significant.

17.b. In Trinidad and Tobago almost all women who
became pregnant while using a barrier method or a
traditional method readopted that method after the
pregnancy. About two-thirds of women who expe
rienced a method failure with the pill or IUD re
sumed use of the method (Abdulah, 1988,1990).

15.c. Across countries failure rates do not vary clearly
by educational level (less than secondary, secondary,
and higher than secondary). The range of failure rates
across countries is smallest for the category of sec
ondary education.
15.d. Across individuals education effects on the risk
of failure were statistically significant in the same six
countries as in 15.b. (for residence), as well as in Thai
land and the Dominican Republic. Where education
was important, women with at least a secondary
level of education failed less frequently than did their
less-educated counterparts.
16. By duration of use: In some data sets failure rates
change depending upon which year of use is in
volved.

17.c. In South Korea far more women who became
pregnant while using the pill or condom returned
to that method after the pregnancy than did women
who discontinued the methods for other reasons
(Park and Kong, 1987).
18. Programs that offer a variety of method choices may
encourage continued effective contraceptive use by
providing reliable alternatives to couples dissatisfied
with a current or recently discontinued method.
18.a. Countries with strong family planning pro
grams (see Chapter 2) tend to have low failure rates.
Across 15 countries with DHS surveys the correla
tion between program strength and the failure rate
(all methods) is -0.75, or -0.68 excluding steriliza
tion. Two Asian countries with especially strong pro
grams (Thailand and Indonesia) and one in Latin
America (Mexico) have the lowest failure rates by a
substantial margin (Moreno and Goldman, 1991).

16.a. In several countries duration of use was as im
portant as age and parity in affecting failure. How
ever, the relationship between duration of use and
failure varies substantially from country to country,
even after controlling for method, age, and parity.
In over half of the 15 countries duration of use was
not related to the risk of failure at a statistically sig
nificant level. In seven countries the risk of failure
declined as duration of use increased, suggesting that
women most likely to experience a failure do so soon
after adopting a method, leaving a residue of more
successful contraceptors.

18.b. In Matlab, Bangladesh, field workers are trained
to encourage dissatisfied users to adopt other meth
ods. This strategy has improved overall persistence
of use, as shown by a comparison of first-method and
all-method continuation rates for different cohorts
of adopters (Akbar et al., 1990).

16.b. In five countries the risk of failure is greatest
between six and 11 months of use. The risk possibly
peaks at this point rather than at 0-5 months because
women who adopt contraception shortly after a birth
are protected from an early conception by postpartum infecundability.
16.c. In the United States (non-DHS data), failure
rates for reversible contraceptives are lower in the
fourth year of use than in the third year of use, and
are lower in the third year of use than in the last quar
ter of the second year of use. This pattern holds for
pills, ILJDs, condoms, rhythm, and withdrawal
(Westoff, 1988).
17. After an accidental pregnancy many women return
to the same method as before.
54 CHAPTER? FINDINGS

18.c. In Surabaya, Indonesia, women who received
their first choice of a contraceptive method were far
more likely to continue use than were other women.
For example, 98 percent of those who received the
pill but wanted another method discontinued within
a year, versus only 26 percent of women who chose
the pill and received it (Pariani et al., 1987).

NOTES
1.

Population-based retrospective data have four disadvantages. First,
respondents sometimes provide inaccurate information on past
contraceptive behavior. Second, if surveys collect information only
on selected intervals of use (such as the most recent ones), esti-

mates of continuation and failure rates may be biased, depending
on the analytic question. Third, many surveys do not collect data
on pregnancies (including accidental pregnancies) that result in a
miscarriage, which biases failure rates downward (Goldman et al.,
1991). Finally, determining whether or not a birth was unplanned
may be difficult. Inclusion of planned births in the estimation of
failure rates can seriously bias results (Goldman et al., 1983).
2.

3.

Short-term rates pertain either to a particular segment of method
use or a particular method used within a limited time interval. Once
that segment or method is terminated or the time period ends, in
formation on the woman's subsequent contraceptive use is not gen
erally available.
Women were asked the main reason why they terminated the
method used immediately prior to each birth (if any) that occurred
within five years of the interview. Data on reasons for termination
are available from Thailand, the Dominican Republic, Egypt, Bo
livia, Colombia, Sri Lanka, Guatemala, Paraguay, Indonesia, and
Trinidad and Tobago.
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Chapters

STERILIZATION
Sterilization1 offers both advantages and disadvantages
compared with other contraceptive methods.

cent in the Middle East/North Africa and sub-Saharan Africa (Table 1).

Advantages

I.e. In terms of numbers, as of 1990, 169 million
MWRA in the developing world used sterilization,
and 22 million did so in developed countries, for a
total of 191 million women (or spouses).

Among all contraceptive methods, sterilization offers the
longest continuation rate and the lowest failure rate. It
is a one-step method with few side effects. For females,
the modern techniques of laparoscopic and minilap ster
ilization permit outpatient procedures under local
anesthesia; these have reduced costs, operator time, and
medical trauma, and have greatly expanded the use of
sterilization internationally.

Disadvantages

l.d. Sterilization users, in absolute numbers, are re
markably concentrated geographically. China has
nearly half of all users of sterilization in the devel
oping world and India has over a fourth, while the
next country, Brazil, has only 5 percent (Table 2).
Many African and Middle Eastern countries have
only negligible numbers.

Because of its permanency, sterilization is appropriate
only for persons who are certain that they want no more
children. Some of those adopting it later regret doing so,
due to new marriages, the death of a child, or other
causes. It is a surgical technique, with the attendant risks
which, however, are much lower than the medical risks
of repeated pregnancies, induced abortions, and deliv
eries in most developing countries.

I.e. In percentage terms, 45-50 percent of MWRA
use sterilization in South Korea and Puerto Rico; over
one-third do so in China and in some Central Ameri
can countries, and about 30 percent do so in India,
Brazil, Thailand, and Sri Lanka. Sterilization is little
used in the Middle East and Africa, except for Tuni
sia (11 percent of MWRA), Kenya (5 percent overall
and 8 percent in some population subgroups), and
Botswana (5 percent).

PREVALENCE

l.f. Globally, vasectomy plays a minor role com
pared with female sterilization; in Table I female us
ers exceed male users by over three to one world
wide. In essentially every country (except perhaps
the Netherlands), female sterilization prevalence ex
ceeds that of vasectomy, especially outside Asia. Va
sectomy is important in China (10 percent of couples
in 1985), India (11 percent in 1982), and South Korea
(11 percent in 1988). For developed countries it is an
important method in the United States, Canada, and
the United Kingdom (12-14 percent in 1988, 1984,
and 1989, respectively); the Netherlands (11 percent
in 1988) (Liskin et al., 1992); and New Zealand (23
percent in a 1983-86 study). The dominance of fe
male sterilization may reflect women's greater mo
tivation to contracept, the failure of providers to
make vasectomy widely and easily available, and
certain cultural constraints; all of these vary by coun
try and region. In Latin America reasons given for
the near absence of male sterilization go beyond pre
sumed cultural attitudes; commentators there often
cite the failure of providers to offer the method even

1.

Internationally, the prevalence of sterilization is
higher than that of any other contraceptive method,
but countries and regions vary greatly in its use.

l.a. In the developing world over one-fifth (22 per
cent) of all married women of reproductive age
(MWRA) rely on sterilization, (Tables 1 and 2). This
represents nearly one-half (44 percent) of all contra
ceptive users. In developed countries 11 percent of
MWRA use sterilization, which represents 18 percent
of all contraceptive users. Globally, the figures are
20 percent of MWRA and 38 percent of all users, re
spectively (1990 estimates).
In the developing world the IUD comes next af
ter sterilization, with 12 percent of MWRA using it
(due heavily to its high prevalence in China.) Next
is the pill, at 6 percent of MWRA.
l.b. Regions vary widely in sterilization use, from 37
percent of MWRA in East Asia to over 20 percent in
South Asia and Latin America, to fewer than 3 per
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Table 1 Percentage of married women of reproductive age using contraceptbn, by method, according to region, 1990 estimates
LDC" regions
Sub-

Method
Sterilization
Female
Male
IUD
Hormonal
Pill
InjectaWes

Saharan
Africa

Latin
America

8.1

1.2
1.2
0.0
1.0

12.2
12.0
0.2

4.4
3.0
1.4

21.6
21.0
0.6
6.6
18.4
172
1.2

World

MDCs"

LDCs 1

East As la

South Asia

Middle East/
North Africa

20.1
15.7
4.4
10.9

11.4
7.6
3.8
5.4
14.4
14.3
0.1

223
173
45

36.5
28.5
8.0
29.4

20.8
16.0
4.8

1.9
1.8
0.1

Condom

8.6
7.7
0.9
5.4

15.1

123
7.1
6.0
1.1
2.9

Other

8.0

16.1

Total

53.0

62.4

4.6
6.7
5.0

3.9
3.7
02.

1.7

2.6

3.9

2.9

0.4

2.6

5.9

2.2

7.1

11.3

5.1

50.5

74.6

43.1

36.4

12.1

11.1
60.3

"LDCs = less developed countries, as defined by the United Nations.
"MDCs = more developed countries, as defined by the United Nations.
Source: Population Council Data Bank; based upon most recent survey data.

though it is far less costly and invasive than female pro
cedures. Where providers have offered the method and
encouraged its use, adoption rates have increased.
(See Chapter 6 for the relation of sterilization adop
tion rates to payments; males may respond more sen
sitively to payments than do females, who often ob
tain sterilization in the period soon after a birth.)

out due to accidental pregnancy.
Its long history of availability in many countries,
permitting a gradual buildup of users over the
years.
Its wide age spread at adoption, with many
relatively young adopters, so that most of those
starting on the method remain in the pool of us
ers many years and contribute to the buildup of
users.

STERILIZATION DYNAMICS
2.

Annual adoption rates of sterilization are low, and
are considerably lower than for most alternative
contraceptive methods, yet sterilization prevalence
can rise to a high level.
2.a. Annual adoption rates vary from 0-3 percent of
all MWRA. In the 17 largest developing countries,
with 81 percent of the developing world's popula
tion, the annual adoption rate averages 2.3 percent
of MWRA per year (average weighted by popula
tion size). In 14 smaller countries, the rate is about 2
percent. The remaining developing countries, most
of them small, have negligible rates.

3.

Despite low annual adoption rates, the prevalence
of sterilization use has risen to over one-fifth of all
couples.
3.a. This seeming contradiction, of low adoption
rates but high prevalence, is explained by four fac
tors that characterize sterilization:
*

Its long continuation rate, of about 15 years, run
ning from about age 30 (the average time of
adoption) to about age 45 (an average time for
leaving the reproductive age group).
Its negligible failure rate, so that few users drop
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Table 2 Number and percentage of married women of
reproductive age using sterilization, percentage using any
contraceptive method, and percentage of all users who rely on
sterilization, by selected countries, 1990 estimates

Country

No. of
MWRA sterilized
(OOOs)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

China
82,582
51,861
India
Brazil
7,909
South Korea
3,639
Mexico
3,146
Thailand
2,796
Bangladesh
2,428
Indonesia
1,188
Philippines
1,135
Colombia
1,037
North Korea
992
Taiwan
950
Argentina
917
Pakistan
837
Sri Lanka
830
Myanmar
752
Nepal
585
Iran
574
South Africa
511
Dominican Republic
407
All developing countries 169,000

Source: ROSS, 1992.

Percent of
all users
sterilized

Percent
sterilized

Percent using
any method

36.9
30.9
29.7
47.6
21.4
30.4
11.0
3.6
12.2
18.8
22.3
26.0
19.9
4.2
31.4
12.0
15.5
6.3
9.4
36.5

74.9
44.9
69.2
76.1
57.9
73.5
32.9
522
48.9
66.7
68.4
78.0
61.5
15.4
65.5
45.5
18.1
30.8
56.3
55.3

49.2
68.8
42.9
62.5
37.0
41.3
33.4
6.9
25.0
28.2
32.7
33.3
32.4
27.3
47.9
26.4
85.5
20.6
16.7
66.1

22.3

50.5

442

PERSONAL CHARACTERISTICS OF
USERS
The personal characteristics of sterilization users are
fairly consistent for family size, age, sex, and residence,
but vary by socioeconomic status.

surveys; summarized in Ross, 1991, Table 4). This
may reflect general modernization or rural program
efforts, or both, as in Bangladesh, South Korea, Sri
Lanka, Tunisia, Botswana, and Colombia.
8.

Number of Living Children, Age, and Sex
4.

5.

Sterilization use is most prevalent at intermediate
ages, following a pattern that is rather consistent
across countries, even though countries differ con
siderably in age at marriage and age at first birth.
5.a. Age patterns of users are rather consistent across
countries, partly for counterbalancing reasons. In
countries like India and Bangladesh, women marry
and have children quite early but adopt sterilization
later in marriage, whereas in societies like China and
South Korea, women marry later but adopt steriliza
tion soon afterwards. Generally, sterilization preva
lence is substantial at ages 25-29 and rises through
ages 35-39, tending to fall off thereafter, since older
women experienced much childbearing before sim
ple sterilization techniques became available and
during more conservative times.
Ages for adopters of sterilization are below those
for current users; adopters generally average about
age 30, but are younger where sterilization preva
lence is high and older where it is low (see Rutenberg
and Landry, 1991, Figure 2).

6.

Nearly everywhere, female sterilization is more
prevalent than male sterilization (see section l.f.).

9.

Studies examining psychological and social-psy
chological correlates of sterilization have been
found to be weak on methodology and to show in
conclusive results (see Philliber and Philliber, 1985,
Table 1). A review of factors affecting the choice
of sterilization (Bulatao, 1989) notes widely vary
ing influences. The economic costs of children are
commonly cited, but a variety of psychological el
ements also come into play in different settings.

DEMOGRAPHIC EFFECTS
10. Sterilization averts large numbers of induced abor
tions and unwanted births.
lO.a. Most MWRA adopting sterilization have two
to four children and are age 30, on average. Without
reliable protection from pregnancy over the ensuing
years, they would experience substantial numbers of
additional pregnancies, induced abortions, and un
wanted births. (Esh'mates for births averted by ster
ilization are reviewed in Ross et al., 1985.)
lO.b. In South Korea, sterilization use was estimated
to avert 540 abortions and 300 births (840 pregnan
cies) per 1,000 women by the 25th year of marriage
(Westoffetal .,1980).

Rural couples use sterilization about as much as do
urban ones.

lO.c. The average family size of sterilization adopt
ers has steadily declined over the years; conse
quently, sterilization has increased its contribution
to averting conceptions, induced abortions, and
births (Ross et al., 1985, Table E; and Ross et al., 1988,
Table 25).

7.a. Rural prevalence equals or exceeds urban preva
lence in 10 of 23 national surveys (principally DHS

lO.d. Younger cohorts of couples are adopting ster
ilization earlier than older cohorts did. This pattern

Residence, Socioeconomic Status, Psychological,
and Social-Psychological Variables
7.

S.a. Philliber and Philliber (1985), who reviewed 56
studies from the 1970s and early 1980s, found some
consistency of pattern within geographic regions, but
that has since disappeared. In 23 recent national sur
veys socioeconomic patterns are mixed and incon
sistent within each region; in some cases sterilization
prevalence rises with education level, in others it falls,
and in some it follows a partial U-shaped pattern.

Sterilization use is most prevalent in families of
intermediate sizes.
4.a. Internationally, sterilization is very little used by
those with no or one child. However, in many coun
tries its use is appreciable among those with two chil
dren, and it rises thereafter quite sharply among
those with three and even four children. At five or more
children, adoption of sterilization usually falls off, re
flecting partly the circularity that the very absence of
sterilization helps to produce larger families.

Sterilization use by socioeconomic status follows
no consistent pattern, at least not according to edu
cational attainment.
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holds in nearly all 18 countries with non-negligible
sterilization rates. Cohort differences are sharper and
appear at earlier ages in countries where overall rates
are higher. Figure 1 shows cohort trends for six highsterilization countries (Rutenberg and Landry, 1991,
analyzing DHS national surveys).

tablished role of sterilization there, those countries
will continue to dominate the global picture. Other,
smaller countries with high sterilization prevalence
will continue to have high prevalence, due to the
carryover effect of current users and to the estab
lished role of the method within their populations.

11. Of those adopting sterilization, the proportion who
regret having done so is low overall but higher in
certain subgroups.

12.b. Projections for sterilization are more reliable
than for other methods, for four reasons: (1) the large
body of current users is a known quantity, since na
tional surveys cover over 85 percent of the popula
tion of the developing world and over 90 percent of
contraceptive users; (2) the relatively young age dis
tribution of adopters and users means they will per
sist into the future; (3) differential adoption rates by
country are fairly stable; and (4) 15-year projections
are reliable for the numbers of women of reproduc
tive age, since all are already born.

ll.a. For female sterilization, one review of the lit
erature identifies these subgroups as being women
who are young; not married or married fewer than
five years; who have only one or two children; who
lack a child of each sex; who feel little control over
the sterilization decision; and who have husbands op
posed to the decision (or who subsequently change
partners or experience a child death). However, these
are also the subgroups with the lowest adoption
rates; in national surveys the overall regret rate is
low. Careful counseling reduces the likelihood of re
gret and points to alternative methods of contracep
tion for sterilization candidates who are unsure
(Church and Geller, 1990).

12.c. These four factors, used in cohort projections
and for individual countries, yield an estimate of ap
proximately 158 million sterilizations in the devel
oping world during the 1990-2000 decade, of which
China will account for half (Table 3).

12. Future sterilization patterns will parallel those pre
vailing now.

LEGAL ASPECTS
13. Sterilization is legal on request in many countries;
in others it is legal with restrictions.

IZ.a. Most future sterilization adopters and users will
be located where they have been in the past. China
and India together have over three-fourths of all ster
ilization users; because of their size and the well-es-

13.a. In one listing of 55 countries, only five make
sterilization entirely illegal with no exceptions; seven

Table 3 Sterilization projections for six regions
Projection, year
Acceptance rate (%)
1990-95
1995-2000
No. of acceptors (OOOs)
1990-95
1995-2000
Total
No. of users (OOOs)
1890
1995
2000
Increase (no.)
Increase (%)
No. of MWRA (OOOs)
1990
1995
2000
Increase (no.)
Increase (%)

East Asia

South Asia

Middle East/
North Africa

Sub-Saharan
Africa

Central
America

South
America

2.37
2.32

2.64
2.46

0.20
0.20

0.20
0.20

1.90
1.86

2.18
2.12

37,233
41,858
79.091

30,160
31,906
62,066

440
514
954

725
846
1,571

2,238
2,567
4,805

4,923
5,420
10,343

75,719
83,111
158,830

94,803
120,207
139,347
44,544
47.0

57.859
81,269
100,027
42.168
72.9

790
1,037
1,242
452
57.2

1,111
1,599
2,100
989
89.0

4,527
6,241
7,688
3,161
69.8

12,238
15,675
18,105
5,867
47.9

171,328
226,028
268,509
97,181
56.7

314,014
360,234
392,189
78,175
24.9

228.359
259,116
291.100
62.741
27.5

43,626
51,139
59,348
15,722
36.0

73,462
85,762
100,775
27,313
37.2

23,543
27,542
31,560
8,017
34.1

45,166
51,061
56,811
11,645
25.8

728,170
834,854
931,783
203,613
28.0

Total
1.94"
1.88a

" Five year acceptors divided by average no. of MWRA, divided by 5.

Note: At the outset the 1990-95 schedule of age-specific acceptance rates is set at a level that, together with the age distribution of nonsterilized
married women, will reproduce the overall rate. That schedule of age-specific rates is kept constant for the 1995-2000 period.
Source: Boss, 1992.
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Figure 1 Percentage sterilized by exact age among various age cohorts in high prevalence countries
Percentage

Percentage

Brazil

Percentage

Colombia

Percentage

45

Percentage

Dominican Republic

25-29

El Salvador

Sri Lanka

45

25

Percentage

Thailand

45-49

Source Rutenberg and Landiy, 1991, Table 1 A, p. 689.
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more permit it only to save the life of the woman. At
the other extreme, 31 countries make it legal simply
on request and seven more permit it for eugenic or
health reasons. Five countries have no relevant law
but do not appear to allow sterilization for contra
ceptive purposes. (Seven countries with no relevant
law still appear to allow it for contraceptive purposes
and are included with the 31 that make it legal on
request.) Thus, while most of these countries permit
sterilization for one reason or another, their laws vary
a good deal in restrictiveness. Nevertheless well over
half of these countries make sterilization legal on re
quest. In the world as a whole as of 1983, 73 percent
of the entire population lived where sterilization was
legal with no restrictions or only minor ones, or
where in practice it was allowed for contraceptive
purposes (see Ross et al., 1992, Table 17; and Ross et
al., 1985, Table 3.2).
13.b. The actual availability of sterilization services
is more limited than the above numbers imply. Be
sides the complete absence of services in many ar
eas, nearly all countries set conditions on access to
sterilization. Usually a woman must have a mini
mum number of children, most often two but some
times three or more. Some countries also set age lim
its; these range from age 21 or 22 to age 25, 30, and
older. Most countries specify that the procedure must
be performed by a physician, and many require ap
proval of the spouse for female sterilization.
13.c. Liberalization of laws and conditions govern
ing sterilization occurred during the decades of the
1970s and 1980s (Vumbaco, 1976; Stepan et al., 1981;
Isaacs and Cook, 1984).

MORBIDITY AND MORTALITY
See Chapter 12 for evidence on morbidity and mortality
associated with male and female sterilization.

NOTES
1.

Findings for this section are drawn from Ross (1992) where not
otherwise stated. Detailed references to national surveys and other
data sources appear there.
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Chapter 9

INDUCED ABORTION
Induced abortion is widely resorted to, whether under
legal or illegal conditions. Where it is safe and legal it
prevents some unwanted births, depresses fertility rates,
and reduces the maternal mortality rate. Where it is ille
gal and unsafe, however, it increases maternal morbid
ity and mortality. Abortion has complex interrelations
with contraceptive use: The two are often used by the
same population subgroups, but contraceptive use at
high levels tends to drive out abortions. In the absence
of contraceptive alternatives, septic abortions may be
come so numerous as to account for a substantial pro
portion of all maternal deaths and constitute a heavy bur
den on the obstetric capacity of the country.

(column 6), and 1.4 to 2.0 abortions in Latin America.
The estimates for South and Southeast Asia, as well
as for Africa, are considerably lower.
Abortion ratio (abortions per 100 live births): Because
this ratio reflects the number of births, it responds
to contraceptive use as well as to abortion; therefore,
the relative positions of the regions may differ from
those for the total abortion rate. In terms of the abor
tion ratio, East Asia ranks higher than Latin America,
due perhaps to its very high level of contraceptive
use. Again, South and Southeast Asia, and particu
larly Africa, show considerably less abortion activ
ity than do the other regions. The East Asia rates are
elevated partly because of the much more liberal
abortion regulations and practices there.

INCIDENCE OF ABORTION
1.

Globally, abortions occur in substantial numbers,
whether legal or not

2.b. In China in the mid-1980s the ratio of abortions
to live births was 45-50 per 100 (Wu et al., 1992), a
ratio that agrees closely with that for East Asia.

1.a. In 1987 an estimated 35 to 53 million induced
abortions were performed worldwide,1 amounting
to about one-fifth to one-third of births. Between onefifth and two-fifths of abortions were clandestine
(Henshaw, 1990).
2.

2,c. The average woman in Brazil and Mexico could
expect to undergo 1.5 abortions in her lifetime, vs.
1.3 in Peru in the 1970s (Frejka, 1984), and 2.6 in Cuba
in the 1980s (Hollerbach and Diaz-Briquet, 1983).

Use of induced abortion is common in at least three
large regions of the developing world, less so in
sub-Saharan Africa and West Asia.

2.d. Statistics from Bulgaria, Czechoslovakia, and
Yugoslavia (reporting in all three is believed to be
nearly complete) indicate that between 40 percent
and 50 percent of pregnancies in the mid-1980s
ended in abortion. In Romania (1983) and the USSR
(1987) (where statistics are incomplete), over 50 per
cent of pregnancies ended in abortion (Henshaw,
1990).

2.a. For four regions, Table 1 shows recent estimates
for abortion measures, under alternative assump
tions (Frejka, 1993). The table gives only one estimate
for East Asia, due to better data there. West Asia is
omitted from the table. The table provides demo
graphic effects, which are discussed in section 6 be
low. (For the methodology used, see Frejka and
Atkin, 1990.)
Numbers of abortions: The sum of the low estimates
in column 5, compared to the sum of the high esti
mates in the column, gives a range of 21 .7 to 34.0 mil
lion induced abortions per year (midpoint 27.8 mil
lion). (The total for developed countries is additional
to this.)
Total abortion rate2: A young woman passing through
the current rates of abortion for the different ages
would have 1.3 abortions in her lifetime in East Asia

2.e. In Japan official statistics indicate that 27 percent
of pregnancies ended in abortion in 1987. These num
bers are thought to be incomplete. Projections from
provinces believed to have complete statistics indi
cate that over half of all pregnancies ended in abor
tion in 1975 (Henshaw, 1990).
3.

Data from hospitals in the developing world indi
cate that increasing numbers of women are seek
ing either induced abortions or treatment for com
plications from abortion.

3.a. For sub-Saharan Africa, one review of the litera
ture found increasing hospital admissions for aborCHAPTER9 FINDINGS 63

Table 1 Estimates of births averted by contraception and induced abortion, late 1980s
_...
. . ..
„,.
.
Births averted (In millions)
Region

Alternative*

Africa
East Asia
South and
South East Asia
Latin America

A
B
One only
A
B
A
B

Proportion of births
^ JL , ,
.
avartad hy InHurari

Absolute number of
, j
j . _..
tpdueari ahnrtlnna

ahnrtinn

Total
..

Abortions
„_
pai-IOT)

Contraception Induced abortion

abortion (in %)

(3)

(4)

(in millions)
(5)

rate
<6)

live births

(2)

3.3
4.7

3.2
3.2

0.1
1.5

3
32

31.9

24.9

7.0

22

23.3
26.9

20.7
20.7

2.6
6.2

11.2
12.2

8.8
8.8

2.4
3.4

11
23
21

Total
0)

28

(7)

0.2
3.4
11.9

0.05
0.7

0.7
13

1.3

53

5.2
12.5

0.4
0.9

9
22

4.4
6.2

1.4
2.0

35
50

• Alternatives A and B were selected to correspond, respectively, ID low and high estimates of induced abortion incidence.
Source: Frejka, 1993, Table 1.

tion complications throughout the region in the late
1970s and early 1980s and high rates of maternal
deaths due to abortion. Kenyatta National Hospital
in Nairobi and Mama Yemo in Kinshasa, which were
reporting 2,000 to 3,000 admissions a year for abor
tion complications in that period, were treating 30
to 60 cases a day by the late 1980s. For Kenyatta Hos
pital, this was a five-fold increase. The few commu
nity-based studies available suggested that the num
bers being seen in the hospitals were ". . . only the
tip of the iceberg" (Coeytaux, 1988).

women account for the majority of abortions re
ported in studies from other parts of the country as
well (Samil, 1989). The majority of abortion clients
in India and Bangladesh are married (Liskin, 1980;
Royston and Armstrong, 1989). In a Philippine study,
75 percent of women who underwent abortions were
married, 20 percent were single, and the remainder
were widowed, divorced, or separated (Gallen, 1982).
4.b. In Nigeria women seeking abortions are often
unmarried (Ovin et al., 1984; Mashabala, 1989). A
study of hospital records from Benin City revealed
that 71 percent of induced abortions were among pri
mary and secondary school students, of whom only
9.8 percent were married (Nnatu, 1988).

3.b. The Khartoum Teaching Hospital in Sudan
treated 700 incomplete abortions in 1974, of which
at least two-thirds were estimated to have been in
duced; by 1988 the number had risen to 3,000 incom
plete abortion admissions a year. These cases repre
sented 80 percent of emergency ob/gyn admissions
(Toubia, 1989).
3.c. In 18 hospitals in Jakarta, Indonesia, the ratio of
abortions to live births increased steadily, from 183
per 1,000 in 1972 to 396 per 1,000 in 1975 (Samil,
1989). The ratio of abortions to births rose dramati
cally in Ramathibodi Hospital in Bangkok. In 1975
the abortion ratio was less than 10 abortions per 1,000
live births; by 1979 the ratio was 258 abortions per
1,000 live births (Chaturachinda etal., 1981).

CHARACTERISTICS OF ABORTION
CLIENTS3
Marital Status
4.

4.c. In Shanghai rates of abortion during the 1980s
increased faster for teenagers than for older women,
although rates still remained higher for older women
than for teenagers. In 1988 three-quarters of abortion
recipients were married. Single women tended to
seek abortions later in pregnancy than did married
women (Wu et al., 1992).

Age and Parity
5.

Where married women constitute the main group
undergoing abortion, clients are older and have two
or more children. Where unmarried women pre
dominate, clients are younger and more often have
no children. However, these patterns are quite vari
able across countries and regions.

In Asia married women seek abortions more
frequently than do unmarried women. In parts of
Africa, abortion clients are more likely to be un
married.

5.a. In Indonesia (Jakarta), India, and the Philippines,
the average age of abortion patients ranged from 28
to 31 (Samil, 1989; Gallen, 1982). Average ages for
clients, across abortion practitioners in a Thailand
study, ranged from 18 to 43 (Narkavonnakit, 1979).

4.a. In Jakarta, Indonesia, 97 percent of women seek
ing abortions in hospitals were married. Married

S.b.Half of the Indonesian abortion patients were
pregnant for at least the fifth time (Samil, 1989). The
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average parity of Bangladeshi women was four; Filipino women had an average of 2.9 living children
(Khan et al., 1984; Gallen, 1982). Averages for the
number of living children among clients of various
practitioners in Thailand ranged from 2.2 to 7.4
(Narkavonnakit, 1979).

pean countries. The decline also exceeded those in
East Germany and Albania, where abortion re
mained illegal for some years (Tietze, 1964).
6.d.When several Eastern European countries re
stricted access to abortion by repealing long-stand
ing liberal abortion laws, fertility increased. Roma
nia reversed its liberal abortion policy in 1966: The
birth rate rose from 12.8 per 1,000 population in De
cember 1966 to 39.9 per 1,000 in September 1967, and
began to decline gradually thereafter (see Figure 1).

5.c. In Jamalpur, Bangladesh, abortion ratios were
three times higher among women over 35 and
women with five or more children than among
women below age 25 or those who were childless
(Khan etal., 1984).
5.d. One-quarter of women admitted to Botswana
hospitals for treatment related to abortion in 1976
were under 18 years old. In Sierra Leone (1980) 23 per
cent of abortions were to teenagers (Mashabala, 1989).

DEMOGRAPHICS OF ABORTION
6.

Liberalization of abortion laws and increased use
of induced abortion can help produce a decline in
a country's birth rate, but abortion is only one fac
tor limiting fertility.

6.e. Abortion is credited for a portion of Japan's fer
tility decline (Davis, 1963).
7.

In the early stages of the fertility transition, abor
tion rates (per woman, not necessarily per preg
nancy) tend to rise. Later, as effective use of mod
ern methods of contraception increases, abortion
rates may fall. (Note: Survey counts of numbers of
abortions are nearly always too low and must be
interpreted cautiously.)
7.a. The proportion of Taiwanese women who had
ever used contraception rose from 28 percent to 76
percent between 1965 and 1976. Over the same pe
riod the proportion of women who admitted hav
ing undergone an abortion rose from 9 percent to 21
percent (Royston and Armstrong, 1989).

6.a. Demographic effects: Columns 1-4 of Table 1 pro
vide estimates of total births averted (in millions) due
to the use of contraception and induced abortion, as
well as the proportion of births averted due to abor
tion. That proportion is one-fifth to one-fourth in East
Asia and Latin America, lower in South and South
east Asia, and rather indeterminate in Africa, where
data are especially poor. It is estimated that abortion
averted about seven million births annually in the
late 1980s in East Asia, fewer in South and Southeast
Asia, considerably fewer in Latin America (due to its
much smaller population), and even fewer in Africa.

7.b. In the 1950s Japan experienced a dramatic drop
in the number of births per 1,000 women of repro
ductive age. The rate declined by 41 percent between
1950 and 1957, in large part because of abortion
(Davis, 1963). The reported number of abortions in
Japan rose from 246,000 in 1949 to 1.2 million in 1955,
then dropped to 568,000 by 1983. Over the same pe
riod the total fertility rate declined from around 4.5
to 1.8 children per woman (Anon., 1987).

6.b. In most industrialized countries declines in fer
tility steepened after liberalization of abortion laws.
In Hungary, for example, the pace of the fertility de
cline increased substantially after legalization of
abortion in 1955 (Tietze, 1964). In general, fertility
decline began long before laws changed and almost
certainly would have continued without the change
in abortion laws (Tietze and Henshaw, 1986), al
though probably not as rapidly.

7.c. In South Korea the birth rate fell by 30 percent
between 1960 and 1968, while the proportion of preg
nancies reported to have ended in abortion rose from
6 percent to 21 percent (Royston and Armstrong,
1989). Between 1973 and 1979 both the abortion rate
and the contraceptive prevalence rate increased rap
idly. After 1979, contraceptive prevalence continued
to rise but the abortion rate fell back to its 1983 level
(Henshaw, 1990).

6.c. A pattern of declining birth rates after legaliza
tion of abortion was observed in many East Euro
pean countries. Nearly all these countries legalized
abortion about 1955, after which their birth rates fell
substantially more than did those in Western Euro

7.d. In China the level of abortion is now substan
tially lower than it was in 1983. France, Italy, and
Japan have all reported recent declines in use of abor
tion, probably as a result of increased use of mod
ern contraceptives (Henshaw, 1990).
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Figure 1 Crude birth rate, abortion mortality rate, and maternal mortality rate in relation to the Romanian anti-abortion
law of 1966
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Source: Royston and Armstrong, 1989, Figure 6.2.

8.

Contraceptive use cannot completely eliminate in
duced abortion in its role as a backup means of
avoiding unwanted births, since no contraceptive
is 100 percent effective.

8.a. Even if 90 percent of couples aim for a two-child
family Iby using 90 percent effective contraception,
the average woman can expect 1.7 abortions within
the course of her life (Tietze and Bongaarts, 1975).
8.b. Probably no population has lowered its total fer
tility rate to 2.2 or less without recourse to induced
abortion. Population stabilization without use of in
duced abortion is improbable unless major changes
in contraceptive technology or sexual behavior oc
cur (Tietze and Bongaarts, 1975).
9.

One hundred abortions prevent fewer than one
hundred births.

9.a. Even when the number of induced abortions
equals the number of live births (as in Hungary in
1959), the birth rate will not necessarily be halved,
since 100 aborted pregnancies account for less expo
sure time than do 100 full-term pregnancies (Potter,
1963; World Health Organization, 1970). That is,
abortions can occur much more often than births can.
9.b. The combination of induced abortion and effec
tive contraception comes much closer to averting one
birth than does abortion alone. Furthermore, fewer
abortions are necessary to produce a given birth rate,
66 CHAPTER 9 FINDINGS

since fewer pregnancies occur. In a noncontracepting
population 100 induced abortions avert only 30-45 live
births, depending on the length of lactation. In a popu
lation that contracepts with 90 percent effectiveness,
100 abortions avert 72-82 births (Potter, 1963).

Contraceptive Use
10. Women highly motivated to control their fertility
tend to use both contraception and abortion.

10.a.The positive relationship between use of abor
tion and contraceptive use has been documented in
Brazil, Israel, Taiwan, the Philippines, Singapore, and
Turkey (Liskin, 1980).
lO.b. Only 12 percent of noncontraceptors in South
Korea had experienced an abortion, compared with
46 percent of contraceptors (1971 data). Of women
who had ever obtained an abortion, 73 percent were
using contraception, while only 29 percent of women
who had never had an abortion were currently
contracepting (Tietze and Henshaw, 1986).
lO.c. Of 115 Filipino women who reported having
had abortions, 70 percent had ever used contracep
tion. Only 33 percent of the 561 respondents who had
never had an abortion had used contraception. Of 269
contracepting women, 30 percent had also experienced
an abortion, but only 8 percent of 407 noncontracepting
women had used abortion (Flavier and Chen, 1980).

11. Contraceptive use often increases following an
abortion; however, postabortion services are inad
equate.

the woman's life is in danger. The remainder live un
der various restrictions that limit the right to an abor
tion (Jacobson, 1990; Henshaw, 1990).

ll.a.Barriers to postabortion counselling and contra
ceptive services include legal problems, separation
of abortion and family planning facilities, and an ab
sence of motivation among some doctors to help
women avoid unwanted pregnancies. Expert recom
mendations are that a range of contraceptive meth
ods be made available at all abortion facilities, and
that clinically all methods are appropriate assuming
no medical contraindications and careful counselling
(Technical Working Group, 1993).

12.b. Government health facilities in China, India,
Tunisia, Cuba, and Vietnam provide legal abortions
alongside other health care (Henshaw, 1990), al
though actual availability may vary.

ll.b. Only 25 percent of Indian women hospitalized
for complications of induced abortion used contra
ceptives prior to the abortion, but 88 percent adopted
a method afterwards. Of 301 Thai women undergo
ing an abortion, only 4 percent had used contracep
tion before the procedure, but 44 percent adopted a
method afterwards (Royston and Armstrong, 1989).
ll.c. Among Filipino women who had an abortion,
only 31 percent had been using contraception imme
diately prior to becoming pregnant, whereas 61 per
cent were using modern methods at the time of the
interview (Gallen, 1982).
ll.d. Several studies in India comment on the fre
quency with which women undergoing abortion
adopt either an IUD or sterilization (Chhabra et al.,
1988; Khan et al., 1990); abortions and sterilizations
are often performed in the same operating session. Ac
cording to official estimates, 29 percent of abortions are
accompanied by sterilization (Henshaw, 1990).
ll.e. In Cubuk, Turkey, women who had undergone
an abortion were three times more likely to switch
to a more effective method of contraception than
were women who had not undergone an abortion
(Bulut, 1984).

LEGALITY OF ABORTION

12.c. In Bangladesh, parts of Indonesia, and Malay
sia, abortion is illegal but menstrual regulation is
available up to 10-12 weeks after a woman's last pe
riod (Henshaw, 1990; Samil, 1989).
12.d. In most of sub-Saharan Africa abortion is highly
restricted. It is illegal except to save a woman's life
in many countries. Abortion for reasons other than
a woman's physical health is legal in only three coun
tries (Table 2).
IS.The legality of abortion is often a poor indica
tion of its availability.
IS.a. Abortion may be easy to obtain even if it is only
partially legal. In Israel, South Korea, and New
Zealand, abortion is illegal for reasons other than
maternal health, yet abortion rates in these countries
are comparable to those of countries with far less re
strictive laws. Most countries in Latin America have
restrictive abortion laws but many physicians in ma
jor cities will perform abortions and some cities have
clinics that specialize in abortion (Henshaw, 1990).
13.b. Laws that allow abortions to be performed only
in hospitals, by highly trained professionals, often
cause delays until the pregnancy is more difficult to
terminate or the woman resorts to use of nonstandard methods. In Zambia first-trimester abortions are
legal but must occur in a hospital with the permis
sion of two physicians and one specialist. In the Uni
versity Teaching Hospital there, nine women are
treated for complications of illegal abortions for ev
ery legal abortion performed (Castle et al., 1990;
Jacobson, 1990).

12. The extent to which abortion is legal differs greatly
from country to country (see Table 2). Common re
strictions include parental notification for minors,
gestational age, husband's permission, waiting pe
riods, and counseling.

13.c. In India qualified physicians perform legal abor
tions at some government health facilities, but 14 out
of every 15 doctors trained to perform abortions live
in cities, while 78 percent of India's population live
in rural areas (Jacobson, 1990; Tietze and Henshaw,
1986).

12.a. About 40 percent of the world's population
have access to abortion on demand, while another
25 percent live in countries that allow it only when

14. In the past five years most legislation concerning
abortion has served to increase rather than restrict
its availability.
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Table 2 Countries by restrictive ness of abortion law, according to regbn, January 1,1990
Africa

Asia and Oceania

Europe

Angola
Benin
Botswana
Burkina Faso
Central African Republic
Chad
Gabon
Ivory Coast
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Mozambique
Niger
Nigeria
Senegal
Somalia
Sudan
Zaire

Afghanistan
Bangladesh
Indonesia
Iran
Iraq
Laos
Lebanon
My an mar
Oman
Pakistan
Philippines
Sri Lanka
Syria
United Arab Emirates
Yemen

Belgium
Ireland

Law
To save a
woman's life

Other maternal
health reasons

Algeria

Cameroon*
Congo
Egyptt
Ethiopia
Ghana* ,t
Guinea
Kenya
Lesotho
Liberia*,t
Morocco
Namibia*.!
Rwanda
Sierra Leone
South Africa*-!
Tanzania
Uganda
Zimbabwe*-!

Social and

social-medical

Burundi
Zambia!

reasons

On request

Togo
Tunisia!!

Hong Kong'.t
Israel'.f
Jordan*
South Korea*-!
Kuwaitt
Malaysia*,!
Mongolia
Nepal
New Zealand*-!
Papua New Guinea
Saudi Arabia
Thailand*

Australia!
India*'.!!
Japan*-!-§§
North Korea*-!
Taiwan'-!

China
Singapore
Turkey§§
Vietnam

Albania
Northern Ireland
Portugal*,!
Spain*-!
Switzerland

North America
Dominican Republic
El Salvador' -!
Guatemala
Haiti
Honduras
Mexico*
Nicaragua
Panama

Brazil*
Chile
Colombia
Ecuador*
Paraguay
Venezuela

Costa Rica
Jamaica
Trinidad & Tobago

Argentina*
Bolivia*
Guyana
Peru

Uruguay*,§

Bulgaria*-!-!
Finland*-!-!-!!
West Germany*.!-!!-*!
Great Britain!
Hungary*.!-!-!!
Poland*.§§4!
Austria!!-*!
Czechoslovakia!!
Denmark!!
France§§
East Germany!!
Greece!!
Italy!!
Netherlands '
Norway!!
Romania!!
Soviet Union!!
Sweden*!
Yugoslavia!!

South America

Canada
Cuba!!
Puerto Rico
United States

!Approval is automatic for women who meet certain age,
!lncludes abortion for genetic defects.
'Includes juridical grounds, such as rape and incest.
"During the lirst 20 weeks.
§Not permitted for health reasons, but may be permitted for serious economic difficulty.
marital, and/or parity requirements.
§§No formal authorization is required, and abortion is permitted in a doctor's
!!During the first three months or 12 weeks.
!!During the first 10 weeks.
'!During the first 18 weeks.
*!Gestation limit is for interval since implantation.
office; thus, abortion is defacto available on request.
Notes: Table does not include countries with fewer than one million inhabitants or those for which information on the legal status of abortion is unknown (e.g. Bhutan
and Cambodia). All abortions are permitted only prior to fetal viability unless otherwise indicated in footnotes.
Source: Henshaw, 1990, p. 77.
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numbers of abortions reported, but decreased the
numbers of deaths from abortion.

14.a. In 1986 Vietnam removed all mention of abor
tion from the criminal law codes. In the same year
Greece and Czechoslovakia made first-trimester
abortion available on request. Smaller countries such
as Cape Verde, Cyprus, and French Polynesia have
recently liberalized their abortion laws. The United
States, Poland, and the Philippines have restricted
abortion (Henshaw, 1990).

16.a. In the United States after liberalization of abor
tion laws in 1973, the number of women dying from
postabortion complications fell sharply, even though
the number of reported abortions increased (Liskin,
1980). Liberalization of abortion laws results in a rise
in the number of safe legal abortions; many of these
replace illegal abortions. It is usually unclear how
many abortions occurred before liberalization, but a
change in laws most likely reduces their numbers.

MEDICAL COMPLICATIONS AND
MORTALITY ASSOCIATED WITH
ABORTION (See also Chapter 11)

16.b. In Singapore abortion became available on re
quest in 1974. Between 1968 and 1970,51 out of 11,151
known abortions resulted in death. Between 1974
and 1976, only 26 of 40,880 abortion clients died
(Royston and Armstrong, 1989).

15. Abortion, when performed correctly, is now one of
the safest of all surgical procedures, particularly
when it occurs in the first trimester of pregnancy,
when risks are lowest
15.a. In the United States death rates from causes re
lated to pregnancy and childbearing are 11 times
higher than those from abortion (Henshaw, 1990). In
1977 1.4 deaths resulted from every 100,000 abor
tions, while 16 people died for every 100,000 tonsillectomies (Liskin, 1980). In Sweden mortality from
abortions decreased from 250 deaths per 100,000
abortions in the late 1940s to less than one death per
100,000 abortions in the late 1970s.

17. Many of the admissions to obstetric and gyneco
logical wards of hospitals in developing countries
are for treatment of complications of induced abor
tion. Treating complications of induced abortion
imposes severe costs.

15.b. In the United States abortion mortality at eight
weeks of gestation is only 0.2 per 100,000 procedures
(Figure 2). The risk of mortality rises by 20 percent
with each additional week of gestation up to 15
weeks, and increases even faster between 15 and 20
weeks (Royston and Armstrong, 1989). At 21 weeks
of gestation, abortion mortality is 12.7 per 100,000
procedures (Henshaw, 1990).

Figure 2 Number of reported maternal deaths per 100,000
induced abortions, by number of weeks of gestation,
United States, 1981-85

IS.c. A 1968 survey of 1,890 women in Santiago,
Chile, revealed that of women who underwent an
abortion at three to five months of gestation, 47 per
cent were hospitalized for complications. Of women
who sought an abortion during the first month of
pregnancy, only 18 percent required hospitalization
(Royston and Armstrong, 1989).
15.d. Most of the gains in reducing mortality from
abortions have occurred at the later gestational ages.
In the United States, risks of mortality at gestations
of 13-15 weeks dropped by 85 percent during the
1970s, while mortality risks at eight weeks of gesta
tion remained more or less constant (Tietze and
Henshaw, 1986).
16. Liberalization of abortion laws has increased the

Complications

17.a. Complications from abortion accounted for 40
percent of admissions to the acute gynecological
ward at Kenyatta National Hospital in Nairobi in the

15.0

No. of reported deaths per 100,000 abortions

12.5
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16-20

S21
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Source: Gold, 1990, Figure 15.
Reproduced with the permission of The Alan Gultmacher Institute from Rachel
Benson Gold, Abortion and Women's Health: A Turning Point for America, 1990.
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early 1980s (Ladipo, 1989). At the University Teach
ing Hospital in Yaounde, Cameroon, 32 percent of
emergency admissions for obstetric complications
were for abortion-related causes (Leke, 1987).
17.b. At the Korle Bu Hospital in Ghana, 60-80 per
cent of minor operations were performed to correct
complications of induced abortion in the early 1970s
(Ladipo, 1989).
17.c. Calculations from the Dominican Republic
show that treating a complicated abortion case costs
12 times as much as managing a simple delivery
(Liskin, 1980). The average illegal abortion treated in
Latin American hospitals requires two to three bed
days, 15-20 minutes of operating time, antibiotics, anes
thesia, and possibly a blood transfusion (Fortney, 1981).
17.d. Hospitals in Latin America and Africa use from
3 percent to 41 percent of their blood supply in treat
ing women with complications from illegal abor
tions. In Turkey and Venezuela blood transfusions
account for nearly half the cost of treatment for abor
tions (Liskin, 1980; Royston and Armstrong, 1989).
17.e. In the International Postpartum Program of the
Population Council, abortion-related cases repre
sented 22 percent of all obstetric-related cases in four
Latin American hospitals, 16 percent in three Middle
Eastern hospitals, and 10 percent in 11 Far Eastern
and South Asian hospitals (Zatuchni, 1970, p.50).
18. Septic abortion4 and hemorrhage are the most com
mon complications of abortion, followed by uter
ine perforation and cervical laceration.
18.a. In Nairobi in the early 1980s, almost one quar
ter of the women needing postabortion treatment
presented with sepsis (Ladipo, 1989). Of 491 women
treated for complications of abortion at the Dhaka
Medical College Hospital in Bangladesh, 85 percent
of the women who tried to induce an abortion by
inserting a solid object into their uterus had devel
oped sepsis. All of the women who tried chemical
instillation were infected (Khan et al., 1984).
18.b. Complication rates following first-trimester
abortions can be very low. Three clinics in New York
City monitored the outcomes of 170,000 first-trimes
ter abortions between 1971 and 1987. Fewer than one
patient per 1,000 was hospitalized for suspected per
foration, ectopic pregnancy, hemorrhage, sepsis, or
incomplete abortion. Fewer than nine patients per
1,000 experienced minor complications (Hakim-Elahi
etal.,1990).
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18.c. Prolonged or excessive bleeding following an
abortion requires a blood transfusion in 2 percent to
45 percent of cases (Ladipo, 1989; Liskin, 1980). Hem
orrhages require immediate treatment, which is of
ten difficult because of inadequate blood supplies or
facilities for transfusion (Ladipo, 1989).
18.d. Uterine perforation, cervical laceration, chemi
cal burns (from drinking or douching with toxic sub
stances), and internal bleeding (from abdominal mas
sage) are all associated with traditional methods of
abortion (Liskin, 1980).
19. In many developing countries, deaths from septic
abortions account for a substantial portion of all
maternal deaths.5
19.a. Estimates suggest that abortion-related deaths
account for a minimum of 23 percent of all maternal
deaths (Royston and Armstrong, 1989). According
to one study of 60 developing countries, an estimated
68,000 women died as a result of illegal abortion in
1977 (Rochatetal., 1980).
19.b. In Addis Ababa, Ethiopia, 54 percent of all di
rect obstetric deaths resulted from complications of
criminal abortion (Kwast and Stevens, 1987). Deaths
from abortion accounted for a full 86 percent of all
maternal deaths in registration data for Romania in
1984 (Royston and Armstrong, 1989).
19.c. In reports for Colombia, Jamaica, and Nigeria,
29 percent, 33 percent, and 35 percent of all mater
nal deaths, respectively, are from complications of
induced abortion (Royston and Armstrong, 1989).
19.d. Septic abortion caused 40 percent of all mater
nal deaths between 1970 and 1978 in the Maternal
and Child Health Institute in Bogota, Colombia
(Liskin, 1980).
20. The legal status and political setting of abortion
strongly affects maternal mortality numbers and
rates.
20.a. In the developing world, illegal abortion kills
one woman for every 1,000 to 2,000 procedures. In
such settings, abortion is 10 to 250 times more danger
ous than any method of contraception (Liskin, 1980).
20.b. Both Hungary and Czechoslovakia legalized
abortion in the mid 1950s. Between 1953 and 1957,
mortality rates from abortion declined 56 percent in
Czechoslovakia. Between 1958 and 1962, mortality
rates from abortion declined 38 percent in Hungary.
No major European or North American country has

achieved such a large decline without liberalization
of abortion laws (Tietze and Henshaw, 1986).

the Philippines and Latin America patients boil plant
material and drink the resulting liquid (Frejka et al.,
1989; Gallen, 1982). Twigs, roots, or bundles of leaves
are inserted into the uterus to induce bleeding in
Bangladesh and parts of Africa (Islam, 1982; Liskin,
1980). About 20 percent of plants used for these pur
poses do have abortifacients in them and may be par
tially effective, according to a WHO study (Frejka et
al., 1989).

20.c. After Romania made abortion illegal in 1966,
the abortion mortality rate rose to seven times its
level when abortion was legal (Tietze and Henshaw,
1986) (see 6.d. and Figure 1).
20.d. In the United States the number of deaths from
abortion decreased after the abortion law was liber
alized in 15 states in 1970 and after the Supreme
Court acted in 1973 (Gold, 1990) (see Figure 3).

TRADITIONAL METHODS
OF ABORTION

22. Most traditional practitioners are middle-aged
women who are long-time residents of the village
in which they practice. Common motivations are
service and profit.
22.a. In Thailand and the Philippines over 90 percent
of the traditional practitioners interviewed were fe
male. In Bangladesh some men provide abortion ser
vices (Islam, 1982).

Women relied on traditional practitioners and folk meth
ods to terminate unwanted pregnancies long before the
development of modern methods. Traditional methods
are still common in countries where access to abortion is
limited.

22.b. In Thailand practitioners averaged nearly 50
years of age; over one quarter had resided in their
village for more than 11 years, and 42 percent had
lived there since birth (Narkavonnakit, 1979). In the
Philippines practitioners were 47 years old, on aver
age, and over 60 percent had lived in their villages
for over 20 years (Gallen, 1982).

21. Inserting objects into the uterus, drinking or douch
ing with special liquids, and abdominal massage
are the most common traditional methods of induc
ing abortion.
21.a. Of the 491 women treated at the Dhaka Medi
cal College Hospital for treatment of complications
from induced abortion (see 18.a.), 42 percent had
tried an oral abortifacient; 33 percent had inserted
objects into the uterus; 8 percent had instilled chemi
cals into the vagina; and 18 percent had had a mod
ern procedure done elsewhere (Khan et al., 1984).
21.b. In Thailand massage and uterine injection ac
count for over three quarters of traditional abortions.
Massage involves locating the fetal mass and press
ing the abdomen until bleeding begins. Uterine in
jection entails dripping a liquid (saline solution, al
cohol, gasoline, or a water-cumin mixture) through
a catheter into the uterus (Narkavonnakit, 1979).
21.c. In the Philippines abdominal massage and cath
eter insertion (placing a rubber catheter in the cer
vix and taping it to the leg in an effort to stimulate
bleeding) are traditional methods of abortion. Clients
. cited catheter insertion as the most common (ac
counting for almost one-half of procedures), while
practitioners reported performing massage more fre
quently (49 percent of procedures) (Gallen, 1982).
Catheter insertion is apparently also common in
Latin America and the Caribbean (Frejka et al., 1989).
21.d. Plants are common sources of abortifacients. In

Figure 3 Number of abortion-related deaths, by year,
according to legal status of abortion, United States,
1965-85
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22.c. The educational level of practitioners reflects the
availability of education within the country. In
Bangladesh most traditional practitioners were illit
erate (Islam, 1982). In the Philippines 17 percent had
never been to school but 13 percent had completed
graduate studies. In Thailand practitioners were
evenly distributed among categories of no schooling,
four years of schooling, and eight or more years of
schooling (Narkavonnakit, 1979).
22.d. Traditional abortionists in the Philippines,
Bangladesh, and Thailand offer their services in the
belief that they meet a community need, as well as
for income (Islam, 1982;Gallen, 1982; Narkavonnakit,
1979). In Bangladesh practitioners state that their acts
save their clients' honor (the importance of perform
ing acts that save honor is emphasized in the Mus
lim religion) (Islam, 1982).
23. Many traditional practitioners hesitate to perform
abortions at gestations greater than four months.
Most abortions appear to be performed early in the
pregnancy. Practitioners may or may not provide
medicines, follow-up service, and family planning
advice or referral.
23.a. In the Philippines 75 percent of patients re
quested abortions during the first trimester of preg
nancy, 80 percent took some form of medication af
terwards, and over 50 percent of the women were
told to return for a check-up after the procedure
(Gallen, 1982).
23.b. In Thailand practitioners base their fees on the
gestational age of the fetus. Over 50 percent of prac
titioners refused to perform abortions after three
months of gestation, while two-thirds would not per
form the procedure after four months. Half the prac
titioners routinely provided some kind of drug after
the procedure, and one-third offered modern anti
biotics (Narkavonnakit, 1979).
23.c. In the Philippines about half the abortion cli
ents of traditional practitioners received advice about
family planning (Gallen, 1982).
23.d. In Bangladesh some practitioners refused to
perform abortions after the first trimester; others per
formed abortions in the third trimester, but refused
women who had been pregnant for only one month.
Some practitioners referred clients to menstrual regu
lation or sterilization clinics; others had never done
so. Few practitioners treated complications of abor
tions, viewing such problems as being the patients'
fault (Islam, 1982).
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MODERN METHODS OF ABORTION
24.a. Vacuum aspiration is the safest widely available
method of first-trimester abortion. It entails the re
moval of fetal tissue by vacuuming the uterus with
either a manual or an electronic suction device
(Liskin, 1980; Frejka et al., 1989; Henshaw, 1990). The
cervix may or may not be dilated first, depending
on its size and flexibility, the length of gestation, and
the skill of the practitioner (IPAS, no date).
24.b. Curettage, common in countries where few sur
geons are trained in suction methods, entails scrap
ing the products of conception from the walls of the
uterus. Risks of uterine perforation or incomplete
abortion are greater with curettage than with suc
tion methods (Henshaw, 1990).
24.c. Menstrual regulation (uterine evacuation with
out a pregnancy test) offers the option of guaranteeing
subsequent nonpregnancy while leaving pregnancy
status at the time of the procedure undetermined
(Akhter, 1988; Dixon-Mueller, 1988). Nonpregnancy is
guaranteed by evacuating the uterus using one of the
methods described above.
24.d. RU486, in combination with a prostaglandin
(PG) (taken orally), provides a safe and effective
means of terminating pregnancies during the first
eight or nine weeks after a missed period. It is over
95 percent effective up to 49 days after a missed pe
riod. Effectiveness declines slightly but significantly
at durations of amenorrhea longer than 49 days
(Ulmann, 1990). Some blood loss usually occurs with
use of RU486/PG; in most cases blood flow is com
parable to a normal period, lasting 1-16 days. In a
trial of the method with 10,244 women, a blood trans
fusion was given in only .1 percent of the cases
(Ulmann, 1990; Aubeny, 1990; Hill et al., 1990). In
rare cases, RU486/PG has caused cardiac complica
tions; therefore it is not used for women with vari
ous cardiovascular contraindications. It is also inap
propriate for women with adrenal insufficiency or
with the usual contraindications for prostaglandins
(such as asthma or severe hypertension) (Klitsch,
1989). Contraindications related to age and smoking
have also been debated (Ulmann, 1990). RU486/PG
offers several advantages over other first-trimester
methods of abortion: it is less invasive and requires
less intervention than surgical methods; the decision
of whether to use anesthesia is irrelevant; it is effec
tive immediately after a missed period; and risks of
laceration and perforation are nonexistent. However,
access to competent medical services is important for

treatment of complications, should they occur. With
RU486/PG the woman takes more responsibility for
implementing the method and ascertaining that a
complete expulsion has occurred (Ulmann, 1990;
Aubeny, 1990; Hill et al., 1990).
24.e. In the second trimester abortion is performed
either by dilation and evacuation or by medical in
duction. The procedure chosen varies across coun
tries and, within countries, across practitioners. Preg
nancies of durations between 12 and 18 weeks are
usually terminated by dilating the cervix and remov
ing the products of conception with forceps (Henshaw, 1990). The uterus is then evacuated either by
suction or by curettage. The procedure requires sur
gical expertise and can be stressful for medical per
sonnel, but it is less traumatic for the woman than
medical induction (Tietze and Henshaw, 1986). Preg
nancies of durations longer than 18-20 weeks are ter
minated by medical induction (Henshaw, 1990).
Uterine contractions are stimulated with oxytocin or
prostaglandins. Saline solution is used when other
agents are not available. Eventually the contractions
expel the fetus. Medical induction is lengthier and
riskier than other procedures (Tietze and Henshaw,
1986; Frejkaetal., 1989).

to approximate the number of pregnancies is to add the number
of births and abortions to an estimate of the number of spontane
ous abortions and stillbirths; however, this is not generally done.
3.

Because of underreporting, samples of women who admit experi
ence with abortion are almost never representative of the true
population of women who have had an abortion. Consequently,
characteristics of women who choose abortions can be determined
only tentatively.

4.

Septic abortion is a condition in which either the endometrial cav
ity or its contents are infected. Septic abortion can occur when the
uterus is not completely evacuated or when unclean instruments
are used.

5.

Deaths from complications of abortion are particularly likely to be
underreported, because they are often classified as deaths from
hemorrhage or infection (without noting that these conditions were
caused by an abortion).
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Chapter 10

CONTRACEPTION, FERTILITY PATTERNS, AND INFANT
AND CHILD MORTALITY
1.

Contraceptive use acts to reduce infant and child
mortality.
l.a. Contraceptive use lowers the number of births
in a population. At constant mortality rates, fewer
births mean fewer infant and child deaths. Fewer
deaths lessen the strain on health care systems and
increase the per-capita expenditure on health for any
given level of funding, which may also act to reduce
infant and child mortality (Bongaarts, 1987).
l.b. Contraceptive use changes the distribution of
births by reproductive parameters. Infant and child
mortality rates will decline to the extent that fewer
births in the new distribution occur to women with
high-risk characteristics (Bongaarts, 1987; Trussell
and Pebley, 1984; Winikoff, 1987; Potter, 1988).
I.e. Contraceptive use may lower infant death rates
by reducing unwanted births wherever those are se
lected for higher risk; moreover, some contraceptive
methods protect the mother and thus the fetus or in
fant from sexually transmitted diseases (National
Academy of Sciences, 1989).
The above relationships are supported in subse
quent sections, which rely upon the following types
of evidence:
*

Bivariate relationships: the association of age,
parity, and birth intervals with infant/child mor
tality

*

Multivariate relations: combinations of risk fac
tors that affect infant/child mortality

*

Changes in the distribution of births as fertility
declines

*

Changes in infant/child mortality from changes in
the pace and ages at which childbearing occurs

*

Reduced infant/child mortality through preven
tion of unwanted births and sexually transmit
ted diseases.

BIVARIATE RELATIONSHIPS
Results presented below are from data from 25 countries
where Demographic Health Surveys were conducted.

The relationships for both infants and children are con
sidered. The first year of life is treated as a whole, but
note that patterns for neonates (babies under one month
old) may be different from patterns for postneonates (ba
bies 1-11 months old).
2.

Mortality rates typically exhibit a U-shaped curve
with age and birth order. Mortality rates decline
with increasing birth-interval lengths.

Teenage Mothers
3.

Infants of teenagers experience higher mortality
rates than do infants of women in their 20s.
3.a. In 23 of 25 developing countries (Ecuador and
Botswana are the exceptions), infants of very young
teenagers (below 17 years) fare worse than infants
of older teenagers (17-19 years). Excess infant mor
tality associated with teenage births varies from un
der 10 percent (Sri Lanka and Bolivia) to over 60
percent (Zimbabwe and Paraguay). Mortality diff
erentials for teen births diminish as children age.

Births to Older Women
4.

Mortality levels of infants born to women aged 3039 are within 10 percent of the levels of infants born
to women aged 20-29.
4.a. In 17 out of the 25 developing countries analyzed,
this relationship holds true. In only two countries
(Paraguay and Zimbabwe) do the excess risks of in
fants born to older mothers exceed 30 percent. For
children, mortality patterns by age of the mother are
less stable. In some countries children of older
women do better than children of younger women;
in other countries the reverse holds.
4.b. In an Egyptian study the infant mortality rate
for mothers aged 15-19 was 45 percent above that
for mothers in their 20s (Ibrahim, 1993).

Birth Order
5.

Infant mortality for first births is about 10 percent
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above that for second- and third-order births.

have died than for children whose siblings have
survived. Risks of short birth intervals or high par
ity are higher for women whose children have died
than for women whose children have survived be
cause of biological and behavioral replacement
mechanisms. Untangling risks associated with
dead siblings from risks associated with short birth
intervals or high parity is difficult.

5.a. Across 25 DHS countries infant mortality aver
ages 76 per 1,000 live births for first births and 67 for
second and third births; in only six countries is the or
der reversed. The mortality difference between first and
second/third births decreases after infancy (see below).
6.

Risks associated with high-order births vary from
region to region.

*

6.a. In African countries infants of birth orders four
to six do not appear to have higher mortality than
do infants of orders two or three. In Latin America
and Asia birth orders of four and higher are associ
ated with excess infant mortality.
6.b. In the Egyptian study (see 4.b.) fifth and higher
order births experienced 38 percent higher mortal
ity than did those of the third and fourth order.

MULTIVARIATE RELATIONSHIPS
8.

Preceding Interval Length
7.

Infants born after intervals shorter than two years
have much higher mortality than do infants born
after at least two years.

7.a. In most DHS countries the excess mortality for
short-interval births was 65 percent or greater. For
children the results are less consistent, but risks gen
erally are at least 15 percent higher for children born
after short intervals (below two years), compared
with children born after two- to four-year intervals.
The strong associations documented above are
bivariate, which are not additive, since risk factors
overlap:
*

The presence of one risk factor often implies the
presence of another. For example, births to teen
agers are often either first births or poorly-spaced
births.

*

Additionally, socioeconomic status is often cor
related both with infant and child mortality risks
and with reproductive risk factors. For example,
the relationship between birth order and infant
and child mortality may be overstated if most
children of birth orders higher than three are
born to poor families, and controls for household
income are not included.

*

Survival status of a child's siblings influences
both that child's mortality risks and the repro
ductive behavior of the child's mother. Mortal
ity risks are higher for children whose siblings
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Duration of breastfeeding influences survival
chances. Lengthier breastfeeding is associated
with lower mortality risks and longer birth in
tervals. On the other hand, if a child dies, breast
feeding stops and conception may occur quickly,
inducing a short birth interval.

The effects of reproductive parameters on infant
and child mortality persist (but are weakened)
when controls for biodemographic and socioeco
nomic factors are introduced.
Most of the results presented below come from
a 34-country multivariate analysis of WFS data, with
controls for a child's sex, birth order, interval length,
and maternal education and age. These are drawn
from Hobcraft (1987), unless otherwise noted.

Births to Teenagers
9.

On average, teenage births carry elevated risks.
9.a. Children born to teenagers have 34 percent
higher mortality before age five than do children
born to mothers aged 25-34. Separate data for moth
ers below age 18 are revealing: Children born to
women under age 18 have 42 percent higher mor
tality than do children born to women aged 25-34,
while the excess mortality for children born to
women aged 18-19 is only 13 percent.
9.b. The combination of a first birth with young ma
ternal age is especially risky, producing excess mor
tality of 80 percent, in comparison with second- and
third-order births of women 25-34.

Children of Older Women
10. Evidence on the effects of childbearing among
older women, independent of parity, is mixed.
10.a. Children born to women over 35 do not suffer
higher mortality than do those born to younger

mothers, in the WFS analysis. In Indonesia and Pa
kistan children born to women over 35 actually have
lower reported mortality than do children of younger
women (controlling for birth order) (Martin et al.,
1983). However, in Guatemala children of older
women are at a significantly higher risk of mortality
than children of younger women (controlling for
birth order and spacing effects) (Pebley and Stupp,
1987).
First Births
11. Infant mortality is higher for first births than for
second and third births.
ll.a. The infant mortality rate of first births averages
86 per 1,000, as compared with 53 per 1,000 for sec
ond and third births—a greater difference than that
observed in the later DHS data (bivariate relation
ship) (see 5.a. above). The mortality difference be
tween first- and higher-order births decreases after
infancy, as seen in the child mortality rates.
11.b. Levels of excess risk for firstborns vary substan
tially by country. In Indonesia, Sri Lanka, and parts
of China, first births do not experience higher mor
tality, while in North Africa and the Middle East ex
cess risks for firstborns are much higher than those
in other regions (Martin et al., 1983; Trussell and
Hammerslough, 1983; Tu, 1989).
Higher Order Births
12. On average, the highest birth orders carry elevated
risks.
12.a. Births of orders four, five, and six experience
no excess mortality during infancy, but do experi
ence 20 percent higher mortality during years one
to five, compared with births of order two or three.
Additionally, births of order 7+ face an under-five
mortality risk that is 20 percent higher than that of
births of order two or three.

children whose closest older sibling was born less
than two years before their own birthday but subse
quently died.
13.b. In Bangladesh and the Philippines children
born within 15 months of a preceding birth are 6080 percent more likely to die before age two than are
other children, even after conn-oiling for prematu
rity. In Bangladesh the harmful effects of a short pre
ceding birth interval are confined to the first month
of life (Koenig et al., 1990).
13.c. Mortality risks for children with a sibling who
is close in age appear to be substantially higher in
North Africa and the Middle East than in other regions.
Closely spaced births are common in these areas.
Subsequent Birth Intervals
14. Short birth intervals can carry an elevated risk for
the child born f irst.
14.a. Children with a sibling born within 12 months
after their own birth have a mortality risk between the
ages of one and five that is 77 percent higher than that
of children whose next youngest sibling is at least two
years younger. A birth 12-18 months after the index
child's birth raises its mortality risk by 48 percent. A
pregnancy of duration three months or more by a
child's second birthday raises the child's mortality risk
between ages one and five by 55 percent.
Combinations of Risk Factors
Hobcraft (1991) analyzes the effects of various family for
mation patterns on mortality below age five, using data
from 18 developing countries in which Demographic and
Health Surveys were conducted. He divides births into
10 categories based on the mother's age and parity, the
length of her preceding birth interval, and her prior pace
of fertility.
Risk categories are defined as follows:
*

Age: Teenage births and births to women aged
20-34 (numbers of women over 35 were inad
equate for analysis)

*

Birth order: First births and later births

*

Spacing: Well-spaced births (after intervals of 2+
years) and poorly spaced births (intervals of less
than 2 years)
Pace of reproduction: (for women aged 20-34).
Hobcraft categorizes the pace of reproduction as

Previous Birth Intervals
13. Short birth intervals can carry an elevated risk for
the child born second.
13.a. Children with a sibling who is close in age (less
than two years older) face a 52 percent higher mor
tality risk than do children with siblings who are at
least two years older. The effect is much larger for

*
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slow, medium, or fast, based on the number of
children by age of mother, as shown below.
Pace of childbearing, according to number of
children and mother's age
Age
Pace
Slow
Medium
Fast

20-24
2
3
4+

25-29
2-3
4-5
6+

30-34
2-1
5-6
7+

These categories give rise to the following 10 risk
categories:
Births to teenagers: (1) First births; (2) poorly-spaced
later births; (3) well-spaced later births.
Births to women 20-34: (4) First births.

Later births: (5) Poorly-spaced births, slow pace; (6)
poorly-spaced births, medium pace; (7) poorlyspaced births, fast pace; (8) well-spaced births, slow
pace; (9) well-spaced births, medium pace; (10) wellspaced births, fast pace.
15. Risks of children born to women aged 20 to 34 vary
according to the combination of birth order, prior
pace of reproduction, and the length of the preced
ing interval.
15.a. First births to women aged 30-34 have a 6 per
cent higher mortality than do higher order, wellspaced births, but differentials for first births vary
substantially by country. First births in Kenya, Mali,
and Tunisia face higher risks than first births in other
countries (excess mortality of about 30 percent),
while first births in Peru, Colombia, and the Domini
can Republic have lower mortality rates than do
higher order births.
15.b. Compared to children born at a medium pace,
those born at a slow pace have 8 percent lower mortal
ity and those born at a fast pace have 24 percent higher
mortality (all with reference to well-spaced, higher or
der births to women aged 20-34). Mortality differen
tials by the pace of reproduction are larger in Brazil,
Colombia, Ecuador, and Peru than in other countries.
15.c. Poorly-spaced births have high excess mortal
ity risks compared with well-spaced births; the size
of the difference in risk increases with the prior pace
of fertility. Relative to all well-spaced children,
poorly-spaced children suffer elevated mortality: 35
percent higher if born at a slow pace, 80 percent
higher if born at a medium pace, and even 123 per
cent higher if born at a fast pace.
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16. Children of teenage mothers experience higher
mortality, compared with well-spaced births to
women 20-34, regardless of birth order or spacing.
16.a. First births to teenage women have 46 percent
excess risk compared with well-spaced births to
women 20-34.
16.b. Higher-order births to teenagers have an ex
cess mortality of 35 percent when they are wellspaced, 117 percent when they are poorly-spaced.

CHANGES IN THE DISTRIBUTION OF
BIRTHS AS FERTILITY DECLINES
17. Contraceptive use acts to reduce fertility, and as fer
tility falls the proportion of all births that are first
births tends to rise, while the proportion of births
at order five or higher tends to fall. This change in
the composition of births implies a change in the
infant mortality rate, because different subgroups
have different mortality rates. The change may or
may not reduce the infant mortality rate, although
hi absolute terms fewer births certainly mean fewer
infant and child deaths.
17.a. The proportion of first births has risen in each
of eight countries where both WFS and DHS data
are available. The largest increases in first births oc
curred in countries where fertility has declined dra
matically, such as Thailand, Colombia, Sri Lanka,
and Trinidad and Tobago (Hobcraft, 1991).
17.b. The proportion of fifth and later births de
creased in 11 countries where fertility declined sig
nificantly between the 1960s and the 1970s-80s. In
the 1960s the proportions ranged from .23 to .45. In
the following decades the range was from .02 to .22
(National Academy of Sciences, 1989).
18. As fertility declines, the proportion of births to
older women generally declines, while the direc
tion of change for the proportion of births to
younger women is mixed.
18.a. In the 11 countries mentioned above the pro
portion of births to older women declined in all coun
tries. The proportion of births to younger women in
creased in only six countries. In four countries the
proportion of births to young women decreased, and
in one country the proportion remained the same
(National Academy of Sciences, 1989).
19. It is unclear how the distribution of births changes

by preceding interval length as fertility declines.
19.a. As fertility fell, the proportion of births occur
ring at short intervals decreased as well, in eight of
10 countries for which data were available (National
Academy of Sciences, 1989).
19.b. In Thailand, Colombia, Sri Lanka, and Trinidad
and Tobago, the proportion of poorly-spaced births
has declined with decreases in fertility levels (Hobcraft, 1991).
19.c. However, cross-sectional analyses often show
that countries with lower fertility rates have a higher
proportion of births at short intervals than do coun
tries with higher fertility rates (Hobcraft, 1987;
Bongaarts, 1987; Trussell, 1988). Also, in Korea,
where fertility declined dramatically in the 1960s, the
proportion of women giving birth to a second child
within two years of the first increased from 35 per
cent in 1960 to almost 50 percent in 1970 (Ross and
Madhavan, 1981; Rindfuss et al., 1982)

CHANGES IN INFANT AND CHILD
MORTALITY RATES DUE TO
CHANGES IN THE PACE AND AGES
AT WHICH CHILDBEARING OCCURS
20. Changes in family formation patterns have the po
tential to substantially alter the mortality experi
ence of individual families.
20.a. In a six-child family, children born to women
who begin childbearing at age 22 and space births
at three-year intervals are less than half as likely to
die before age two as children whose mothers begin
childbearing at age 18 and space births at 18-month
intervals (Hobcraft, 1987).
20.b. Most women who begin childbearing early and
reproduce quickly will have a child die, while less than
half of the -women who delay childbearing and repro
duce slowly will have a child die (Hobcraft, 1987).
20.c. One quarter of women with poor reproductive
patterns will experience the death of two children
under age two. Only 8 percent of women with bet
ter reproductive patterns can expect two children to
die (Hobcraft, 1987).
21. Changes in family formation patterns have the po
tential to alter overall mortality rates within countries.
21.a. If teenagers delayed all births until they were

20 and stopped reproducing by age 34, gains in child
survival would range up to 12 percent. (However, re
sults are from DHS data, which are based on the strong
assumption that all excess mortality for teenage moth
ers would disappear if they delayed childbearing).
21.b. In Peru an increase in birth intervals to at least
18 months would reduce the risk of death during the
first year of life and in the next four years by 13 per
cent and 9 percent, respectively. Eliminating later
conceptions occurring before the child was 3, 6, or 9
months old would lower mortality by 4 percent to
11 percent (Palloni and Tienda, 1986).
21.c. In Pakistan postneonatal mortality would de
cline by 14 percent if all birth intervals shorter than
24 months increased to 24-29 months (Cleland and
Sathar, 1984).
22. Changes in the distribution of births by reproduc
tive parameters have contributed to declines in in
fant and childhood mortality.
22.a. Favorable changes in the distribution of births
across risk categories have contributed to declines
in mortality below age five, in seven of eight devel
oping countries from which WFS and DHS data are
available. (Relative risk patterns have worsened,
however, offsetting some gains) (Hobcraft, 1991).1
22.b. In Costa Rica and Trinidad and Tobago changes
in the distribution of births over a 10-year period (15 years before the WFS survey versus 11-16 years
before the survey) accounted for about a 15 percent
decline in mortality rates between the two periods.
The benefits of the distributional change in births
were smaller in other countries, but they often ac
counted for around 20 percent of the decline in mor
tality between the two periods (Hobcraft, 1987).2

REDUCED INFANT/CHILD MORTALITY
THROUGH PREVENTION OF
UNWANTED BIRTHS AND SEXUALLY
TRANSMITTED DISEASES
23. Contraceptive use reduces the number of unwanted
children, thereby reducing infant and child mor
tality.
23.a. Unwanted children probably experience el
evated mortality rates. In Matlab, Bangladesh, as con
traceptive prevalence increased from below 10 per
cent to 34 percent, the mortality rates of girls 2-4
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may suffer because women fear that their STD will
impair their fertility. She calls for the addition of STD
screening and treatment in all related reproductive
health services.
Evidence from both developed and developing
countries indicates that the HIV virus can be trans
mitted across the placental membrane and during
delivery through contact with infected maternal
blood (Senturia and Peckam, 1987). Children born
to mothers infected with HIV have a 25-35 percent
risk of HIV infection (Ellerbrock et al., 1991). Addi
tionally, HIV virus has been identified in children
delivered to women who were seronegative at the
time of delivery but in whom HP/ was later isolated.
This finding suggests that breastfeeding is a mode
of transmission from mother to child (Ziegler et al.,
1985; Lepage et al., 1987). The AIDS virus has been
isolated in breastmilk (Thiry et al., 1985).

years of age decreased significantly. No change oc
curred in the mortality rate of boys that age. A multivariate analysis of time-series data shows the in
verse association between contraceptive use and
female child mortality to be significant (Phillips et
al., 1987).
23.b. Preventing the birth of unwanted children
through contraceptive use (or abortion) will prevent
some infant deaths and may lower the infant mor
tality rate. Unwanted children may die more fre
quently than wanted children, either because they
are born disproportionately to high-risk women (Pot
ter, 1988) or because their families do not or cannot
care for them properly (National Academy of Sci
ences, 1989).
24. Barrier contraceptives protect infant health and sur
vival by impairing the transmission of sexually
transmitted diseases (STDs).
24.a. Barrier methods of contraception may protect
women from herpes simplex and cytomegalovirus
(CMV), which have been linked with fetal death, intrauterine growth retardation, prematurity, malfor
mations, congenital infection, and various postnatal
infections. Hepatitis B in pregnant women is associ
ated with prematurity and neonatal and postneonatal infections (National Academy of Sciences, 1989).
24.b. Barrier methods of contraception protect wo
men from contracting infections that they could
transmit to their children during gestation or through
breastmilk (National Academy of Sciences, 1989).
24.c. Wasserheit (1989) concludes that STDs "...are
common in almost all of the developing countries in
which they have been investigated..." (p. 153). Ex
amining over 60 studies, she found that 10-25 per
cent of women in various subgroups had gonococcal cervicitis (with some results both below and
above that range) and a somewhat higher percent
had vaginitis. (Most subgroups came from clinical
settings: antenatal, family planning, peripartum, as
well as gynecology and STD clinics; a few studies
were on a population basis). STD levels are higher
in sub-Saharan Africa than in other regions.
Wasserheit notes that "...the population pyramid
is heavily weighted with individuals in the age
groups of most intense sexual activity" and that fam
ily planning programs may experience elevated ter
mination rates because women confuse their STD
symptoms with side effects from their contraceptive
method. Moreover, contraceptive acceptance rates
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NOTES
1.

Hobcraft calculates mortality rates for children under five from
both the DHS and the WFS data. He decomposes differences in
rates into portions due to (1) a change in the baseline, or reference
risk group (well-spaced births to women aged 20-34, (2) changes
in the distribution of births across risk categories, and (3) changes
in the relative mortality of births in different risk categories.

2.

Hobcraft examines fertility patterns and mortality levels in WFS
countries 11-16 years before the survey and 1-5 years before the
survey. He decomposes changes in mortality rates between the two
periods into portions that result from a change in the level of risk
and those that result from a change in the distribution of births.
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Chapter 11

CONTRACEPTIVE USE AND MATERNAL
MORBIDITY/MORTALITY
Complications from pregnancy and childbirth can cause
illness, injury, or death. Contraceptive use benefits
women's health by reducing the absolute number of
pregnancies, by reducing septic abortions, and by help
ing to restrict childbearing to those ages and parities for
which risks of obstetric complications are smallest (ages
20 to 34 and low parities).

because only a select subset of women give birth in
hospitals, and those who do are rarely followed for
42 days (Adetoro, 1987; Trussell and Pebley, 1984).
Prospective population-based studies are more rep
resentative but rare (Zimicki, 1989). Recently, re
searchers have interviewed women as to whether
their sisters died from causes related to pregnancy.
Preliminary evidence from The Gambia, Sudan, Bo
livia, and Egypt indicates that this method yields
plausible estimates (Graham et al., 1989; Rutenberg
and Sullivan, 1991). Brothers may also be inter
viewed about their sisters (Graham et al., 1990.)

DATA AND MEASUREMENT
1.

Maternal mortality is defined as the death of a
woman while she is pregnant or within 42 days of
a pregnancy termination. Direct deaths result from
complications of pregnancy or labor. Indirect
deaths result from diseases that pregnancy aggra
vates, such as hepatitis or malaria.
l.a. The maternal mortality ratio, the number of ma
ternal deaths per 100,000 live births, measures the
level of obstetric risk associated with pregnancy and
can be combined with the total fertility rate to esti
mate a woman's lifetime chance of dying from preg
nancy-related causes (Blacker, 1987).
1.b. The maternal mortality rate, the number of ma
ternal deaths per 100,000 women of reproductive age,
reflects both the medical risks of pregnancy and the
level of fertility within a population. The maternal
mortality rate indicates the relative importance of
maternal mortality as a cause of death when com
pared with other causes or with the overall death rate
for women of reproductive age.

2.

Measuring maternal mortality is difficult. The
number of maternal deaths is small relative to the
number of women exposed to the risk, so reliable
measures require large samples (Winikoff, 1987).
Vital registration systems and retrospective sam
ples may undercount both deaths and live births
(Zimicki, 1989). The pregnancy status of a woman
who dies may go unreported.
2.a. Hospital-based studies compare the number of
maternal deaths in the hospital to the number of live
births in the hospital over some time period. These
data are unrepresentative in developing countries,
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EXTENT OF MATERNAL MORTALITY
AND MORBIDITY
Maternal Mortality
3.

Maternal mortality claims the lives of hundreds of
thousands of women of reproductive age each year.
Most of these women live in the developing world.
3.a. In 1988 an estimated 509,000 women, 99 percent
of them from developing countries, died from causes
related to pregnancy and childbirth (see Table 1)
(World Health Organization, 1991).1
3.b. More maternal deaths occur in India in one week
than in all of Europe in an entire year (Royston and
Lopez, 1987). One woman in every 21 in Africa will
die of complications of pregnancy or delivery. In
Northern Europe, only one woman in every 9,850
will die (Maine, no date).
3.c. By recent WHO estimates, Africa is the region
with the highest number (630) of maternal deaths per
100,000 live births. The ratio in Asia is 380 per
100,000, and it is 200 per 100,000 in Latin America
and the Caribbean. For developed countries the av
erage ratio is around 26 per 100,000 (WHO, 1991).
3.d. Maternal mortality ratios across 12 subregions
of the developing world range widely, from 120 to
760 per 100,000 live births as of 1988 (see Table 1). By
far the highest rates occur in sub-Saharan Africa.
3.e. If women in all countries faced the same risks

4.

when pregnant as do women in the developed
world, 460,000 fewer women would die each year
(Royston and Lopez, 1987).

length in a multinational study conducted by the
World Health Organization (reviewed in Winikoff
and Castle, 1988).

Children suffer greatly when their mothers die.
Each woman who dies from pregnancy-related
causes leaves behind more than one child, on av
erage (Winikoff, 1987).

6.b. No relationship between length of time spent
pregnant or breastfeeding and cumulative nutritional
status emerged from a study of Ugandan women
(Costello, 1986).

4.a. In Matlab (1960s) 95 percent of infants whose
mothers died in childbirth died within a year (Chen
et al., 1974). Between 1976 and 1985, three quarters
of the children born to women who died from preg
nancy-related causes also died within a year (Koenig
etal.,1988).

6.c. Many studies rely on simple measures of childbearing patterns and nutritional status, so the lack
of an empirical relationship thus far should not be
taken as conclusive evidence that one does not exist
(Merchant and Martorell, 1988).

4.b. In a rural area of The Gambia pregnant women
were followed between 1982 and 1983. Live births
accompanied eight of 15 maternal deaths. All of these
children died in infancy (Greenwood et al., 1987).

Morbidity
5.

For each woman who dies from pregnancy-related
causes, many others experience disabling injuries
and infections.
5.a. In Colombia, Pakistan, Syria, and the Philippines,
3-25 percent of women under age 45 suffered from
uterine prolapse, a painful condition where the
uterus descends into the vagina (Lettenmaier et al.,
1988).
5.b. In parts of Africa many women suffer from open
ings between the vagina and urinary tract that cause
incontinence. The condition is especially prevalent
among teenagers and women experiencing ob
structed labor or female circumcision. Often these
women become social outcasts (Harrison, 1987;
Starrs, 1987; Tahzib, 1983).
5.c. In Nigerian and Kenyan studies 8-20 percent of
women developed genital tract infections after de
livery. Such infections increase the chance of con
tracting pelvic inflammatory disease, having an ectopic pregnancy2, or becoming in fertile (Lettenmaier
etal.,1988).

6.

Though pregnancy and childbearing make extra
nutritional demands on women, little evidence so
far supports the theory that frequent or rapid
childbearing harms a mother's nutritional status.
6.a. Neither a woman's hemoglobin levels nor her
ponderal index (weight squared, divided by height)
were associated with age, parity, or birth-interval

CAUSES OF MATERNAL MORTALITY
Direct Causes
7.

Hemorrhage, eclampsia, obstructed labor, infec
tion, and complications from induced abortion are
the major causes of maternal mortality.3

Table 1 Estimates of maternal mortality and numbers of live
births, by region, ca. 1983 and 1988, developing and developed
countries
Maternal
mortality ratio
(per 100, 000
live births)*
Region
World
Developed countries
Developing countries
Africa
Northern
Western
Eastern
Middle
Southern
Asia
Western
Southern
Southeastern
Eastern
Latin America/
Caribbean
Central
Caribbean
South

Live births
(millions)

Maternal
deaths
(OOOs) '

1983

1988

1983"

1988"

1983

1988

390
30
450

370

137.6

500

509

26
420

17.3
120.3

6
494

4
505

640
500
700
660
690
570

630
360
760
680
710
270

128.3
18.2
110.1
23.4
4.8
7.6
7.0
2.6
1.4

26.7
4.9
8.7
8.8
3.0
1.3

150
24
54
46
18
8

169
18
66
60
21
4

420
340
650
420
55

380
280
570
340
120

73.9
4.1
35.6
12.4
21.8

81.2
4.4
39.6
12.5
24.6

308
14
230
52
12

310
12
224
42
32

270
240
220
290

200
160
260
220

12.6
3.7
0.9
8.0

12.2
3.5
0.8
8.0

34
9
2
23

25
6
2
17

Northern America

12

12

4.0

4.0

1

1

Europe
Oceania
USSR

27

23

6.6

6.4

2

1

300

600

0.2

0.2

2

1

50

45

5.2

5.2

3

2

• World Health Organization estimates.

b Estimates for 1980-85 from United Nations Demographic Indicators of Countries:
Estimates and Projections as Assessed in 1980. United Nations, Department of
International Economic and Social Affairs, New York, 1982.
c Estimates for 1985-90 from United Nations Demographic Indicators of Countries:
Estimates and Projections as Assessed in 1990. United Nations, Department of
International Economic and Social Affairs, New York, 1991.
Source: World Health Organization (WHO). 1991. Weekly Epidemiologies! Record
No. 47, 22 November. Table 1, p. 346.
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7.a. Hemorrhage and complications of induced abor
tion accounted for almost 40 percent of maternal
deaths in Matlab, Bangladesh between 1976 and
1985. Eclampsia, infection, and obstructed labor led
to most of the other deaths (Fauveau et al., 1988).
7.b. In Lusaka, Zambia 20 percent of maternal deaths
resulted from eclampsia. Complications of abortion
killed almost 17 percent of the women. Infection,
hemorrhage, and complications of infectious diseases
were also major causes of maternal mortality (Mhangoetal., 1986).
7.c In Jamaica eclampsia, hemorrhage, ectopic preg
nancy, and abortion accounted for two-thirds of ma
ternal deaths (Walker et al., 1985, cited in Zimicki, 1989).

Indirect Causes
8.

Hepatitis, anemia, and malaria are the most com
mon indirect causes of maternal mortality. About
25 percent of maternal deaths are from indirect
causes.
8.a. Viral hepatitis is one of the six major causes of
maternal death in Ethiopia, Nigeria, Ghana, Malawi,
and South Africa (Kwast and Stevens, 1987), and is
also an important contributor to maternal death in
China and India (Lettenmaier et al., 1988).
8.b. Parasite activity associated with endemic malaria
is heavier and more frequent during a woman's first
and second pregnancies than when she is not preg
nant, which increases the risk of anemia (Zimicki,
1989; Lettenmaier et al., 1988).
8.c. In 12 Indonesian hospitals anemic women died
during childbirth four times more frequently than
did nonanemic women. Similar results are reported
from Malaysia (Lettenmaier et al., 1988). Anemia
worsens the deleterious effects of blood loss and can
contribute to heart failure (Zimicki, 1989).
8.d. Pregnancy can ignite inactive tuberculosis — an
indirect cause of mortality in some areas (Letten
maier et al., 1988; Maine et al., 1985).

REPRODUCTIVE RISK FACTORS
Age
9.

Women below age 20 and over age 30 die more fre
quently during pregnancy and childb earing than
do women in their 20s.
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9.a. In Matlab, Bangladesh maternal mortality ratios
for women under age 15 were five times higher and
ratios for older teen mothers were two times higher
than those for women aged 20-24 (Chen et al., 1974;
Koenig et al., 1988). Similar patterns hold in Zaria,
Nigeria (Harrison and Rossiter, 1985).
9.b. Younger women are especially likely to suffer
from pre-eclampsia and eclampsia, obstructed labor,
and malaria (Zimicki, 1989).
9.c. In Nigeria women over age 30 face a 2.5 times
greater risk of dying per pregnancy than do women
20-24 (Royston and Lopez, 1987). In Bangladesh
women over 30 die much more frequently from preg
nancy-related causes than do women 20-24 (Chen
et al., 1974; Koenig et al., 1988). Similarly, Jamaican
women aged 40-44 experience risks five times higher
than women who are 20 years younger (Royston and
Lopez, 1987).

ParityIGravidity
10. Women pregnant for the first time and women
pregnant for the fifth time or more die more fre
quently from pregnancy-related causes than do
other women.
lO.a. Women pregnant for the first time faced higher
risks of death than did women of higher parities in
all of the population-based studies and most of the
hospital-based studies reviewed by Zimicki (1989).
Eclampsia is the most frequent cause of death for
these women. Women having their first child in
Matlab, Bangladesh had over three times the risk of
death of women having their third child (1976-85)
(Koenig etal., 1988).
lO.b. Women of parity five and above have 1.5 to 3
times the risk of death of women at parity two or
three (National Academy of Sciences, 1989). Fetuses
of women of high parity often lie in awkward posi
tions, complicating delivery (Zimicki, 1989). Highparity women are more likely to require blood trans
fusions during delivery and to die of hemorrhage
(Rinehart et al., 1984). In Matlab, Bangladesh mater
nal mortality ratios for women of parity six or higher
were three times higher than were those for women
of parity two (Chen et al., 1974).
lO.c. The J-shaped relationship between parity and
maternal mortality ratios holds across countries with
different levels of mortality and socioeconomic de
velopment (Zimicki, 1989; Winikoff and Sullivan,

1987). Generally, however, as conditions within a
country improve, the curve becomes flatter (National
Academy of Sciences, 1989).

Combination of Age and Parity
11. Age and parity are closely related. Efforts to sepa
rate their effects on maternal mortality risks have
yielded mixed results.4
ll.a. In hospital-based studies the relationship be
tween parity and risk of death or complications is
stronger than that for age. Within age groups risks
rise with parity, but within parity groups risks are
often constant by age (Zimicki, 1989).
ll.b. Data from Matlab for the late 1960s indicate that
for women at the extremes of both age and parity
(young age-low parity or old age-high parity), incre
ments in either age or parity are important. For
women in the middle ranges, on the other hand, an
incremental change in age or parity does not sub
stantially change risks (Zimicki, 1989).
ll.c. However, data from Matlab for the 1970s and
1980s lead to a different conclusion. At each parity
older women face higher risks than do younger
women, while high parity carries a higher risk only
for the oldest ages (Koenig et al., 1988).

Birth Intervals
12. Almost nothing is known about the relationship
between short birth intervals and maternal mortal
ity. No studies specifically address this question
(Zimicki, 1989; National Academy of Sciences, 1989;
Winikoff,1987).

INTERVENTIONS
In developed countries maternal risks to women today
are only one to two percent of their levels 100 years ago
(Rochat, 1981). Moreover, between 1983 and 1988 mater
nal mortality ratios declined from about 420 to 380 deaths
per 100,000 live births in Asia, and from about 270 to 200
per 100,000 in Latin America. The improvements point
to the potential for gains in decreasing maternal mortality.
Among other measures, such as increasing the avail
ability of prenatal care and medical attendance at deliv
ery, increasing the use of contraceptives is an appealing
means of reducing the absolute numbers of maternal
deaths. By preventing pregnancies, contraceptive use

avoids both abortions and births and the associated risks
altogether (apart from contraceptive failure). Numbers
and rates of maternal deaths will fall at least in propor
tion to the reductions in pregnancies and births.5
13. Contraceptive use can reduce maternal mortality
very substantially by decreasing the aggregate
number of births and the number of births per
woman.
13.a. If women who say that they want no more chil
dren actually have no more children, the number of
births would decline by an average of 17 percent in
Africa, 33 percent in Asia, and 35 percent in Latin
America. The number of maternal deaths should fall
by at least as much (WFS data, reported in Royston
and Lopez, 1987).
13.b. In Matlab, Bangladesh maternal mortality rates
in two areas diverged significantly as contraceptive
prevalence increased sharply in one area but not in
the other. In the treatment area contraceptive preva
lence rose from 8 percent in 1975 to 44 percent in
1985. In the control area prevalence rose from 8 per
cent in 1975 to only 16 percent in 1984. Before 1978
maternal mortality rates in the two areas were simi
lar, but from 1978-85 the rate in the treatment area
was only 66 per 100,000 women, while that in the
control area was 121 per 100,000 women (a statisti
cally significant difference). The maternal mortality
ratios (deaths per 100,000 live births) were not sig
nificantly different in the two areas. Thus, contracep
tive use helped to reduce the number and rate of
women who died, even though it did not reduce the
risk of death per pregnancy.
13.c. The lifetime risk of maternal mortality decreases
when women have fewer children, even if the risk
per pregnancy is constant. Childbearing in Bali is
four times more risky than it is in Egypt; however,
Balinese fertility is much lower than Egyptian fertil
ity, so Balinese women are only 1.5 times more likely
to die from maternity-related causes than are their
Egyptian counterparts (Fortney, 1988).
14. Use of contraceptives, by preventing unwanted
pregnancies, can lower the number of unsafe abor
tions.
14.a. Unwanted pregnancies end in abortion more
often than do wanted pregnancies. Prevention of un
wanted pregnancies through the use of contracep
tives can reduce mortality from complications of
abortions, particularly if abortions are unsafe or ille
gal. Contraceptive use by Chilean women increased
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from 3 percent in 1964 to 23 percent in 1978. During
the same period the number of women hospitalized
for complications of abortion decreased by 33 per
cent, and the number of deaths from abortion plum
meted (Rinehart et al., 1984; Maine, no date).
14.b. Unwanted pregnancies and abortions often oc
cur to high-risk women (Rinehart et al., 1984). In
South Africa 46 percent of women dying from com
plications of abortion were of parity five or higher,
and 60 percent were unmarried (Barford and Parkes,
1977).
15. Use of contraceptives can change the distribution
of pregnancies and births so that proportionately
fewer occur to very young women, older women,
and women of high parity. Most pregnancies and
births, however, do not fall into high-risk catego
ries, so the effect of a distributional change on the
overall maternal mortality ratio is attenuated.
15.a. Most births and deaths occur to women in
"safe" categories of age and parity, which limits the
extent to which the maternal mortality ratio will fall
through changes in the distribution of births by age
and parity. A strategy that focuses only on high-risk
women will ignore one-half to two-thirds of the
women who will die (Winikoff, 1987).
IS.b. Strategies to prevent maternal deaths by focus
ing on high-risk groups are further limited, since
some members of those groups actively want more
children or will not use contraceptives. A more fea
sible and effective strategy is to focus broadly on
couples who want no more children (soon or ever),
since those numbers are large. Unwanted pregnan
cies lead disproportionately to unsafe abortions, and
in any case unwanted births fall heavily in the up
per age and higher parity groups (Maine, 1988; Rooks
and Winikoff, 1990).
15.c. Achieving large reductions in maternal mortal
ity by focusing only on high-risk groups may require
preventing a large proportion of all births. For ex
ample, in Bangladesh in the 1960s, eliminating births
to women under age 20 or above parity four would
have lowered maternal mortality by 58 percent but
would have required preventing 43 percent of all
births (Winikoff and Sullivan, 1987).
15.d. Additionally, the potential for lowering the
maternal mortality ratio by eliminating high-parity
births is reduced by the rise in the proportion of first
births as the other births are prevented (Winikoff,
1987; Blacker, 1987); this is especially true if the safer,
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middle-parity births also decline.
15.e. In Matlab Bangladesh, maternal mortality ra
tios were not reduced significantly in an area in
which contraceptive prevalence rose to 44 percent,
in comparison with an area where contraceptive
prevalence remained below 20 percent. Maternal
mortality ratios did not change because many of the
shifts in the distribution of childbearing were among
groups with similar risks (ages 20-34, parities 1-6)
(Koenig et al., 1988).
16. Childbearing in the developing world is far more
dangerous than use of oral contraceptives, lUDs,
or condoms.
16.a. An unplanned, unwanted pregnancy is 20 times
riskier to the woman than use of any modern method
of contraception (Rosenfield, cited in Starrs, 1987).
16.b. In Menoufia, Egypt, calculations from birth and
death data, together with contraceptive use informa
tion, showed that one pregnancy and delivery was
48 times more risky than taking the pill for a year
(Fortneyetal.,1986).
16.c. The relative risks of contraceptive use versus
pregnancy and childbearing can be heavily influ
enced by other risk factors, as well as by context. In
England and Wales, for example, women over 40
who do not smoke have a lower risk of death from
use of oral contraceptives than from pregnancy or
childbirth. For women over 40 who do smoke, pill
use is riskier than pregnancy and childbearing (Jain,
1977). The relative risks may be different in coun
tries where medical services are underdeveloped
(that is, where mortality risks of pregnancy and
childbirth are high) (Segal, 1977).

Prenatal and Medical Care
17. Prenatal care helps reduce death rates.
17.a. Women who had never attended a prenatal care
clinic died at 2.6 to 22 times the rate of clinic attenders
in a number of studies reviewed by Zimicki (1989).
17.b. Though prenatal care provides an opportunity
to predict in advance which women will have com
plications, such screening, even when done correctly,
is often inaccurate (Winikoff et al., 1991). For ex
ample, in Zaire women who during screening were
identified as being at high risk for obstructed labor
were 9.2 times more likely to develop obstructed la
bor than were other women. However, they ac
counted for fewer than 33 percent of the women who

later developed obstructed labor, and for every
woman whose obstructed labor was correctly pre
dicted, nine were treated as high risk but had per
fectly normal deliveries (Maine et al., 1985).

ficult pregnancies or births. Unfortunately, staff of
these centers are often unable to provide first aid for
women who are hemorrhaging, in convulsions, or
at risk of developing infection (Maine et al., 1985).

17.c. Additionally, prenatal screening for maternal
risk factors is often not done correctly. In the Cote
d'lvoire 73 percent of complications that should have
been identified in prenatal visits (high blood pres
sure, anemia, narrow pelvis), were not (Maine et al.,
1985).

18.d. Many of the smaller hospitals to which women
are referred do not have the resources to maintain
sterile conditions, perform cesarean sections, and
provide blood transfusions, all of which are essen
tial in the treatment of obstetric complications
(Anon., 1987;Tazhib, 1983).

18. The existence of accessible medical facilities is criti
cal. Approximately 15-20 percent of women who
become pregnant develop serious complications
that are hard to predict or prevent. Consequently,
adequate and accessible medical care is essential
for lowering maternal mortality.

18.e. With training, nurses and paramedical work
ers may be able to perform cesarean sections, admin
ister prostagland ins, and do other procedures (Winikoff et al., 1991). In two hospitals in Zaire nurses
performed 326 cesarean sections and laparotomies
with only five deaths (White et al., 1987).

18.a. The difference in maternal mortality between
industrialized and least developed countries is of the
order of 100- to 200-fold. In comparison, the differ
ence in infant mortality between these two sets of
countries is from 10- to 20-fold. In the past many of
the improvements in infant and child mortality were
attributable to the direct and indirect effects of socioeconomic development in general. This pattern of
improvement in child survival has not been observed
with respect to maternal mortality. Improvements in
maternal health require functioning health systems,
not merely community-level activities. They require
skilled midwives, anesthesia, blood replacement,
health centers, and hospitals. Between 10-15 percent
of women require skilled assistance and facilities to
handle the complications that arise during pregnancy
and delivery. Without those skills and facilities, 10
percent of those women will die (Belsey, 1991).

18.f. Though many pregnant women rely solely on
traditional birth attendants, TBAs often neglect pre
natal care and hygiene. Training high proportions
of active TBAs is difficult and expensive, and evi
dence on the success of such programs is mixed
(Maine et al., 1985; Lettenmaier et al., 1988).

18.b. Incorrect or delayed treatment was an element
in 11-47 percent of maternal deaths in studies in Co
lombia, Tanzania, Vietnam, and India. In Africa only
about one-tenth of the women who need cesarean
sections receive them (Maine et al., 1985). Of preg
nant women in Addis Ababa who sought treatment
for viral hepatitis, the majority were in or very near
a coma by the time they arrived at the hospital
(Kwast and Stevens, 1987). In the teaching hospital
in Zaria, Nigeria, the family must buy drugs and su
tures before a woman can be treated for obstructed
labor. The waiting time between admission and sur
gery has increased from 3.5 to 7 hours in the last six
years (Maine, no date).
18.c. Rural health centers are usually the closest
source of modern care for women experiencing dif

NOTES
1.

1983 estimates of ratios were developed for each subregion from
local studies and other available information (Royston and
Armstrong, 1989, pp. 30-35). UN estimates for the number of births
in each region were then applied to obtain each subregion's num
ber of maternal deaths. This analysis was updated for 1988.

2.

In an ectopic pregnancy the fertilized egg implants in the wall of
the fallopian rube

3.

Hemorrhage can occur before or after birth and is often fatal un
less treated by transfusion (Winikoff et al., 1991). Eclampsia is a
condition of extremely high blood pressure, causing convulsions
and, if untreated, stroke or heart failure. Obstructed labor causes
several conditions—ruptured uterus, infection, exhaustion—any
of which may be fatal. Infection can occur from nonsterile deliver
ies, premature rupture of the membranes, or long periods of ob
structed labor. Fatal complications of abortion include infection
and hemorrhage (Lettenmeier et al., 1988; Maine et al., 1985).

4.

Evidence is limited because absolute numbers of deaths are usu
ally small in any one study, and sample sizes are often too limited
for detailed breakdowns by age and parity.

5.

Numbers and rates of maternal deaths may fall by a proportion
even greater than the reduction in pregnancies. The pregnancies
that contraception prevents will likely occur disproportionately to
women in high-risk groups, including women who opt for an un
safe abortion. Since these women have a higher risk of maternal
death than the average woman, preventing their births will have
a greater effect on maternal mortality than preventing births to
other women. Whether the maternal mortality ratio will fall dis
proportionately is a separate question (see item 15).
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Chapter 12

CONTRACEPTIVE USE AND HEALTH
ceptive did not change this result (Sattin et al., 1986).

Contraceptives, while removing risks that attend preg
nancy, also alter the user's risk of acquiring certain diseases
or conditions. Evidence on the size of the benefits and risks
associated with use of contraceptive methods comes pri
marily from the developed world. Effects for diseases preva
lent only in less developed countries (schistosomiasis or
malaria, for example) are not well-known.

2.c. A further analysis of the CASH data revealed an
increased risk of premenopausal breast cancer for
women who experienced menarche before age 13,
remained nulliparous, and had used OCs for eight
or more years (relative risk of 3.8, compared with
nonusers) (Stadel et al., 1988). Only a small number
of cases were analyzed, but the results add to evi
dence from other studies that some subgroups of OC
users may face higher risks of breast cancer than do
nonusers (Hoick, 1987; Anonymous, 1989).

ORAL CONTRACEPTIVES
Pelvic Inflammatory Disease and Reproductive
Tract Infections
1.

2.d. In developed countries current and recent users
(within the past year) of oral contraceptives have a
reduced risk of benign breast disease relative to
noncontraceptors (Lee et al., 1989).

Oral contraceptives reduce the risk of contracting
pelvic inflammatory disease (PID) for women who
have used them for at least one year.
l.a. Women who are currently using oral contracep
tives and have used them for at least one year have
a 40-50 percent lower risk of developing PID than
do users of no method (Lee et al., 1989; Family Health
International, 1986). In the United States in 1982 use
of oral contraceptives prevented approximately
50,000 episodes of PID (Winikoff, 1987). Oral contra
ceptives are most effective against the more serious
forms of PID and least effective against common re
productive tract infections, such as yeast infections
(Hatcher et al., 1988). Use of oral contraceptives may
increase the risk of vaginal candidiasis (Elias, 1991).

Endometrial and Ovarian Cancer
3.

3.a. In eight published case-control studies, users of
oral contraceptives have only 40-80 percent the risk
of developing ovarian cancer that nonusers have.
Protection appears to last for at least 10 years after
discontinuation. Some studies demonstrate increased
protection with duration of use (Hoick, 1987).
3.b. Women who use combined oral contraceptives—
each tablet contains a mix of estrogen and progestogen—have a 50 percent lower risk of endometrial
cancer than do nonusers, according to four case-con
trol studies carried out in the United States (Hoick,
1987). Additional studies carried out in other devel
oped countries agree (World Health Organization,
1986b). Estrogen-only pills, however, appear to in
crease the risk of endometrial cancer (Hoick, 1987).

Breast Cancer
2.

Most studies show no overall increase in the risk
of breast cancer for oral contraceptive (OC) users
relative to nonusers. A few studies indicate that
very specific subgroups of OC users experience in
creased risks. OC users face a reduced risk of be
nign breast disease.
2.a. A case-control study of Costa Rican women
found no elevated risk of breast cancer for OC users
compared with nonusers (Lee et al., 1987).
2.b. OC users in the United States face no increased
risk of breast cancer relative to nonusers, according
to an analysis of case-control data from the Cancer
and Steroid Hormone Study (CASH) of the Centers for
Disease Control. Consideration of type of oral contra
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Use of oral contraceptives significantly decreases
the risk of endometrial and ovarian cancer relative
to nonuse.

Cervical Cancer
4.

The relationship between cervical cancer and use
of hormonal contraceptives is difficult to analyze
because it is confounded by numbers of sexual
partners and frequency of Pap smears, which are
related both to use of hormonal contraceptives and

to risks of cervical cancer. The most careful stud
ies show slightly increased risks of cervical cancer
among users of hormonal contraceptives, but the
differences are not always significant.

OCs occur primarily to women over 35, women who
smoke, and those with a prior history of high blood
pressure, heart disease, or diabetes. Excess risk to
younger women, especially those who do not smoke,
is minimal (Hatcher et al., 1988).

4.a. A World Health Organization case-control study
that tried to control for numbers of sexual partners
gave a relative risk of cervical cancer of 1.2 for OC
users compared with nonusers (95 percent confi
dence interval of 1.0-1.4). These results are consis
tent with those of other well-designed studies, but
epidemiologists remain unsure if they have ad
equately controlled for various confounding factors
(Hoick, 1987).

6.b. Simulation studies provide information about
risks of death from cardiovascular disease for women
by age, smoking status, and OC use. Risks of death
are greatest for women aged 40-44 who smoke more
than 25 cigarettes per day and use the pill (208 deaths
per 100,000 women). Fewer than 20 deaths occur per
100,000 women who are under 40 years old and
smoke fewer than 25 cigarettes per day, even when
they use the pill. Among women aged 20-44 who
smoke more than 25 cigarettes per day, risks of death
are eight to nine times higher for OC users than for
nonusers. Among women aged 25-44 who use OCs,
risks of death are 20 to 25 times higher for heavy
smokers (25 or more cigarettes per day) than for nonsmokers (Kost et al., 1991).

4.b. A case-control study of Costa Rican women
found that OC users had no increased risk of devel
oping invasive cervical cancer, relative to nonusers.
For carcinoma in situ, however, risks for recent OC
users were 1.6 relative to nonusers (95 percent con
fidence interval of 1.2-2.2) (Irwin et al., 1988).

6.c. In the United States women who take OCs for five
years in their 30s lose 18 days of life expectancy, on
average. Women over 45 lose an average of 80 days.
Decreased life expectancy results from increased car
diovascular mortality (Fortney et al., 1986).

Liver Cancer
5.

Use of oral contraceptives significantly increases the
risk of liver cancer, but liver cancer is so rare in most
countries that the increase has little impact in terms
of actual numbers of women with the disease.
5.a. A case-control study of women in the United
Kingdom estimated the relative risk of liver cancer
among OC users as 3.8 (95 percent confidence inter
val of 1.0 to 14.6). Use of the pill for eight years or
more was associated with a 20 fold increase of death
from liver cancer, compared with controls (Forman
et al., 1986). These excess risks have little impact on
the numbers of women with liver cancer, because the
baseline risk of the disease is very low.

6.d. In the developing world many users of oral con
traceptives are younger women trying to space their
children. These are not the women for whom OC use
raises the risk of heart disease (Gathinji, 1984).

Anemia and Glucose Tolerance
7.

7.a. Oral contraceptives help prevent anemia because
they reduce the amount of blood lost through men
struation (Lee et al., 1989; Hatcher et al., 1988;
Winikoff, 1987).

5.b. As yet no evidence on risks of liver cancer asso
ciated with use of oral contraceptives is available
from the developing world (Hoick, 1987). In coun
tries where hepatitis B infection is common, use of
oral contraceptives may increase the risk of liver can
cer (Lee et al., 1989); the issue needs considerably
more study. In some parts of the developing world
the prevalence of hepatitis B virus may be 80 per
cent or more (Hatcher et al., 1988).

Cardiovascular Disease
6.

Heart attacks and strokes occur more frequently
among certain subgroups of OC users than among
other OC users or nonusers.
6.a. Cardiovascular problems associated with use of

Oral contraceptives lower the risk of anemia.

7.b. Substantial evidence shows that use of combined
oral contraceptives (even low-dose OCs) is associ
ated with decreases in glucose tolerance (WHO Task
Force on Oral Contraceptives, unpublished data cited
in World Health Organization, 1986b).

INJECTABLE CONTRACEPTIVES (DMPA)
Breast Cancer
8.

There is little evidence to suggest a link between
injectable contraception and breast cancer.
8.a. World Health Organization studies of women
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in Kenya, Mexico, and Thailand, found no increased
risk of breast cancer for women using injectable con
traceptives (DMPA). The relative risk for DMPA us
ers was 1.0 (95 percent confidence interval of 0.7 to
1.5). Risks did not change with increased duration
of use (World Health Organization, 1986a).
8.b. A much smaller analysis in Costa Rica found that
DMPA users had a relative risk of breast cancer of
2.6 compared with nonusers (95 percent confidence
interval of 1.4 to 4.7). An elevated risk existed even
for women who had used DMPA for less than one
year. Because of the small number of cases and the
lack of a dose-response relationship, the authors of
this study warn that their results are inconclusive
(Lee etal., 1987).

Endometrial and Ovarian Cancer
9.

Use of injectable contraceptives appears to reduce
the risk of ovarian and endometrial cancer, but re
sults are tentative because adequate data are scarce.
9.a. The relative risk of endometrial cancer among
users of DMPA, compared to controls, is estimated
at .3 (95 percent confidence interval of 0.04 to 2.4) by
the World Health Organization, using data from
Kenya, Mexico, and Thailand. This estimate is ten
tative because very few cases were available for
analysis. Nevertheless, the estimate, along with in
direct evidence from endometrial biopsy studies and
other sources, suggests that DMPA use is negatively
associated with the risk of endometrial cancer (World
Health Organization, 1986b; Hoick, 1987).
9.b. The World Health Organization estimates the
relative risk of ovarian cancer for DMPA users as 0.7,
compared to nonusers (95 percent confidence inter
vals of 0.3 to 1.7). Again, the figure is tentative, but
it suggests a negative relationship between DMPA
use and risk of ovarian cancer (World Health Orga
nization, 1986b).

Cervical Cancer
10. DMPA use appears to have no effect on risks of
cervical cancer.
10.a. DMPA use does not appear to significantly raise
the risk of cervical cancer, according to data collected
by the World Health Organization in three develop
ing countries. The estimated relative risk was 1.2 (con
fidence interval of 0.9 to 15) for DMPA users as op
posed to nonusers (World Health Organization, 1986b).
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Liver Cancer
11. DMPA use does not appear to increase the risk of
liver cancer.
ll.a. A World Health Organization analysis of data
from Kenya, Mexico, and Thailand revealed no evi
dence of altered risk of liver cancer among users of
DMPA (World Health Organization, 1986b).

Blood Composition
12. Use of DMPA positively affects iron levels, while
it has no effect on several other aspects of blood
composition.
12.a. Undernourished lactating women in Hyder
abad, India showed a significant increase in their se
rum iron level after use of DMPA for one year (World
Health Organization, 1986b).
12.b. Undernourished lactating women in the cities
of Bombay and Hyderabad (India) and Chiang Mai
(Thailand) experienced no change in liver function
or in levels of serum protein, albumin, hemoglobin,
or triglycerides after one year of DMPA use (data
are from a longitudinal analysis conducted in fam
ily planning clinics in these cities by the World
Health Organization, 1986b.)
12.c. DMPA users in the WHO study experienced no
change in glucose tolerance and, in Bombay and
Chiang Mai, a decrease in serum cholesterol levels
(World Health Organization, 1986b).

NORPLANT®
Hemoglobin
13. Use of NORPLANT* may increase blood levels of
hemoglobin.
13. a. Preliminary evidence from trials of NOR
PLANT* implants in six countries show that hemo
globin levels of continuing users rise slightly, despite
intermittent bleeding and spotting (Sivin, 1988).

Procedural Complications of Insertion
14. The medical procedure for inserting NORPLANT®
is simple but carries some risk.
14.a. NORPLANT* implantation carries slight risks
of infection, expulsion, or local reaction. A shady of

2,674 NORPLANT® acceptors in seven countries
found one-year incidence rates of 0.8 percent for in
fection, 0.4 percent for expulsion, and 4.7 percent for
a local reaction (pain or itching). Only three women
expelled a capsule without prior evidence of infec
tion, while 40 percent of the infections resulted in
an expulsion. One-third of the infections and twothirds of the expulsions occurred more than one
month after implantation of the capsules, indicating
that a follow-up period of several months may be
necessary (Klavon and Grubb, 1989).

Ectopic Pregnancy
15. NORPLANT® is associated with a decreased risk
of ectopic pregnancy.
15.a. In Population Council studies submitted to the
Federal Drug Administration, the ectopic pregnancy
rate among NORPLANT® users was 1.3 per 1,000
woman-years, and this rate is used in the United
States in NORPLANT® labelling. Ectopic pregnancy
rates are expected to diminish as the proportion of
acceptors using improved implant technology in
creases (Sivin, personal communication, 1993).
15.b. Multi-country trials sponsored by the Popula
tion Council's International Committee for Contra
ception Research yielded an ectopic pregnancy rate
among NORPLANT* users of .28 per 1,000 womanyears. This figure is influenced by data from China,
where the ectopic pregnancy rate was only .1 per
1,000 woman-years (Sivin, 1988).
15.c. When NORPLANT® fails, the risk of ectopic preg
nancy is increased. However, since NORPLANT* fails
less than 1 percent of the time, the absolute risk of ec
topic pregnancy is less with NORPLANT® than for
women using lUDs or not contracepting at all.

INTRATJTERINE DEVICES
Reproductive Tract Infection and Pelvic Inflamma
tory Disease
16. Use of an IUD alters a woman's risk of contract
ing a reproductive tract infection that could then
lead to pelvic inflammatory disease (PID) or other
serious outcomes (cervical cancer, systemic infec
tion, increased risk of ectopic pregnancy, or HIV
infection).
16.a. Several studies and secondary analyses indicate
that the risk of pelvic infection occurs primarily in

the first four months after insertion (because of in
fection of the endometrial cavity at the time of in
sertion) and to women exposed to sexually transmit
ted diseases (Elias, 1991; Potts et al., 1991; Mishell,
1975; Treiman and Liskin, 1988). The risk of PID for
women who are in a mutually monogamous sexual
relationship is probably not increased by IUD use
(Lee et al., 1989). Though these findings are encour
aging, the difficulties of providing safe IUD inser
tions in resource-poor settings (where it may be hard
to identify women with or exposed to sexually trans
mitted diseases) should not be ignored (Winikoff et
al., 1993).
16.b. In Matlab, Bangladesh 68 percent of 472 symp
tomatic women were confirmed to have vaginal, cer
vical, or pelvic infection. Twenty-two percent of us
ers of lUDs (and 24 percent of tubectomy users) were
infected. Women using these methods were seven
times more likely to be infected than were women
who were not contracepting (Wasserheit et al., 1989).

Anemia and Blood Loss
17. lUDs alter various indicators of nutritional status
and metabolic functions.
17.a. Nonhormonal lUDs increase the amount of
blood lost during menstruation, because blood flow
is heavier and bleeding lasts longer. Increased blood
loss and lowered hemoglobin levels are most likely
to occur during the first two years of use, after which
they return to original levels (Andrade et al., 1988; Sivin
et al., 1991). Greater loss of blood heightens the risk of
anemia, which is a problem in developing countries,
where anemia is already prevalent (Hatcher et al., 1988).

Insertion Procedure
18. One major risk associated with IUD insertion is
perforation of the uterus.
18.a. Perforation of the uterus probably occurs in
about one of 2,500 IUD insertions, though the exact
frequency is unknown and some perforations are
probably undetected. Risk of perforation increases
if insertion occurs within two months of childbirth
(Hatcher etal., 1988).

Tubal Infertility and Spontaneous Abortion
19. Use of lUDs is associated indirectly with height
ened risk of tubal infertility. For pregnant women
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who do not remove the IUD, there is a risk of spon
taneous abortion.
19.a. Because IUD use increases the risk of developing
FID for some women, lUDs are indirectly associated
with increased risk of tubal infertility (Lee et ah, 1989).
19.b. The annual failure rate of lUDs is only 1 per
cent or 2 percent, but if a woman does become preg
nant and her IUD is left in, the chance of a spontane
ous abortion is 50 percent. Early removal of the IUD
reduces the chance to 25 percent (Lee et al., 1989).

Ectopic Pregnancy
20. lUDs are associated with a decreased risk of ectopic
pregnancy.
20.a. Most lUDs protect against ectopic pregnancies.
Users of lUDs with 200 mm2 of copper had an ec
topic pregnancy rate four-tenths that of noncontraceptors in the United States during 1970-78. For
users of lUDs with 350mm2 of copper or lUDs releas
ing 20mcg/day levonorgestrel, the ectopic pregnancy
rate was one-tenth that of noncontraceptors. However,
users of progesterone-releasing lUDs had ectopic preg
nancy rates that were 50-80 percent above those of US
noncontraceptors (1970-78) (Sivin, 1991).
In general, the IUD prevents more intrauterine
pregnancies than ectopic pregnancies, so the ratio of
ectopic to intrauterine pregnancies is greater among
IUD users than among users of other methods
(Hatcher etal., 1988).

21.b. Serious complications from sterilization occur
in only about 2 percent of the cases and include
perforation of blood vessels or injury to the gas
trointestinal tract and bowel injury. Risks of serious
complications are doubled by obesity, lung disease,
diabetes, or a history of FID (Lee et al., 1989).
21.c. Death resulting from sterilization procedures
occurs very infrequently. Death-to-case rates for
tubectomy were 19.3 per 100,000 operations in
Bangladesh, according to a retrospective study of
sterilizations taking place in 1979 and 1980. The most
common causes of death were complications of an
esthesia, tetanus, and hemorrhage. Though the ster
ilization procedure may carry some risk, of 100,000
operations performed, an estimated 1,015 women are
saved from dying in pregnancy and childbirth at
some time during the remainder of their reproduc
tive span (Grimes et al., 1982).

Ectopic Pregnancy
22. Female sterilization so rarely fails that the associ
ated risk of ectopic pregnancy is extremely low.
22.a. When sterilization fails, the risk of ectopic preg
nancy is increased. However, since sterilization fails
less than 1 percent of the time, the absolute risk of
ectopic pregnancy is less for sterilized women than
for women using lUDs or not contracepring at all
(Lee et al., 1989; Hatcher et al., 1988).

MALE STERILIZATION

FEMALE STERILIZATION

Procedural Complications

Procedural Complications

23. As a minor surgical procedure, vasectomy produces
few complications.

21. Surgical procedures carry risks of complications.
Most complications of female sterilization are not
serious, but occasionally there are grave outcomes.
21.a. Minor complications associated with steriliza
tion include light hemorrhage, infection, and uter
ine perforation. A multinational study conducted by
the World Health Organization reported that minor
complications occur in 6-11 percent of sterilization
procedures (Lee et al., 1989). A study in Matlab,
Bangladesh indicated that among women showing
symptoms of infection, those who had received a
tubectomy were considerably more likely than
noncontraceptors to be confirmed as infected (see
16.b.) (Wasserheit et al., 1989).
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23.a. Any complications usually subside within one
or two weeks. Hematomas (a collection of blood un
der the skin) usually occur in less than 1 percent of
cases, and infection in less than 2 percent of cases,
though the proportion is higher when surgical rou
tines are careless or where excessive physical activ
ity following the procedure encourages hematomas.
Together, infection and hematomas occur in fewer
than 3 percent of cases (Liskin et al., 1983).
23.b. No-scalpel vasectomy (NSV) has even fewer
side effects than does conventional vasectomy. (In
stead of an incision to enter the scrotum, with NSV
a tiny puncture is made in the scrotal skin and wid-

ened enough to draw out the vas, which is then
blocked by one of the usual methods.) Over 9 mil
lion NSVs have been performed in China, and the
procedure is being performed increasingly in other
countries including the US. Numerous studies report
fewer complications for NSV than for conventional
vasectomy, and a five-country randomized clinical
trial (preliminary results) of almost 1,000 men shows
significantly fewer complications and complaints
with NSV than with the traditional procedure (Fam
ily Health International, 1991, cited in Liskin et al.,
1992).
23.c. Long-term safety after vasectomy is excellent.
Over 15 major studies show that vasectomized men
are not at greater risk of any clinical diseases than
are other men (Liskin et al., 1992). In the largest study
done so far, 22,000 vasectomized men had similar or
lower rates of 98 diseases than did controls (Massey
et al., 1984). Only genitourinary tract infections or
inflammations (up to two years after vasectomy)
showed elevated rates, and these are minor and eas
ily treated. A few studies linking vasectomy to pros
tate or testicular cancer are contradicted by other,
more carefully designed studies; a review of avail
able evidence by experts convened by the World
Health Organization found no causal connection be
tween vasectomy and cancer (Liskin et al., 1992).

CONDOMS AND SPERMICIDES
HlVInfection
24. Use of condoms and spermicides can lessen the risk
of HIV infection. Use of these methods is the only
recourse for protection apart from abstinence, mu
tual monogamy, or restraint in sexual activity
(avoiding direct contact with the genital area and
body fluids).

24.a. In a study of 546 prostitutes in the United States,
1 1 percent of the 524 prostitutes who reported hav
ing unprotected vaginal intercourse were HIV posi
tive. None of the 22 prostitutes whose clients had
used condoms in every episode of vaginal inter
course was HIV positive (Centers for Disease Con
trol, 1987).
24.b. In a study in Zaire, 34 percent of the 77 prosti
tutes who reported that under half of their clients
used condoms were HIV positive, while none of the
8 prostitutes who reported that over half of their cli
ents used condoms was infected (Mann et al., 1987).

24.c. Among married couples in the US in which one
partner had AIDS, the relative risk of the other part
ner testing HIV positive was 0.1 to 0.2 for couples
who used condoms, compared with couples who did
not (couples were followed for 12-36 months).
Among couples using condoms, 17 percent of the
uninfected partners eventually tested positive for
HIV, while 82 percent of the nonusers did so (Fischl
etal.,1987).
24.d. Several laboratory studies have demonstrated
that HIV cannot pass through latex and synthetic
skin condoms (Feldblum and Fortney, 1988), but it
does appear to pass through some natural skin
condoms (Centers for Disease Control, 1988).
24.e. Additionally, nonoxynol-9, the active ingredi
ent used in many commercial spermicides and in
contraceptive sponges, inactivates HIV (Feldblum
and Fortney, 1988), although it is not clear that use
of spermicides in the anal canal can prevent trans
mission of HIV (Centers for Disease Control, 1988).
24.f. Condoms do not provide adequate protection
against infections spread from lesions rather than flu
ids, since condoms do not cover all the skin areas
that might be infectious or infectable (Centers for Dis
ease Control, 1988).

Reproductive Tract Infections and Pelvic Inflamma
tory Disease
25. Use of condoms and spermicides lowers the risk of
reproductive tract infections that can lead to pelvic
inflammatory disease (PID) or other serious out
comes (cervical cancer, systemic infection, increased
risk of ectopic pregnancy, or HIV infection).

25.a. Barrier methods of contraception, especially
when used with spermicides, can protect women
from a variety of sexually transmitted diseases that
may lead to reproductive tract infections and PID
(Kols et al., 1982; Winikoff, 1987).
25.b. Laboratory studies indicate that latex condoms
are impermeable to the herpes simplex virus, cytomegalovirus, hepatitis B, Chlamydia Irachomatis (re
sponsible for yeast infection), and Ndsseria gonor
rhoea. Both cross-sectional and case-control studies
reveal lower frequencies of gonorrhea, ureaplasma
infection, pelvic inflammatory disease, and cervical
cancer among condom users than among nonusers
(Centers for Disease Control, 1988).
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